var title_f9_50_10016="Contents: Valvular and aortic disease";
var content_f9_50_10016=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?5/3/5182\">",
"       Cardiovascular Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Valvular and aortic disease",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Valvular and aortic disease",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Aorta",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/16/37126\">",
"           Aortic intramural hematoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/11/22712\">",
"           Clinical features and diagnosis of thoracic aortic aneurysm",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/19/25914\">",
"           Clinical manifestations and diagnosis of aortic dissection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/53/23385\">",
"           Clinical manifestations and diagnosis of coarctation of the aorta",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/35/10809\">",
"           Embolism from aortic plaque: Thromboembolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/15/31994\">",
"           Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/3/20538\">",
"           Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/7/10361\">",
"           Management and outcome of thoracic aortic aneurysm",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/51/5945\">",
"           Management of Marfan syndrome and related disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/54/25449\">",
"           Management of aortic dissection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/27/20922\">",
"           Management of coarctation of the aorta",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/50/20262\">",
"           Pregnancy and Marfan syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/23/37240\">",
"           Thoracic endovascular aneurysm repair",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/8/31878\">",
"           Transesophageal echocardiography in traumatic rupture of the aortic isthmus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Aortic valve",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/35/20022\">",
"           Acute aortic regurgitation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/11/1208\">",
"           Aortic valve area in aortic stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/24/38279\">",
"           Aortic valve sclerosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/12/21706\">",
"           Clinical features and evaluation of aortic stenosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/1/6169\">",
"           Clinical manifestations and diagnosis of bicuspid aortic valve",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/29/25050\">",
"           Course and management of chronic aortic regurgitation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/8/31881\">",
"           Indications for valve replacement in aortic stenosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/14/35047\">",
"           Low gradient aortic stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/62/2025\">",
"           Medical management of asymptomatic aortic stenosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/43/41654\">",
"           Medical management of symptomatic aortic stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/38/30310\">",
"           Minimally invasive aortic and mitral valve surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/53/30551\">",
"           Natural history of aortic stenosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/14/13544\">",
"           Noncardiac surgery in patients with aortic stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/11/13495\">",
"           Noncardiac surgery in patients with mitral or aortic regurgitation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/9/38039\">",
"           Pathophysiology, clinical features, and evaluation of chronic aortic regurgitation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/31/39411\">",
"           Percutaneous aortic valvotomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/25/27032\">",
"           Pregnancy in women with a bicuspid aortic valve",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/37/11865\">",
"           Surgical valve replacement in aortic stenosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/29/34264\">",
"           Transcatheter aortic valve replacement",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/39/35445\">",
"           Transesophageal echocardiography in the evaluation of aortic valve disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/58/7078\">",
"           Treatment of bicuspid aortic valve stenosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/36/34377\">",
"           Valvular heart disease in elderly adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/59/954\">",
"           Valvular heart disease in patients with end-stage renal disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/14/14567\">",
"           Vasodilator therapy in severe chronic aortic regurgitation in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infective endocarditis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/36/585\">",
"           Antimicrobial prophylaxis for bacterial endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/37/20058\">",
"           Antimicrobial therapy of native valve endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/57/34712\">",
"           Antimicrobial therapy of prosthetic valve endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/39/40566\">",
"           Candida endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/52/18249\">",
"           Complications and outcome of infective endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/24/41352\">",
"           Diagnostic approach to infective endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/40/2697\">",
"           Epidemiology, clinical manifestations, and diagnosis of prosthetic valve endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/31/14840\">",
"           Epidemiology, risk factors and microbiology of infective endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/19/44345\">",
"           Infections involving cardiac implantable electronic devices",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/17/40215\">",
"           Infective endocarditis in injection drug users",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/23/31094\">",
"           Infective endocarditis: Historical and Duke criteria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/19/17718\">",
"           Pathogenesis of vegetation formation in infective endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/27/14775\">",
"           Pseudomonas aeruginosa bacteremia and endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/57/15255\">",
"           Q fever endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/27/5556\">",
"           Renal disease in the setting of infective endocarditis or an infected ventriculoatrial shunt",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/8/20617\">",
"           Role of echocardiography in infective endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/49/22297\">",
"           Surgery for native valve endocarditis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Miscellaneous",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/3/34874\">",
"           Clinical utility of cardiovascular magnetic resonance imaging",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/4/33866\">",
"           Drug therapy of obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/5/7252\">",
"           Estimating the mortality risk of valvular surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/41/3737\">",
"           Hemodynamics of valvular disorders as measured by cardiac catheterization",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/56/29573\">",
"           Natriuretic peptide measurement in non-heart failure settings",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/59/22456\">",
"           Non-coronary cardiac manifestations of systemic lupus erythematosus in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/36/34377\">",
"           Valvular heart disease in elderly adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/31/1528\">",
"           Valvular heart disease induced by drugs",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Mitral valve",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/19/17719\">",
"           Arrhythmic complications of mitral valve prolapse",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/24/13705\">",
"           Definition and diagnosis of mitral valve prolapse",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/30/9705\">",
"           Etiology, clinical features, and evaluation of chronic mitral regurgitation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/36/9799\">",
"           Functional mitral regurgitation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/32/25096\">",
"           Indications for corrective surgery in severe chronic primary mitral regurgitation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/55/18297\">",
"           Ischemic mitral regurgitation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/20/37187\">",
"           Left ventricular afterload in chronic mitral regurgitation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/37/4697\">",
"           Medical management and indications for intervention in mitral stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/38/30310\">",
"           Minimally invasive aortic and mitral valve surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/58/37801\">",
"           Mitral annular calcification",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/25/3476\">",
"           Mitral valve prolapse syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/31/6649\">",
"           Natural history of chronic mitral regurgitation in mitral valve prolapse and flail mitral leaflet",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/29/18901\">",
"           Natural history of mitral stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/37/2648\">",
"           Nonarrhythmic complications of mitral valve prolapse",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/51/33593\">",
"           Overview of the management of chronic mitral regurgitation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/2/36901\">",
"           Pathophysiology and stages of chronic mitral regurgitation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/18/13610\">",
"           Pathophysiology, clinical features, and evaluation of mitral stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/45/28376\">",
"           Pathophysiology, clinical features, evaluation, and management of acute mitral regurgitation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/45/33497\">",
"           Percutaneous mitral balloon valvotomy for mitral stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/48/29447\">",
"           Pregnancy in women with mitral stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/4/17480\">",
"           Surgical management of mitral stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/53/36697\">",
"           Surgical procedures for severe chronic mitral regurgitation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/36/34377\">",
"           Valvular heart disease in elderly adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/59/954\">",
"           Valvular heart disease in patients with end-stage renal disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/27/29109\">",
"           Vasodilator therapy in chronic mitral regurgitation",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Noncardiac surgery",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/14/13544\">",
"           Noncardiac surgery in patients with aortic stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/11/13495\">",
"           Noncardiac surgery in patients with mitral or aortic regurgitation",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pregnancy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/26/29097\">",
"           Acquired heart disease and pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/53/1882\">",
"           Management of pregnant women with prosthetic heart valves",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/7/29818\">",
"           Pregnancy in women with congenital heart disease: General principles",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/21/35159\">",
"           Pregnancy in women with congenital heart disease: Specific lesions",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Prosthetic valves",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/57/34712\">",
"           Antimicrobial therapy of prosthetic valve endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/11/18618\">",
"           Antithrombotic therapy in patients with prosthetic heart valves",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/57/25497\">",
"           Complications of prosthetic heart valves",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/18/6438\">",
"           Echocardiographic evaluation of prosthetic heart valves",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/56/15238\">",
"           Management of patients with prosthetic heart valves",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/53/1882\">",
"           Management of pregnant women with prosthetic heart valves",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pulmonic valve",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/62/39910\">",
"           Clinical manifestations and diagnosis of pulmonic stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/27/12727\">",
"           Natural history and treatment of pulmonic stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/61/10198\">",
"           Percutaneous pulmonic valve implantation",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Rheumatic fever and rheumatic heart disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/20/23879\">",
"           Clinical manifestations and diagnosis of acute rheumatic fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/8/8327\">",
"           Epidemiology and pathogenesis of acute rheumatic fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/17/14617\">",
"           Natural history, screening, and management of rheumatic heart disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/2/44070\">",
"           Treatment and prevention of acute rheumatic fever",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Tricuspid valve",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/11/12472\">",
"           Carcinoid heart disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/52/38729\">",
"           Ebstein's anomaly of the tricuspid valve",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/9/149\">",
"           Etiology, clinical features, and evaluation of tricuspid regurgitation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/48/30471\">",
"           Management and prognosis of tricuspid regurgitation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/27/5558\">",
"           Tricuspid stenosis: Clinical features, diagnosis, and percutaneous tricuspid balloon valvotomy",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-228F323D70-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f9_50_10016=[""].join("\n");
var outline_f9_50_10016=null;
var title_f9_50_10017="Mechanisms of reentry";
var content_f9_50_10017=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F52134&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F52134&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mechanisms of reentry in cardiac arrhythmias",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 217px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADZAYwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAK88+LfjbVvh7a22ujTo9T8PBlgvIogyT27M3EoblSuPl2kDkj5ua9Dr5Q/ar+Ltyt7c+CPDk6x26pt1O4jOWcnrCD2AGN2OuccYIIB6Pb/ALQ3hXVbS2XQSH1Oc82+pTLZRwAMATJK2V6EkBNxOOldxo8Pja7VZ9T1Pw/bxSOWENlaSTYjP3cStIATjHOzFfm3X1l4E+OmvJ4P0rTvDfw81XWYdOtIbN7qFnZS6RqDwsbY6Z696APcr2Dx1a3CyaffaBqNuJDut7m3ltnKeglVnGf+AU+08Zx20tta+KrGXQLydhFGbh1e3lkOflSUcE/LkBtpORxXlVj+0Y+m6nb2vj7wZq3h2GcDZcOGb+IAsUZFO0ZySNx9q9q0+80Xxl4bjubV7bVNGvo8gldySKeoIPQjoQeQaANgHI4orz/w09z4M8Sr4Yvpbq40O9OdFuZvn8lgrM9oz53HaqlkLD7uRkkCvQKACiiigAooooAKiu7mCztZrm7ljht4UMkksjBVRQMkknoAO9S1X1Ca2trG4mv5IorSONmmeUgIqAclieMYoAdZ3Vve2sVzZzxT20qh45YmDK6kZBBHBBFTV+fN98QrrwT441c/CzWr6Dw485a3gm+aIggbv3bgjGRgEjdtA5r2X4Hz3vxgg1G51vxb4ws9U05o/OFlqCQW8ofdt2oqDb9wgjn1zzQB9Q55x3orz3/hU2hF0lfUfEb3aIUW5bV5/MAOCed2Ow7dqzpvhz4l0YSXPg/x9rf2stvNvrbi9glA5EfIDRgngsMnFAHqdFeWaD8VTp+profxL04eGdXOViunfNjd7VBLRynhev3WPGQM5OK9RR0kGUZWB5yDmgB1FFFABRRRQAUUUUAFFFFABRRTJZoolJlkRAoySzAYFAD6Ko2esabesVs9QtJ2BIIimViPyNXVIYZUgj1FAC0UUUAFFFFAHNR+N9Ak8cyeEFvv+J/HB9oa32NgLgNjdjGcEHGeldLXhMXwk8Vx+IbLxUNb05vEKa3JqctsVPkCGT5GiWbZ5h/cqi4K4zn617heXUFlaTXV5NHBbQoZJJZGCqigZJJPQAUAef8Axd8Z674Agttfg0+11Pw1GRFfwqWS5hZmwsitkqV5A2kA5xzzxlaD8efCfiWOGDRLlI9VmUkW2qSC0VMOFw0hyCSDkBdxOO1eFfHv4+TeK4Lzw54UUwaGzbJ7s/6y7UHoB/ChP4kYzjkV8+pw659aAP0muNN8W37Q+Zr9jp1uWDSJZWW+UD+6skjFfx8v8qfc+FLu5dGl8Va8Cq7f3bwoCck5IWMc84/Cs/RvE13d6FpqeFtEn1CP7PGouZ5Ps1sPlH8TZdh6FVYH1p97/wALDuJy1ifC9hCFGEl8+5Ytjn5h5eBnI6f4UAa0eh6lBBtg8Sai7qBtM8cLjhs84QE5HHXp781Uvbjxdpcnni10/W7QIu6G1BtbgNuAYrvZkYYJOCy9MZ5qG31LxraIG1PQNLvUDYJ02/IkI9QkqKv/AI/VzS/Guj3uqjSbiV9O1koH+wXy+VKwO77mflk+62ShYDFAF7QvENhrO5LZ5IrqP/WWtxGYpo+AeUbBxyORke9a9Y/iXw/aa9aok7SwXUJL213A5SW3cqV3KR7HoeD0INZHh3xJeQ60fDniqOKDV9pe0uYwRDqEYHLJn7rj+KPJI6jIoA6+iiigCKe5gt9v2iaOLd03uFz+dSg5GR0rwn9pDQLrW/E/gdk0+9udPhj1JLqa30h9SEG+KMIWiUcksPlJxgjI+7XoPwWttRsvhZ4btdasH0+/gtRFJbOxZkCkhSc8glQDjtnHagDovE+qx6F4b1TVp0Z4rG1kuWVOrBFLYHvxX5jahdz399cXl3K81xcSNLJI5yzsxyST3OTX6L/GtnX4TeLDGSG/s6Ucem3n9K/OCgD2b4D/AAWb4l6fquo319LYWFsTbwPGgYyT7c85P3VypI75wCK+wPhNpN9oXw70PStWtktr6zg8iVEYMCVJAbI45AB/GuG/ZJvLS4+DllDa7RNbXM0dxgYO8tuBP/AWX8q9noAzfEOh6b4i0m40zWrOK8sbhSkkUgyD7g9QR2I5FeA+HNMu/gp8ZdK8P2moO/grxOX8qO5OfJuAMBVwc7smNd2ACHGclcj6Qrwv9pW+sLPxD8M/tLBLtNdjnWQ9EiVk3kntyU/KgD0j4oaM2teDrtbUAapZ4vtOkCqWS5i+eMruB6kYPsSK2vDOqprnh3S9ViRo0vraO5CN1UOobB/OiGfTNd0+C/s5bS/t1LPBcRMsihsMhKsO+Cy8epFUfh6iJ4D8PJEcxrp8AU+3ligDoKKKKACivHvGOtXuofFqXw1e+Kp/CukWulLfQyQPFE95KzkE+ZKpG1QPujrz+Hqujvv0ixf7YL/dAh+1qABP8o/eADj5uvHHNAFyvjb9qj4sS63q9z4P0K5/4k9qwW9dVIM06scrnPKKcdvvA9Rivaf2l/iL/wAIP4IktNPmC65qoaCDaxDwxkfPKMdCOgOepB7Gvg5VeaUKoZ5HbAA5LE0AT6dp93qU7w2MDzSJG8zKo6IilmY+wAJr6B/Ze8J+IL3U/Fmn23iO78PJaPDFfw2sMbyzN+9AAkOdm0g8jOc16F4K+FqeAfgV4outSgj/AOEjv9Kne5fO4wp5ZKxA9sdTjqe5AFe06F4b0zTta1LXbGIpe6vFALohsq/lKQjAdjhscegoA4x/hdq1oDNofxF8VwX38L30yXcX4xsoBp1xb/FXw9aW7Wd/oXi2OLLzrcW7WNzKM/cQqxjzjuQPxr0+kdlRSzsFUckk4AoA838M+PPC3xCt20HxBYx2es7VN1oWsQgSBsbvlVxhwMbgQM4wSBUemfCTwnbPfJpFlrOiYlx5lpqc0YlyoO9QJCMDOOQOQeMVmePNW+HnjS4XTW0dvGOpJsAGkxF3iDE4JuFKqi5HPzj6VyEXwj8YavJAbTULzwhpjI261fWZ76WNh90hVKqP++jQB32o/C29hdbvQ/G3i+K9iK+Uk+p+ZAOR8zIynfgZOD1xjjrVeXxV4r+Ht1Cnj8W+seG5HjhXX7KHyXgdjjNzFkhVJONy8DAzycVj33w38XeDNC/tfwl4313VdYsU82Sx1KQzW14q8tGsfJQkDg5J7ZGc13OkapZePPhrc6nFBNqljrFq5/s9ysZU7NjwBuP41b5iepODjFAHbRusiK8bBkYAqwOQR606vNvgPd3Q8JXeg6hI0tz4dv5tJ818BpI4yDG2B0GxlA/3a9JoAKK4Tx/4w1XQ/FfhXw/oWmWV7e699r2NeXLQRx+RGrnJVGPIJ7dQPw1Ph14ui8Z+H21BbSSxuYLiWzurV3D+TNGcMoYABh0IOB17UAdPWX4j1yy8P6Y97fsxAO2OGMbpJ3PRI16sx7CsP4n+KNX8H+HX1jSNAGtQ24aS7T7WIGhiVSS/KncBjkDmvjf4hfGu98Y3N9LPpMMfmqkdoHndzZIpVj5eNuHYg7m67eOB1APqCHW/FHiTVr6x1yaTwNYJdC1t1KRtPfeZG20RTsxTdn5iqqSMYz1rg/7CsbO00/RPEpE02oajc6Lfaxr9nMb+6c4EMlmcuEUbgAzED5Qaj8D/ABsvPG1rYW+reDdP1fU45mNmtvcRh/tSgshWJyzIAvJlJAGDjng4XxTl+Kng7w1Fputbr/wgSyXN1bzfabl4pHbMcs7plWAO0OEA5Uc9KAKHjLwdN4es4LuDRNGgj0jXYLRbp5PtU9/GgxAJI4zgbgSXXClht4yOayjxj4Q8SXkE3iuw8J3pe6v109HmuIWTazbkiVWjWIkHAYbwBnngV6f4A+FngnxN4Z0/WPCWua5DZPLHdCLzYn8ueMYXerIw3rnHv7g1x/j74U674C8LFtEtbLVtEglM+pXMBe21C4t/nMkMrbiDDt2g7cdAdvGaAOv+Gv7QCX8traeO7SHTWu18y11GDItpU3lNzBiWjG4bQx4PtXvwIYAggg8givzjufFjxWutwJYWu65mS2RppFuXtrRQwFvGXDfKPlw68gp7ivoj9k34hXl1bv4Q8RXOZIk3aYZ5F80ooBaLBO4gAhl46bhnC8AH0rRRRQAV8i/tffEiS71JfBOlSstrbFZdQdHI8yQjKxn1Cghj15I6ba+p/E+rxaB4b1TV50Z4rG2kuWRTywRS2B7nFfmbr2qXGt63qGqXhU3N7O9xLtGBudixwPqaAG6Lpl5rWrWemabCZ727lWGGMEDczHAGTwPqa+tl/Zm0y3+GFzaF/tPjIp56XgchBKBkQqCQNh+7uPPOeOAKH7Hfw8WGym8bapBG0k+6HTc4YooJWST2JI2jvgN2NfUFAGZ4YjuIvDelR3sBt7pLWJZYiQfLcIMrkZBwfStOiigAqhrej6frlhNZaraRXVtKpRkkGeCCOD1B5PI5q/RQBw0F5qfg7V7ew1SSS/8ADFwFit9RlbdNaS5CrFMf4lbPyydc8N1Brd1/w9HrkVxHdXU6qyKbYxhVe0lG797G2MhvmHUkcYxyc6Gs6db6vpN3p14u63uomicYB4Ix3rC8J6nqU1r/AGbeCKfVNNmFrfSPIELpsys6qoP3gVO3gZ3emKAL/hbVJb+1nt77Yup2Ept7pEORuABVxwOGUq3tnHatquXu4pNM8e218uXttWgFjIvyjy5IhJIjdcnKmQHGei11FABRRRQByXxdUN8LfFoYZH9l3B/8htX5tR43rnpkV+lHxY/5Jf4u/wCwTdf+imr81hxQB9SaZNe/Ar4hR6w8Rf4feJVSSSSCIOIXKFlUYxtKsxwOcoTjJHH0t4b8UaH4m09b3QdUtL63IBJikBKZGQGHVTg9Dg1keEbCx8S/C3w/b61awX9rdaZbNJHOgdWPlqc4PfPNeb+IP2b/AIfLNJem91PR7UlV8uO8URKxIUcyKxySQOvU0AeneO/H/hzwRpct5r2owxsELR2yMGmmI7ImcnnAz0GeSK+ZdQsNZ+JyeKvidr8Vxpul6faGPRoHAUSKM9zyQASSR1ZuD8uK9b8E/An4b6fdT3EO/X57Sfy3N5ciZYJFHKMiALnkEhge1Zv7UOtXNxotn4L8NRmbUbj/AE+7hiVdsVpCC+XJ+6CyqR67SO+CAe2yzeTFZxJbSyLOfLZowNsQ2M25ueBxjjPJFUvBMMNv4S0m3tm3QQW6RIc5yFGB/KrVlqNteve2cDs09ntjnBRgFZkDDBIweCOma5f4Jlh8M9HibI8nzYACc8JK6j+VAHc0UUUAZet+HtF10QjXNI07UhCcx/bLZJth9V3A4/CtKONIYkjiRUjQBVVRgKB0AHYU6qGv38el6FqN/N/qrW3kmbtwqkn+VAHwD+0F4ql8WfFTWbhnDWtnKbG1CkECOMkZBHUFtzf8Crvf2O/Btprvi/UNe1GNJo9HRPIjdcjznzh/T5Qp/Eg9q+fZG3SM3qSa+6f2RtJXTvg9bXSuWbUbqa5YH+HB8vH/AJDz+NAHpnjyxn1PwRr9jZhTc3NhPDEG6bmjIGfxpnw+vJNR8B+Hbyf/AF1xp9vI/wBTGpNb7rvRl9RivALv4qp8MPhi2l6gi3vibSbt9HhtWIj8xVGYpioOfL8oxnI6k44zmgD2nxT4j0nwto8+p67ew2lpEpO6RgC5AJ2qP4mOOAOTXill4l0D4k3Caj428XaXp/h/dvtvDYvo4zIoOUe6fdlmPB8scDC5ycisPwx8F/EfxJvv+Em+LmqXUaXCCS206B9rxAnO1gQRGuAPlHPzckEHPoF/+zr8OLmykgh0ee0lZcCeG7lLqfUBmK/mKAPVNLhsoLC3j0uO3jsljVYVtwAgQDgLjjGOmKtV8n3WleOP2dbl9S064/t/wTLMBLAxKmPIGCwwfLJJxuXIOBkcgV7J4I+LNprttpkmtaZNoyamD9ju2lWWznOSAgmGMSfKfkYKeCKAPTK85+FsGk3VvOkIRb3R9U1GOOKOUjykkupOqA4wdvGR/DxXowORkcivM/g68drF4o+0yxxNe+Jr9bZXIBkwxyF9fuucfWgBvw+huofjB8SDd7E88WEqRRuXVV8t1DZwOSEBI7H1616dXmnw5t7x/ib8Q76e5iubYyWVojoMESRwZkBHblx+Zr0ugDkfGnga18Vazoeqvquq6XqGj+f9ln094lI85VV8+Yjg/KuB06n2xqeEPDWneE9Ej0vSEkECu0rySuXkmkY5Z3Y/eYnvW1RQB4B+2P4ok0jwDZaNaXDxT6tcESKo+/BGMsM9vmMf1Ga+L7aCS5uIoIEaSaVgiIoyWYnAAHevoT9te8mk8f6NZMx8iHTRKq+jPI4J/wDHFrz79nXToNU+M/hiC6GY0nacDP8AFGjOv6qKAPob9m/wD4m+Gvi3W9L12wilstQtY54tRtnLxb4zjy+QCCfNPUD7pxmvoSRFkRkkUMjDBVhkEVwHj74q6H4TvhpMCXOs+I3GItK09DLMTjI3Y+6Oh55wcgGsTRvE3xXn8XwrqPgrT4NBuERmT7cpktMnBLSDhz8pO0L0ZRkUAU/hBaaV4R+Jnjjw1p2r2jWVzNDe2Ngk6kxMwkEyBR0KlQMdlC5617QRkYPSuIm8NaH4Q1zxX4/MNzPf3NoJLhVCsUjiTlYhgcttBOTyQOlL4M+KHhHxfp8l3pWsW6CJtskdywhkU4BztY5xz16cGgD55/a9+G0Gl3cHjHRbZYre7k8rUI41wBKeVkwOm7BB98dzXz54d1y+0LXtM1aymYXNhKssJYkgYbO36HJyPc19fftIfEvwXffDnVfD9rrcF/qF6iGJLBhMFKyBgWYfKBleRnPPSviygD9SdIv4NV0mz1C0cPbXcKTxsO6soIP5Grdebfs5X0+o/BfwzNdMWkWF4QT/AHY5GRR+SivSaAPLf2nLhrf4JeIjHIY3cQxgg9QZkBH4jNfn8oLMFHUnFffH7VMHnfBPWn3Y8mSCT6/vVH9a+CYm2SK390g0Afpj8PdI/sHwNoOllUV7WyhifYMAuEG449zk10FZnhjUY9Y8N6VqUGfKvLWKdMjBwyAj+dadABRRRQAUUUUAFcRqIvdJ+JRvbK2a8g1HSwktvEFV98MyhWDMQMbbh8gn+Hiu3rl9V1KGHxtawRBrm9h0q5uPssRHmMu+IDGcLyVIGSOn1wAZXxM0+2T+z/EMt3cLLYXloiR+c3kpuuY1Z9g/j2sy59GIrva4H4gW+npok+kWVobWW7vbS5kaO1Kxsz3cYLFwApcnqM7u9d8OBQAUUUUAcr8WP+SX+Lv+wTdf+imr81a/Sr4r/wDJMPFv/YJuv/RTV+atAH3DN46udB+FXgfQ/CbJeeM9Q0u1+x2KxiU7REpZn+YBFwDyT68HBxLaa74xuvhVf6t8S7XTdOjd7VrWOBWSYZmUEyhiQpJ2Yx05zik/Zq8EaZ4M+HMHibU1gi1PUbf7VPeTOMQ2x+ZFDHhV24Y+556DFTxv+0N4FVptKttNufEwyvyxwKYHcNkDL8kggEEKR0waAJoPC2ueI/CvxD0jw7qlvpkt/wCIbjzJJYy2+IxxhlBH3c884PH1zW34T8CXXgn4Z+Ik1SeHVdduraVp71FfzJlEZCIWYknb0GMDGOM5J5Hw7+0h4WtbySDW/Deo+H7m4nD3DLCrqGIA3yY2sTgLztJwK9f1HxVpt38PtR8R6NdR39hHZS3CPAQ27ahOPY8YweQetAGxeyX6w2Z0uC1m3SoJ/PlKbIv4mXCncw7A4HuKwPhVaPY+D1gdGTF7eMqt12tcyEfoRWnoupaPDo9xLbTW9vbWpL3RJCLE7qJWLE8AneGP1pPBbO+jzGQ5P267A/3ftEmP0xQBu0UUUAFY3jWxOp+D9csQCTc2U0IA6nchH9a2aRxuUqehGKAPytYbWI9Divs/9lbxnBD4L0nw1qxgtpHWWTTpdxC3I81t8eTx5ik52g52sp9a+TPHWjjw/wCM9c0ld5SyvZYEZxgsquQp/EYNfQf7Iz6X4m8N+JfB2v21ndWwkW9hikH7w71McjKeo2gJgjBBbrQB9aV8yfFTw1p+u/tX+D7K5hiWG4s47q4AjB89ojMwDgj5siNVOewxXqixeKvAaAW/2rxZ4bjUkozA6lbKF/hPAnXg8HD8/wAVeMfHHxPaW/jvwf8AEvwxfC7t7FxY3tupCSwkM7eW6N8yl1aUcjjb9KAPq4cUVn+H9Z0/xDo1pquj3Ud1YXSB4pUPBHp7EHgg8gjFaFAGX4p0e18QeHNS0nUED2t5A8LgjOAR1HuOo9xXgP7JyWfif4Xa94a12Bb7T4L0gQzfMoR1BAHphlZgR0JzXqPxv8e2ngLwNfXbXCJqtxG0NhDkFnlIxuA7hc7j24x3FecfscRSad4b1iw1CwntNQnki1FHlXb59vIpWNlHXGY3/wC+hQB3Ftb638NbwIsp1P4fooVQ7E3OkoAecnmWIe5yo9l5X4L6zPrHg99Qjgs0tr++vbnTXLsXkLXExO9do2445BOQe1emTjMMgIyCp49eK8P/AGaJ5Ivh7pLf2yWht4ZbeXSI4BI0Mz3cu2Vyo3jI4wcKACfegDf+Ak89wvj1rogyjxTeocc4wEAGe+OleqV5f8MfO0b4g+OPD12kCmSWDV4pEGz7Q00YWZ1XJwvmRnucZr1CgAooooA+T/23dFK3vhvXI4nKvHJZyyY+UYIZB9Tuf8q+bPD+s6h4f1m11TR7lrW/t23RSrglTjHfjoTX6F/GbwWnjz4falpAVftoXz7Nj/DMuSvPbPKk+jGvzpu7aazupra6ieG4hcxyRyKVZGBwQQehBoA++vgP8OrLwnoCazdzLqXiXV4xcXmoM4kJ3/NsRsnK5PJB+Y8+gHd+MLzU9P8ADWoXOhWsV1qSRnyI5n2xhum5j/dX7xA5IGBzXyn+zT8bYfDcUHhPxZIsekbj9jvSP+PdmJJR/wDYJJw3Ynnj7v17MsOoWEiApNBPGVyDlWUj19OaAPP/AICXfiPU/AEd/wCMJ2ury9lNxHMWVlkhdVK7QoG0DJG0jqD7VqT/AAs8DT2LWknhfS/KZmbIgAcbmLEBx8wGSeAcDoOK8+/Zg8TpBpOo+ANVKQ634euZotu8ETRmRiSvOTtbIPGMFfWvUfHfjTRPA+hzanr94kMaKTHCCDLO3ZUXueR7DqcDmgDxD9pjQvA/gn4Xmx0zw/pdrquoSpFayRQJ5yBWDO+4/NjA2nn+MV8fgZOB1rsPip4+1L4ieKptX1ICGIDy7a2U5WCMdFz3PcnufQYA1/2f/BY8cfErT7K4QPp1p/pl4D0MaEfL77mKr9CT2oA+3vhJpD6F8M/DWnyxNDNFYxGWNhgq7LuYH8Sa66gAAADoKKAOU+KvhseLfh5r2ihN8tzbMYV3bcyr80eT6blWvzXYFWIPUHBr9UzzX56/tCeD5/B/xP1aJottjfyte2jKoVSjkkqADxtbK/gDjkUAfTv7JvjNPEfw4TSJ5GOo6IRA4YkloWJMbdMYwCuOfuZ717bX5v8Awi8cXPw/8cWOsQlja7hFeRKM+ZAxG4AZHI6jnqBX6H+Hta07xFo9rqmjXcd3Y3KB45YzwR7jqCDkEHkEEUAaNFFFABRRRQAE4GT0rziwv01i58Sa/HqD6XpkqRW9rrURgKeVDI4bBbd1cyDlcYIIOemx468RCx+zaVaSrHdX0yWz3BDFbUSHaGO0feJ4Ucc8ngGrOm2x0bRbHR7aK00/E7Rwpa27ywpCrlsNwArNGOS3G49+hAIfEaXOpeItD07lbWO4+3SNFcbS8canAdcDjzGTgE5x+FdZXHeBLfUZL3U9R1G9+227CO1srh4kV5okyTKSnHzO7ADA4QHHOa7GgAooooA534jRLN8P/EsT/dfTbhT9DG1fmbX6geKrc3fhjV7dfvS2kqDj1QivzBcYZh6GgD6L0XV7/wCMNv4P+G2jXM9pomnafHLq9ygwXKKBjBOSASqj/aOcEKDX1D4H8DeHvBOlrY+H9OhtxtAkmKhpZiM8u/U9T7DPGK+fv2HEj8rxe4IMu62UjHRf3n8+fyr6noAztc0PS9esJLLWdPtb20f70U8YYZ9eeh9+tfMfjrw5ffBHUtRk0WYzeBvEsUti9rK+TazvG2zknoDzu67QQeQCfq2vFf2ube1m+EUj3OfOhvoHt8H+Mkqf/HWagD0bw5c3MllYLKEtraKJIZRPFzcuY42Vo23fdGWU5GSR2xzL4IguLfR7iO7x5n9oXjjBz8rXMjL/AOOkVl2Dabf6HdPcXltdR2GyY3NyYpYbC4jjAIAzlWQrvO7kF+vYbPhG/t9U0p7yynS4gkuZgsqHKttkZSR7ZU0AbVFFFABRRRQB8gfthfD65tNeXxpp8Bawu1SG9K5JjmA2qxHZSoUfUe4rwvwD4s1DwT4rsdc0pyJrZ/njzgSxn7yH2I49uo5FfpJr2j2Gv6Pd6Xq9slzYXUZjlifowP8AI9wRyDX58fGT4dX3w58Vy2E6ySaZMTJY3RHEseehPTcvQj6HoRQB93fDXxpp/j3wnaa3pjKvmDbPBu3GCUAbkPA6Z645GDVfxx8NfCnjaFhr+kwyznpcxfu5gQCAd64Jxk8HI9q+B/hz4+1z4f60NR0G4wG4mtpMmKcejqCM4zweor7W8C/HLwX4n0Nbu61e00i9jjDXFpeyiMo3OQrHAccH7vOMZAJxQB5da+Dvij8Frq/k8DiLxJ4bmLP9jfLvGBjDeWCDvOSPkznGSOlWtb+PvjtJbDTbT4c3Gn6vfNstxfCVhKRjO1NqE4z68Zr04ePtW8WNHD8N9JNxaugdtb1SKSC0UE/8s1IDynhhxgA4ya2/B/glNGv31jWr+XXPEssYik1G4RVKIP8AlnEg4jTOTgckk5JoA8Y8P/BPxZ4z8W23iX4valFNGmHGmxPuIx0jO35EXgE7Sc9+cmvWNUtrbTfjH4cvIY9sl/pV1p7ANgBY2jkT5enGXH/Aq7+uAumbUfjZaI0KNa6Lozymbd9ya4lCqMf7sL/nQB39eQfCTXr2YeINE03T1BsfEN9EszoVgWAXCs6lgOJMTNtXvt7V0fxM+J+heBtMm865ivNaIC22mQOGmldvu5Ucqvqx/DJwDz/w3stT07wdbm+W41C/vANWvl06VY0aaWZpVMcnyrIWBCsA+3ag4w3IAmh6Zb2fx5t7i0iuIIZNAuoBFcMxcMl6GZssScMXyOemOleu15TojvqH7QepS20doLfTtF8q8NuwYrcSzgoHOB8xiiUkdsYya9WoAKKKKACvmH9pH4G32s6pd+LfCESSzPGZb2xXh5GGBuiAHJIySOpI4yTivp6igD8rpY3ikaOVGSRThlYYIPoRXVeEfiL4t8IYXw/rt5awqCBAW8yIZ6ny2yuffGa+3Pih8GfC3j9ZLi7t/sOsMPlv7UBXJxgbx0cdOvOBgEV4BrX7Knii3uZP7H1nSr22ABVpt8MjH02gMB/31QB4rrfjHXdZ8S/8JBeX7rrPB+12yLA+QMA5jA5x361m6vq2o6zeG71e/ur66IAMtzK0jkDoMkk17HZfsyePbiZkm/sq2UdHluSQf++VJ/Su58H/ALKJysvjDXhjJBt9NXr6HzHH5jZ+NAHz34D8Ea7451mPTvD1k8zFgJZ2BEUAP8Tt2HB9zjgE192fBX4aWfw08MGySRLnU7lhJeXQTG9uyjvtXPH1J711fhfw3o/hXSk03w/p8FjZrzsiXBY4A3MerNgDk5Na9ABRRRQAVxPxZ+HWlfEbw2+n6igjvIgXs7xR88EmP1U4GV7/AFAI7aigD8x/GXhfVfB+v3Oj65bNBdwn/gMi9mU91PrWh8PfiB4h8Aao154dvPKEm0T28g3xTKDnDL+fIwRk4IzX3l8VPhxovxG0FrHVYxFdx82t9Go8yBvb1U91PB9jgj478ffAPxr4UeeaCx/tjTY+Rc2Pzttycbo/vA4GTgEDPWgD6M+F/wAf9O8W2ipqejajZ3isIpHtYWuYWcozALsBfJCOcbTgDrXodt8RfB1wiFfE2kxu3/LKa5WORT3DIxDKR3BAIr5s/Z/0m6t/BiyNb3SR3uoBizzMoZIzHI4SH/lqGjSVSVy3JUrjJr1s6JcyWsNwselPqJuR+8igKgsC8cj+ZBtfzN9wysxAX5HbameADt7v4ieFoLmG2i1aG9upnaOOGwVrl2ZQWK4jBwQATzjpWFrOoeKvFzXGkaHjwzDLZCY3s7JLdxsxXapiDfu9wEg3cn5W6ECm6TJ/adu9l/ZszEzSS+dHFCzWbTSTIfneR03JtdXC7j+8HyjkVnXPilbPVBplt9kvtRs3+0yWroJmt3WNQ1nBtVMMVlXy3Oc5lBxigDptH0mz0DSmg0TTLlHR57h1M6veTMZQSwLkhw+3OWYHG3v0q22m2GveJb1YLeNoLaeQzXlnmFCzeXvgkAYiZzsG5sYAwvXNWrXT9W1i3s4Ujn8N6VbAbIE2LPs8raI/lZlCgs3PqBwMZPW6bY2umWMNnYQJBbQrtSNBgAUATxoscapGoVFGFVRgAelOoooAKKKKAGyrvjdfUEV+XviHTbjRte1HTL0KLmzuJIJQpyNysQcH0yK/USvlL9rD4T3k2oTeNvD9t50JiH9pwxgl0K8ecBnkbcA4HG3PckAHm37MvjtPBfxDji1G6S30bVF+z3TyEhEYZMbn0w3GTwAxr70ikSWNZInV42GVZTkEeoNfmP4T0+y1HVDHqklxHZqjFjbhTJuPyrgNhThiCckfKDyK9j8O3HxD8Iahe6Z4K1uSLTLeVilhqUsMkiIHUYEeW6tJt/d8swYY3DFAH2vXzj8a9UT4o+OtH+HPhia3uFspmvtRuijPFFIiMFjZlPA5KtjuyjOQRXLnU/iN47Nxa6r40tbDSGnks3GlwFfMuFIUQI5CAs+4YBkwRk9K9C8FeBvD/hW3ttO0yO3lu2veW1KRre481ZJXildQ2JFJgQIABxvYcMwoA7XVWTQdJ1TWZk1GSHSblruSysYFgSbdAokGGwJky7SZJzuGOduK3/AOnXemeE7CDUpPMvnDT3B2hcSSMXYYHHBYj8K4OXRY/HGuDTkj1gaDYarJeai97cmSK6lUjbbxqWIaHIV8YwAAOCTj1wDAwOlABRRRQAUUUUAFYvi7wto3i/R30vxDYxXtox3BX4KN/eVhyp9xW1RQB8J/F74Ca74Ie41HSt2q+HgxbzY1zNbpwf3qjsOfmHHGTtzisEeEbF1t7yyu4dS02G9hgRltZFS6iP3ixTc6sGIBXGRvXHBUV+hRAYEEZB6g15N4x+BXhjWp5r7RHuvDmqvlxPprlEL7doLR/dx1zt2k5PPNAHivhPXvGng6Sz03w74kN2VIT+zdXhcxSKHZN8W4CQIBs/dr82Vk4+Xn0rT/AIxeN5LmDTpfh5HPqLLHkpqqQq5dZGUhXXK5EUnyk5G3B5rkte+EnxF0rUrvULMaX4kd1jt1fzjFO8QK7w4kOBvAIOH3AYCkL8tJr9nr9trGnfbfB3iGwjZ1eaGyjS4tGAupJcyeR97arYCtnJY8cZYA3tY+LPxCu7C/uLbQNK8MQ2sCsx1R5JpJmeJpVEJVQpbYhO1u+AcdK5vxL8OdRu/EqSa14h1HWL/VXje8SeJbCxuiqxrGjOj9UMijKhtxbaMEMaWx1CeKzSVtH8XajfiO1SU2mkvFJFIsUkUksWFVBtSUKpZSTswccMN/Q/CPi3UdOstI0fRX0nTGtyX1bWdqSxO+4TGO2jkO0t+7YIxCBo92AcGgCXwr8P7LSvFEnlaRpmkPNBJb2rNdlbiFyZMrFu3+ZIsEhZySy7tgHCmoV8axDwvpGjeGrIah4ocrGun6a0UwTaqCK5mYxbVePy40bcE25Y4wAa7iz+Cuk3dvIvjHV9Y8RvK3myRTXLQWyykks8cUZAXJJ7mvQfD3h7R/Dll9k0HTbTT7fglbeIJuOAMsRyTgDk80Ac98KPBj+D9Bn/tKaK78QalO97ql4ibfOnckkD/ZGcDoOpwM121FFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc54j8E+HvEckEmrabHLLCJAkkbtEwEi7XGUIJBXgiua1n4SadqrRrJr3iKO1jkWRLX7WJIlKqVACyK3G1iCO+ec16RRQBxVx8N9GvWvhqU+o3UF40TvALloI1aMKFIEW3kbFOTnpXRaNoGlaKH/ALMsYIHcASShcySYzjc55bqepPWtOigAooooAKKKKACiiigApGUMpVgCpGCDyCKWigD5/wDHXwFt4NVbX/AqLDdrcfaxYmTYqOFYjyc/IMv5Z2sNvy9QOKxdB0nWra+uYdf0bxJZXD/YopsRC8WdEkRQ4kRCA4UFmdGjK7UOGYbq+mqKAPAdGttQ0a0sILLQdaikt7uSe9s4POKXxlDROckFTtHlOoMvAJ5ytdZpHhTxBrWm2Ona3t0Tw9BbRWkum20xeS4WPeoxIDuiVgVJAdyQACRzn1KigCvp1lbabZQWdhBHb2sKBI4o1wqqOgAqxRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFBooAKKDx1rmL3xnZC4Nvotrea7cq5R005VZYyM5DSsyxqRtPyls9OKAOnormbPVPE14Gk/4R22s49zBUvL8CUgY2kiNHUZ543HHFSjUPEkUsRuNDs5ICf3n2W/LyLwTwHjQHnA6jr7UAdDRXNW3jCyF9HZavbXejXUshjhW+VQkxA/gkUshJ/u7t3B4rpQQRkcigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKK81+LHxA1b4dzWupz6CdT8LybI7i5t5Ns1o+45LKRhlIIxyOQQTyKzdF+NOg+MwLHwnqllYanIIgp1j92AztjaiZ/eOMfdBAyRyaAPXKK4nSNB15r26TUvEmumGB1VHItBHdKUBLAJFuTDFhgnPHU5qvd6H4gZWij8Y6zZ3dy8q2pS2t7qGMDJUufIBHGOCw54DHrQB31Feev4t1zwpOkfjuxhl0x5BGmt6ajGJM52+fESWjzgDcCy5YZIr0FSGAZSCDyCKAFooooAKKKKACkJCgkkADkk0tcR46kk17VrPwbaytHHewvcanImNyWg+XYPQyMdo/2VfHIoAijvB8RTcwWTf8AFHqzwTXCMytqLDKssbKQRECMFh945A45Pa2VpbWFrHbWUEVvbxjakcShVUewFRWNxYb3sbGa2L2qqrwRMMxAj5cqOnHSuO+LXxP0b4baQtxqW64v5w32WyiIDSkdyf4VzjJ/IGgDvaK+ZNA1X48+PpBq2ky2Hh3R7mPzbYXEUYQr0GAyvIcjnJAB6jtU2uX/AMePAZi1fU7iw8TaXCC1zBawqdq+pCoj++RkDHNAH0RLpVhNYS2U1nbyWcrM0kLxhkYsxZiQeDkkn8a4mKab4c3ghvZTL4LncLbzOSz6W7YAjcn/AJYZ6N/BnB+XBEHwh+LWj/Eq3kWzBsNVthm40+Yhnxx86NxuXPBOMg9QMjPeMn26dXjuYpdP2SwzQbAwkfcBy3bbtcEe/tQBeBBAIOQaK5Pwq8ujaxd+Grqd5oo0+1ac8hLN9nJ2mMnHJRsDOSdrLmusoAKKKKACiiq9hPNcWwkuLV7WQsw8p2ViACQDlSRyAD+NABbXkNzNdRQli9tIIpMoVAYqrcEjnhhyMjt1Bpr3FwNUit1s2a1aJne63qAjgqAm3qSQWOeg2+9PvJzbQiRYJJsuilUKggFgCxyQMAHJ74HGTxXOzfEPwbGzo3izQFkUlSrX8QwfQ/NQB0ck7LdRwiCRkdGYygrtUjGFIJzk5JGBj5TkjjMEuoC30tL27trqLKqXhWIyyIWwMFY92SCecZHviuY0y/0TXNO0vXr660zVNU0mNpDLpMrXCRyMhV/LVSSwIyACCavah58720+rXUlgtvqStapp0zOblCNirMuzoSxJUcDaDng0AXH8QwLaXlz9kvhFaXQtZDJAY+6gyDdjMa7slhxhTjOKt2usWN1q95pkE269s0jkmj2kBVk3bDnGDna3Q9q5W5sdSk/t/TDPpzX+p3BkysRnSG1KBVM0MknO4RsnycEnOOtZPiDU7iM/a4r6CysD/p1pFqNxJaMwggkLosSosmwOsbMrbwVZuOgoA9PBB6HNFeLaZ4l1LSrk3NlqmnXunSQW9zPZ2YimJuJxNPKIk3JJl8KEDZJ3ZwcHF28+LMmiNs1K1h1G3EzK97ayJAkcaB0bcsj5DmaGRVH3TlfmzxQB65RXNeBvGel+MbO4l03zobi1laC6tLgBZYHDEYYAkds8E1sazqthommzajrF5BZWMOPMnncIiZYKMk+pIH40AXaKpRarYTatPpcV5A+owRrLLbBwZERujEdgah8SahdaVotze2Gmz6pPCAwtIGVZJBkZ27uMgZOO+MUAadQXt3bWNrLc3s8VvbRKXkllcIqKOSSTwBXhOrftL+HY4rmztrDUdP1dJfI2arB5aQtyGaQIWb5ccrjJOB6kdN4C0nwh4/sDrdxq1x4yaCYwtNqMbLBHJsXcEtyqoBgg52k89TQB0MnxK0Sd549Bi1HX5oZBE40y1aSMNgE/vjiLgHJ+apINf8XXlxN5HhCKztkGVfUdTRGc5/uxLJgY96yfH3xJ8LaBZXtncKuqW8KmPUbWziabykZWG1tqlAxIxtdl4ye2DxeifEbW/F+j3mu+ANEjumjhNi+nJq4Se0UM+yUQPH5YYjBBy2cY5waAO9g8Za1daBBrNjp2hXWn3DIkMkeqyDzGZwgUZgGDvO3nH4VPN8QRp8uzXfD2s6eqRebPKiR3SQDaT84hdnA4YBioBwa8t+HHxN1/xf8AECWyk0yDTNSsbJoH0zUtQlhNwc7t4jEW0SAgZOAQGOAR0q+LPiNqnhDMPjrw/eabcHzbSBo4f7QsruzIwqSs0ymSQEZyecE8DcaAPfPDvifRPEkHm6FqlpfKFVmWGQFkDDK7l6qTzwQOlbFfOev32m+INM0vxKbi3uLy1dg7LexWcwLSq8UccgAQfu43JRn8xFfBJLczeHPiD4r8FPBL44mh1Hw26FHuWliWe0ZCVxkHbMcqcoru4xk4PykA+hqKpaLqthremW+o6TdRXdlOu6OaJtysP8e2O1XaACiiigDyS++LFzD8X7vwUlppMSW9xaQ+ddXrxyziZFc+WgjIZl3EYLDPHPPHrdcOfh1ap48v/FVlruvWV3qEtvJd2tvNELecQKFRWUxltpAOfm/iOCO3aXEqwW8k0hCpGpZiegAGaAPlv9rv4nMhbwLo0pUkK+qNs7Ha6Rgn8GOPYZ6ivlaJtkqP/dYGtbxhrlx4l8U6rrN6T597cPMVLFtoJ4UE9gMAewru/g38INQ+JGl69ewTi1isotls7Dia54YIf9nbnJzkFlODyKAPc/8AhcPj3xGuzwN8P764tLo7obrU0PktHtAIGAigZBPLnqfoE0z4u+NfA0S2nj34ezWuj2ipGLnS0byreMfKBklkbnaB84r3DwBDd2/gbw9DqUbRXsenwJPG3VZBGoYH8c1uSxpLG0cqq6MMMrDII9CKAPPLPxjofjvwZc65oMMd/FGz2Rt7zftZXZVYSRoGJBHIBX8uTTfDpb4fa7a+G7u6dvDN8CNImuWJa1m3f8ehc8FSCDHuO7hl5wK8q+I2jj4KePrTxR4cSaDwprzNZanZwSbFhdsnMfdTjLLjoVYAgECvWvGenaLqnhq+0ubUZre+0mwjmjmubyVBAx+aGWVwwDEPCDkkng+vIB6FRWR4P1GfV/Cmj6jeIkdzd2kU0qR/dV2QEge2Sa16AKOu3Uljomo3cO3zYLeSVNwyMqpIz+VeY/Anxp4m8Z2323xACttJaiVFXR5baPcWx8k7OVkGAegr1e7t4ru1mtrhd8EyNHIuSMqRgjI56VU8P6PYeH9GtNK0iD7PYWieXDFvZ9i+mWJJ/E0AGvT6jbaVPLotlDfXygeXbzT+Sr88/PtOOPavhf4qfEb4iw+MdWtNbu20TUGjhhubbTpAoVVVmRQ6sTj96xPzc7uemB98V+f/AO09EIvjf4jABAYwt9cwof50Acz8MfHGoeAvGNprtiGnCZS4t2kKrPGeGUkfmM5wQDg4r3/4RaDH8ZfiXr3j7xNE1xo1pP5On2c+CpI5VWXJ4VdpI6Fmz614N8Hfsb/EfRrfUQv2a7d7Q7l3ANKjRqcf7zCvo79jHStNi0PX7vDJrsN61tOnmuCsO1Sm6PO37wkwSM9RmgD6SAAAAAAHAAooooA+Uf2kfDM3w78b6P8AEjwp5dqZboLcQqNqmfBbJAPKyKGDAY6H+9X0H4L8XW/iPwyNcgspYNOkiE8LJiRphsDPhEy25X3KRjJK8ZzXmf7ZF3FD8LbW3eON5rnUYljLEZTCuSw/LH/Aq3fhMlr/AMK+0nTmuYYdVhN1ZWt2lpkxz5cyPGxBVh3JHBIIOTkUAaXjOSfSfEPg7Vki1K9RtSaKa5IVFtre4URiJlAUkeY0JAIJ+Q5NekV5z45vbvZpq3SX1vam9sold2gMU8v22PBwpL7iqlh/DtbkZGB6NQBxXxc8V3vhDwrFdaVDbyaheXsFhA1znyYnlbG98c7QM9/SoPhv4guNT1bxBpV74it9Zu9KMKTKulS2Elu778hg5Kup2gqV7Z6ggnrdd0fT9f0q40zWbSK8sJwBJDKMhsHI+hBAII5BFZvhPwZoXhOS9k0KzeCa98v7RLLcyzvLsBCAtIzHCgkAZ6UAdDWL4p8VaJ4VsWu/EGpW1lEEaQCRwGcLjO1erHkcD1FbVfOf7aWrPb+EtD0qNtn2+7ZpCDyyIB8v03Mp+qigDko5vG37RniC8jtLybQ/BFsxQkA7H5BUMAR5snCnBOF9sjPq+kfs4/DuysFgu9NudQmGc3FxdSK5/BCq/pXpHgvQLTwv4V0vRdOUC3s4FjBChS5x8zkDuTkn3NbVAHyD8Vvghc/Dm4tPF/gfzdS0/T5lubmxuh5hiCtu3HGN8fYjqBzkjJEV9q+kfETwZ/a+nxNo17oxjZmsQLfyrpxuNw7AHbErFwiLmRz0wa+wiAwIIBB4INfLHha2s/B/xs+I2hRQvJpgij1KKG2tRJIkhZCiRIOAR9oZVJ4HBPSgCLwT4zudR8Oabq2n614nt7oNBZ6gTIbmOR4x8wiEiuZJpQchEwEzubgcvv8AxLrfhLTPCE8PiN7vw494yXNrcstxMn7zPNwCnmqrYDFSFUkKS4OK6TVvCmi+GRbppNiLWxlgeSO1jum+0zSEAyIj5xDFgL5s2TkYUEDGcz4mWEnib4baalvKmliRR+9jgeOJoFxkIo+ZLfsqld0j+WQKAFXWb+G2trazi0p59t1O08EAh3RsTLHfCCSNEURkoFkd8H5wNxOa4aLxT4f8SeFbHTvEYTTF053hlW4ifIRXSNYyVZN/+tSVgm07oGO07hj0rw5YWFpot34etruXTp7SCN1+3IbqSBDxG9wPuiRusdvngYJHJFcJ4Zsrq4+M914fgsLM6VfxK2oR3H+lSTLHIWLS7j5ZuHIIYrnZubGCpoA8yvfiPqWla8934funF9EVWPU/tU0sjIMFkw21TGzhn2tHxu9hX0jqXiS4+OH7O+rWvh6CGfxOwt47qwSRY9kizxsSC5AClUZhk9iMkivlD4maInh3x3rGmwpDHBHMXhjhlMqpG4Dooc/ewrAZ9q9S/Y68RPpfxLm0h3f7Pq1syBAODLGC6k/RRIPxoA+h/AXgnV/DvxY8Q6nd3eo6lpd1p0EMOoahPFJK7qxLJhApAHbKj6mtr40eO1+HvgW61eNElv5GW3soXBw8zZxnA6ABm7Z24yM13VfN/wC0PdnU/i/4K0N7Vp4LO3lv5Bk7csSqs2OymMH8aAPk/wASXGqX2s3N/ron/tC8c3EjzJsLljnOMDj6V7r+y0mo6hqeqeDNRv73TtMniTU5LWMGKS4XCjAfgqrKyE7eWAHIGc7Hirw3c6lp3hDTfEcdtdXN9rUNrPcwxKriJmyQrY+X5Rz9O9fSV74O0W78SaNrzWixappKtHbzRfKTGyFPLb1Ubsgdj06nIB5BpVxp3wT+Jg8Mx3Elx4c8SbZrGxVWkmtLkuqbck8o2TyST8o9MnR+KfhK18CamvxM8JJHY3dlIp1WzWUQw3tuxw4x08zkEepGcFsZ9Y1rw3pOtajpV9qdlDcXWlzGe1kdQTGxBH5dDj1APYVZ13SrTXNFvtL1FPMs7yFoJVBwSrDBwex560AeT/EDRNG+I3hG1+IHg++FtrWmRvc6dqW3yw/lMxMcgfA2lgwy3Tr0yD0nhTXfD3xk+HcqzQpc29xELe+gaNsQTlAWVWYDJUkEMPY11/hvQ7Lw94esdG06PbZWcKwRqQMkAYy2ByT1J7kmqngzwnpPg7TJ7DQ7fyLea5lunHH33bPbsBhR7KKAPn3wp4Z0ePxHqfw71bU3t/FtjuXR9bsSwmmt3izsm28fIq7cOQQCApHBrxD4swa/4c8Zahp+ux3SXO52j+0Sm4hkjcEGSPfnIbAOc5BHqOPu+PwjpUfjibxYsTf2tJZLYlsgKIwxbOMcseBk9lAryj9qnR7a7s/CV/KUE41E6enmRiRFE8ZyxU9cGNSPxoA8g/Ze+KM3h/xe+h61MDpOtT5DkHENy3CkAcAMcKeP7p4ANfa1fDXj3w49p4eCaSbdbayYTTrGgiMjKoy64zzxnk54r7V8O6jHrHh/TdSgBEV5bRzoCc4DKCP50AaFFFFABWF49gubrwP4gt7DP2uXT50h29d5jYD9a3aRgGUg9CMUAflawIYg9R1r7S/YrdT8M9UQMC66q5K55AMUWD+h/Kvlf4qeG28JfELXdF8sxxW9yxgBbcfJb5oyT67StdR+z58S2+HXi/N43/Ej1ArFfDaSUAJ2yjHOVyeB1BPfFAH6A0Vl+HPEGk+JdLh1HQr+C9s5QCskTZxxnBHUEZ5BwR3pfEWv6X4b0qfUtcvoLKzhUs0krY/ADqSccAZJ7UAeT/tdTWcXwlKXakzS38CWxA+7Jkkn/vgPXo2ox31zp0YsZrqKWGWFTJthcXUJaMucZA24LLngj5iAeM/OfjLXbr43+ObOPSYLpPAuiM8puJbd2hvJUAYhuVVcghRuZcKxJIzivYNZvbSWwli0W/aXUdQlFlo95Y2yulvHtiYxiSNWCxDBY7sEgNjgA0AdR8LreS1+HugwzHLLapjnOFPIGfpiupqrpdlHpum2tlb58m3iWJMnJwowOfwq1QAUUUUAFfIn7anhaWDXNH8UQpm2uYvsU5VcbZFJZST3LKSP+AV9d1zfxE8JWXjfwhqGhagFC3EZ8qUruMMo+5IBkdD2zyMjvQB+cvhTRrjxB4i0/S7NhHLcyhfNbhYl6s7HsqgFiewBr3PUX1/4IfEeTxFo39o6n4V1Ehrl7jH+kKW5L7eFO4koxAyDxxmpfhB8MLzwn4l1e/8AFmnwSXFiz21hDcSmKOcqR5tzzgtCqdTjB3Y68V6jLd6XPfagl2l7JaXrGRvtdq0qbnzGs0iMPmLEBIYADgDcRzkAHpPgX4heGvG2nw3OhanBJK8e97R3CzxeoZM5GDxnp6E0vjv4geHPA+myXevalDG4QtHbIwaab2RM5PPGeg7kV846h8GPCUkj3ttcalAm6YLYxHynYooATdICBtIYySZ2g/KB0qx4X+FHh3Rr3SdQdG1eVlgeRL5t8McTIWe48oIGIJBjjRvvNyc4oAyI7rUvjd42m8S+IIby38F6MxS2t4Yw8kjnGyKNSCHkY7S3BAHXAxXvvhmzht9ItdNS6l06G2KWtvvlEkdwwD7rd1MaoQGYqSnzOFGWyDXNjVLW6maK10/V7CWCI28JSMtJblvn8mFQMefJHksw4iGASMUsniFLCy1SSyvJ9Q85S6pEzq6CN9pERHyqi42KcHzJGOTjNAGxYaINW8baJDIZktNHjW9eylgIigbYfJjXDGM4Mr4dM4EQXJxmvVq5b4eeH7jQ9ED6pcPdaxebZryVwowwQKI1CgAKoGAAB3PeupoAKKKKACvBv2wfDMurfDy21m1BaXRrgSOM/wDLJ/lY4xyQ2w/TNe8MQqknoOa+C/iP8cfF2u6pr1hY6yV8O3Ms0MMAto13W5JUAkru5Xrz3oA+yvhf4ph8XeAdG1pJonknt1FxsBVUmAxIuD0w2fwxXV1+Z3hHxTcaFd2sd2kmo6GlwJ59JkuHSCcjHLBTjPAOcHoMgjivqXS/2rPDUlgrajoWrW97yPJgMcqe3zFlP/jtAH0Ne3UFjZz3d5NHBbQIZJJZGCqigZJJPQYr5E8L+JLbU9Y+JfxDvpbnZcKbSyjhlWFngVlPzkHKjakKkggkuQvzVu+JZviL8cLqDRm0W48IeF4mR71rssGm5yDyql8AZCgYzgk9MbuoeAo9a8C3nh/TdOu9J8PwRotqTlLm9KA5nuFxnYGJdYQAzMMnbmgCPxN9n1QQ3wvrY6fHZ291JdSRkRC3KhkM6AAsCxPl2oPzHBbIwKTW/GVpo954f0a5vNVTVdXuvtpE9uk93ChVmiDArsSZnKIqYKxjk461lfCy9i1zQdMtJJfscnhsJHdWc0byG1lDbPMZWwXnYo23+GFfcVifFjxHoMV9bayl1peoa1pd6EuIre52g2bF1NshGWdyrZeTop+6e1AHXeFhf6fPdxyWsjNd3Egiit7jc8s7ZLrE7geaygbpbhjhSNqDCgVQ+CGuSanda9FKsEa2NxLFBcWtvstjaAgsnnEYWNc7iOHcsCT1q9qnxc+Hk/mWqao0Vg8UcP7qGRQ8fI8oKFzHEv8AEBhm+nXw74gfE2aTV9bs/BN9eWug6jHHFcoyqizsi7N6RgfulK4UKDkhRnnoAc/8Y/ENn4p+JGtarpkjyWMsipC7KF3IihAQMDAO3IGM4xnmuu/ZP06e9+M+mTwjKWUE88p9FMZT+brXjtfYv7HngK70XR9Q8T6vaGCbUlSKyEi4fyByX9lY7cZ/uZ6EUAfR9fPP7RGn6npnxF8I+ItGXc96jaTOz42IA3mLg+pBf67a+hq474seEpfGfgy502ylgg1OORLmynmj3rHMjZBI9CMqTzwx4PSgDyHxhatFo1v4kaW8uLvw3dQ37Kn7tHVJF3pjGcFT16Zr6G0y+t9U021v7GVZbW5iWaKRejIwyD+Rr85PG+teMYdS1LRvE93fW8u9Rc2LHy48r9392uFx3BAwc5r2/wDZm+NemaFoo8LeMbxraGKTNjeSDKKrEfumwMqASSGPGCQcACgD3TW/iKml/F/RfBb2kjpf2TzmeNC5WTcdgOOi4R8nHdegzT/jJ8QU+HPh/T9Te0N0tzfxWrop+ZUOWdgO52qQBnqRUnxN0KfxN4SOoeE7lY9ftNl9pd5bspLugJVN2cFXVmXk7fn5rm/D/jTwp8WNIm8OeIoF03xGY5IZtNvE2zwSFGVmiLDlgu45HIHUUAerW12lxYR3cayLFJGJVEiGNgCM8qQCp9iMivPfgd8RL34h6Nqd3qGkvYPa3bRIwPySIfmUDPO4KVzxg5BHXA5XwZ8TZfA+rP4I+Kl2YLy1KrYaxMCUvoSxCs5AwpAxliexycjJt/ED+2PCXiWP4i+B7ddZ0a9gjj1mxtm3mZBjZcR44JC8ZHbHYkgA0dW8b69Z/HvTfDyWsy+G7m0MBkmhKRyXODIWjk2/MQgA25x174qh8f5U1HxF4C8ONG7/AGi/kv8AETAPmBOAM+u8/XHbrXNfFP4v/Djxd4BnhTWb6DV4Qt3YrBbyJPb3S8oQ2NoIJIPzdM4PSvlbxf4u1vxfrY1bXr6S5vhGsav90KFGBtA4XueMckmgD6D+J9xa2+hakJIrsTXA+ywIqqxeSQYAXHUdc/j3r6g8NaZHovh3TNLgJMVlax26E9SEUKP5V8o/sveB9c8T32n634hmvG8L6O/m6dbTO3ly3ALYZF6YUljn1wOea+wKACiiigAooooA8f8A2iPhMvxD0NL3SUjTxHYqfIZsKLhM5MbNj6lc8AntkmvhfVtMvtH1Cax1W0mtLyE4khmQoyn3Br9SK474h/Dfw14/svJ8QWCtcKMR3kOEni64w/ccng5HtQB+dWk6tqOj3S3Ok311ZXKjAlt5WjYfiDX0L8KPhhF8RdJsPF3j3Xdc1KFnMItX3SM+1+P3gZm8s/MDwpBJOeMnf1D9ku1e8lbT/Fk0NqT+7jmshI6j3YOoP5CvTfhp8KrnwXoB0eXVNO1G0WR5Y2k0sLIC2NwZt5yPlHoeOvAoAfJo+geE/D7q2lw2+mW4Jt7OwVPMnVUhfc+7DPIXiVPcsuQetdR4V0ue5ul1zV7V4LzyhDawTbC8EXUl9o2iRiecZAAAHfN/RfC2kaRa2kNrZQ5tlASRlBYtgDeT3YhRluvFbdABRRRQAUUUUAFeZa58ZdC8P3moW/iDTNe0pbaR4oLi7sHEN46kjETrnIOMgnHBr02kZVYYZQR7igDyCHWNK8T6pbPFq+gald7A07Wt2PMZlZmChc58qIEtyDvbb0rIWzxHDBFPqWkJKN0yGIPOkkkmPPdl63cy7dox+6XceOBXe+IPhJ4E17ab/wAM2CuHMnmWqG3dmPUloypP41zrfA+xhuJptM8XeLrIu7ypGt+HSN2QoWAZSc7SRnOfegDl720u0uMJZ2Lxr5ib72df3oSbmAsVDfZoceZK55kfjJFTyyC41C6vLywv1yxk+0wKUnlk8vyhcrGxJQv/AKuCLsCz+9O/4Ub4kUNEPiAJrUxww+Tc6PHMPKiIKR8v93KgsBgMeTkmtOf4VeN5CZF+JksdyzvLJMmlIGd2XZnh+MLwMfd7YoAhtdMkn1m4s11a5UQulvBZ25MUaqiFvsayglt2cNNMOvC8dKs6tPcaTA99q2raHbyJskeacL5cIyxWXYcMyJgrEo5ZiWPs9/gve6rbIvijx74ivJltzaZsSlnG0RJyrKA27Pck5OOa3dH+DHgXTbhbl9ETULryxG0uoyvclwBgEq5K547AY7UAZGm/G7w7JZC1sE1XXtXiyPsmmWrXEskYOBKWCqnI2kgHgnFej+F9QvtV0K1vdW0uTSbyUEvZySLI0YyQMkcZIwcds4q7YWNpp9rFbWFtBbW8S7I4oUCKi+gA4AqxQAUUUUAcR8atbOg/C/xDdx+d9oktmtbcQHEnmy/u0K98gsDxzxXwz4u+F3i7wpo1hqutaRPHZ3cXml1BfyDuwFlx9xjlTg+uOoIH6K3lla3ohF5bQziGQTR+agbY46MM9CPWp3VXUq4DKeCCMg0AflZRX6D+KfgZ4A8ReY8uhRWNwyBBNYMYNuDnIRfkJ9yprgL/APZS8MuR9h1zVoR3Eojk/kq0AfHZmkPWR/8Avo0ebJ/z0f8A76NfWNx+yXZM5+z+K7hF9Hs1Y/owp0f7JmniYGTxTdNF3VbVQfz3f0oA+Sg7Akhjk9eetNr7Rt/2VfB6xgT6trjyd2SSJR+Ww1t6N+zZ8PdPjZbq0vtSYn711dMpH/fvbQB8J10XhbwV4k8VTiPw/ot7e5cRmSOI+WjdcM5+VfxIr9ANH+F/gjSIoUsvC2kgxEFJJbdZXBHQ72y2ffNdiiKgwihR6AYoA+afhB+zVDpV3b6v47miu7qF1ki0+A7oQQM/vSR82D/COOOpBxX0uAAAAAAOABRRQAUUUUAea/GX4SaP8S7CNp2+xazbqRb3yKCcf3HH8S559QenUg/EXxA+HviLwHqRtfEFg8cZJEV1GN0MwHdW/XBwR3FfpPVe/srXUbSW1v7aG5tpV2yRTIHRh6EHg0Afm/4O+InizwcceHdbu7WHn9wWEkXOMny2yueBzjNdF8Qfir/wntik2t6BZ23iO3dTbarp8jQsFB5WRTu3+xyCD07g/T/ir9nDwHrcjTWdvd6PMzO7Gyl+Ri3qjhgAPRcV56f2SBk48Y8ds6d/9soA8mT4u3Os+HW0T4g6XD4mtY4ytpcySeTd2zYADLKAc9MkMDk9SelcTpHizX9Dilg0LW9U062d95it7t4wT0yQpAJxgZr6O/4ZI/6nH/ynf/ba09D/AGT9HhmkOueJL68jI+RbWBYCD7li+f0oA+SybrU78n99d3txJk9XeR2P5kkmvoj4Nfs43+qzQ6r4+iksdOBV49P3YmnHB+fH3F7Efe69OtfSngz4beEvBh3+HtEtre45/wBIfMkvIAOHbJA46AgV19AENnawWVpDa2cMcFtCgjjijUKqKBgAAdAKmoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAP/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of possible reentrant circuits. The thick black arrow represents the circulating impulse; thin black lines represent advancing wavefronts in completely refractory tissue; speckled areas are partially refractory tissue; white areas are fully excitable tissue. A is the original model of circus movement around a fixed obstacle. There is a fully excitable gap and the length and location of the circuit are fixed. B represents circus movement around two fixed anatomic obstacles. A fully excitable gap is present. C represents rapidly conducting bundles forming closed loops that serve as preferential circuits through which the impulse may travel. D is the leading circle type of reentry which does not require an anatomic obstacle. Instead, the impulse propagates around a functionally refractory core and among neighboring fibers that have different electrophysiologic properties. Since the refractoriness of the core is variable, the circuit size changes, but will be the smallest possible circuit that can continue to propagate an impulse. Functional circuits tend to be small, rapid, and unstable. E represents reentry around a fixed anatomic obstacle but a fully excitable gap is absent. F demonstrates an area of slowed conduction (hatched lines) between anatomic boundaries, while in G all areas of slowed conduction neighbor an anatomic obstacle. H represents anisotropic reentry. There are differences in the conduction of a single impulse in various fibers as a result of differences in their orientation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_50_10017=[""].join("\n");
var outline_f9_50_10017=null;
var title_f9_50_10018="Patient information: Pleural effusion (The Basics)";
var content_f9_50_10018=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/17200\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/17/41237\">",
"         Normal lungs",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?17/12/17601\">",
"         Patient information: Heart failure (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/41/36499\">",
"         Patient information: Medicines for heart failure (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?4/45/4819\">",
"         Patient information: Pleuritic chest pain (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?6/46/6883\">",
"         Patient information: Shortness of breath (dyspnea) (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?33/5/33877\">",
"         Patient information: Heart failure (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/50/28450\">",
"         Patient information: Shortness of breath (dyspnea) (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/3/24624\">",
"         Patient information: Thoracentesis (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Pleural effusion (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/pleural-effusion-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H6662402\">",
"      <span class=\"h1\">",
"       What is pleural effusion?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Pleural effusion is a buildup of fluid around the lungs (",
"      <a class=\"graphic graphic_figure graphicRef67527 \" href=\"UTD.htm?40/17/41237\">",
"       figure 1",
"      </a>",
"      ). It is sometimes called &ldquo;water on the lungs.&rdquo; Heart failure is the most common cause of this problem. Pleural effusion can also be caused by an infection, cancer, or other health problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6662417\">",
"      <span class=\"h1\">",
"       What are the symptoms of pleural effusion?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Chest pain &ndash; This pain can be sharp and get worse when you cough or take a deep breath. Sometimes the pain is a dull ache.",
"       </li>",
"       <li>",
"        Breathing problems &ndash; You might breathe faster than normal or feel short of breath.",
"       </li>",
"       <li>",
"        Cough",
"       </li>",
"       <li>",
"        Fever",
"       </li>",
"       <li>",
"        Hiccups",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6662432\">",
"      <span class=\"h1\">",
"       Will I need tests for pleural effusion?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Tests for pleural effusion include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        An X-ray of your chest",
"       </li>",
"       <li>",
"        A CT scan - This is a special type of X-ray.",
"       </li>",
"       <li>",
"        Ultrasound &ndash; This test uses sound waves to take pictures of the organs inside your body. Your doctor might do this test if you need to have some fluid taken out.",
"       </li>",
"       <li>",
"        A test in which a doctor takes a small sample of fluid from around your lung using a needle. Another doctor then checks the sample under a microscope.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6662447\">",
"      <span class=\"h1\">",
"       How is pleural effusion treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The treatment depends on your symptoms and the cause of the problem. If you are having trouble breathing, your doctor will remove the fluid from around your lungs with a needle or plastic tube.",
"     </p>",
"     <p>",
"      If heart failure caused the fluid around your lungs, your doctor will prescribe medicines called &ldquo;diuretics.&rdquo; These help pull fluid out of your lungs. Examples include",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?12/14/12518?source=see_link\">",
"       furosemide",
"      </a>",
"      (brand name: Lasix&reg;), and",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?36/44/37573?source=see_link\">",
"       torsemide",
"      </a>",
"      (brand name: Demadex&reg;). You might also need to take other medicines for heart failure.",
"     </p>",
"     <p>",
"      If an infection caused the fluid around your lungs, your doctor will prescribe antibiotics. Your doctor might put a flexible plastic tube into the fluid to drain the infection. This tube might stay in for a few days.",
"     </p>",
"     <p>",
"      If you have cancer and get fluid around your lungs, your doctor might put a flexible plastic tube in the side of your chest to drain away the extra fluid. Your doctor might leave the tube in for a few weeks and you will drain the fluid at home. You might also need chemotherapy.",
"     </p>",
"     <p>",
"      You also might need surgery to remove a small sample of tissue from around your lungs. This is called a &ldquo;biopsy.&rdquo; Tests on this tissue can help explain why the fluid keeps coming back. At the time of surgery, the doctor might use a powdery substance called &ldquo;talc&rdquo; to close the space and keep the fluid from returning.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6662463\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/45/4819?source=see_link\">",
"       Patient information: Pleuritic chest pain (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/46/6883?source=see_link\">",
"       Patient information: Shortness of breath (dyspnea) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/12/17601?source=see_link\">",
"       Patient information: Heart failure (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/41/36499?source=see_link\">",
"       Patient information: Medicines for heart failure (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/50/28450?source=see_link\">",
"       Patient information: Shortness of breath (dyspnea) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?33/5/33877?source=see_link\">",
"       Patient information: Heart failure (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/3/24624?source=see_link\">",
"       Patient information: Thoracentesis (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?9/50/10018?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 17200 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-197.136.42.3-BC92F1AF1C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_50_10018=[""].join("\n");
var outline_f9_50_10018=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6662402\">",
"      What is pleural effusion?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6662417\">",
"      What are the symptoms of pleural effusion?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6662432\">",
"      Will I need tests for pleural effusion?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6662447\">",
"      How is pleural effusion treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6662463\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/17200\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/17/41237\">",
"      Normal lungs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?33/5/33877?source=related_link\">",
"      Patient information: Heart failure (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/12/17601?source=related_link\">",
"      Patient information: Heart failure (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/41/36499?source=related_link\">",
"      Patient information: Medicines for heart failure (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/45/4819?source=related_link\">",
"      Patient information: Pleuritic chest pain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/50/28450?source=related_link\">",
"      Patient information: Shortness of breath (dyspnea) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/46/6883?source=related_link\">",
"      Patient information: Shortness of breath (dyspnea) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/3/24624?source=related_link\">",
"      Patient information: Thoracentesis (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_50_10019="Wt length boys z 0 2";
var content_f9_50_10019=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F77428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F77428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 626px\">",
"   <div class=\"ttl\">",
"    Weight-for-length boys: birth to 2 years (z-scores)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 606px; height: 383px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: The WHO Child Growth Standards. World Health Organization, Geneva, 2008. Available at file://www.who.int/childgrowth/standards/en/. Copyright &copy;2008 World Health Organization.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_50_10019=[""].join("\n");
var outline_f9_50_10019=null;
var title_f9_50_10020="Nod lymph predom HL CD20";
var content_f9_50_10020=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F78028&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F78028&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nodular lymphocyte predominant Hodgkin lymphoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 255px; height: 285px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The malignant (L&amp;H) cells stain positively for the B-cell marker CD20. In other sections, the small lymphocytes also stain for this marker (not shown).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Warnke, RA, Weiss, LM, Chan, JK, Cleary, ML, Dorfman, RF. Tumors of the lymph nodes and spleen. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 14, 1995, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_50_10020=[""].join("\n");
var outline_f9_50_10020=null;
var title_f9_50_10021="Main airway management algorithm";
var content_f9_50_10021=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F63518%7EEM%2F58510%7EEM%2F73509%7EEM%2F73112&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F63518%7EEM%2F58510%7EEM%2F73509%7EEM%2F73112&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 533px\">",
"   <div class=\"ttl\">",
"    Main emergency airway management algorithm&copy;",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 513px; height: 522px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: The Difficult Airway Course&reg;: Emergency and Walls RM, Murphy MF. Manual of Emergency Airway Management, 3rd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    The difficult airway algorithm&copy;",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 382px; height: 361px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BMV: bag-mask ventilation; EGD: extra-glottic device; DL: direct laryngoscopy; FO: fiberoptic method; VL: video laryngoscopy; RSI: rapid sequence intubation; ILMA: intubating laryngeal mask; BNTI: blind nasotracheal intubation.",
"     <br/>",
"     * RSI may require a double set-up. See text for details.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     If not used for awake laryngoscopy.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: The Difficult Airway Course&reg;: Emergency and Walls RM, Murphy MF. Manual of Emergency Airway Management,&nbsp;4th ed, Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    The crash airway algorithm&copy;",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 440px; height: 463px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: The Difficult Airway Course&reg;: Emergency and Walls RM, Murphy MF. Manual of Emergency Airway Management,&nbsp;4th ed, Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    The failed airway algorithm&copy;",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 393px; background-image: url(data:image/gif;base64,R0lGODlhsAGJAcQAAP///wAAAIiIiERERLu7uyIiIpmZmd3d3WZmZjMzMxEREe7u7szMzFVVVXd3d6qqqn9/fz8/P9/f37+/v5+fn8/Pzw8PD+/v719fXx8fH6+vr4+Pjy8vL4CAgG9vb09PTyH5BAAAAAAALAAAAACwAYkBAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/EBgYKDhIWGh4iJiouCf46PXwFvkpCVllWUbZmXnJ1Km2ugnqOkP6Jpp6WqqzSpZ66ssbIpsGW1s7iztykCAyoEu6a5w8QjpwKDAiXAAL2/tQEEwsXUuicCBSzOKcxLwdXgjsfZIgeCCQvMzgQFgQYA7I0k7QEFDADRwMACCiQMAQvo2TOgYEGzBCe+hVu459igEeYeqPOl4N2DfgqUdTNRwAE+AvsALAjAwECBAwIa/8zzWOBdy4QMY3IaN4LBAEEGJpobZO4AvE0LEAhC8HFjAgEJDCBoICDo0GYDHpAzoVCmVTk0RSBAODKnJGcVSWRstskAQAAJiObLxI+oAgUlz6YVqeAoiqpX82q6NpWAgnoBvEKFJxCA2QAJNh1IXE8tyEz/pDnItjhQAaIAHBS8q7ezHrxSBijj7Ll0HdBQHpwlbbo1HNRbYLuenUV2bdq41djGsju3bye9T4j+yCIaj+C/kyNBfldaEubKowux3SBQv8CXRQsNdKA64nTRAkfb+d0GdOnoe8jG5lNEAJUAhhtHavBoSOLlAjwwn76/FdkIYOaec/JJs10gCGwUjf9NOPHn34NRrHeSMQQqo99BBomgIAFbiRSYgxCGyIRtNwVwXYUAbNcdThv6Bdg7NZwn4ozFTULjjUbICIWOOPbono0+BqkekEIWiQOPwBmpJIhsILnkg06O+OSUMDBi5ZVYZlkIlVxSEWWXYHoZ5ph0fEnmmd6gqWaTa7aJhpluxukDnHLWmQOddubZip588tbnn2ICmpuWhBZqaKEQbCDPBIs2GogIjD4KQKSUUAqpo5Vieqmklk6qqaecyiPoEXiOaqoxp6a6nKoTqEpEqTPC+qesIdLKp61QujoErrrayWuvcv6aXqvATnOqsGtKoMGPAGggwajIqnmBBRkoukH/BhZc0GcFHFCADwAUcFBBsTh4QIgHgEYQgAUYWBBABOTiIAEhz/5JASHexnuDuoHAK6i7gVigLw4aCLKsoBAIAsHAOGQQQAamzhtIvQzXYO2pGASAQcU3XBCAtqYySizHNYxsqr8kp6zyyqYe6vLLMGfJcinR3kZzzDhfqVzNftI8Bs+frQI0Jj/vLLQqQ6+Q9B1LT9F0hEUn9zTUPosx9RyyDVcm0lH/lkqJgTg3gjNaz2CcDmWTkLbao9VY9Q4FknBAO20zOSgKAwiYwtpVih0E3zJcnSQMyATSQHts4yeCA77oIHgcXwt4WABEkS2AOdKYFF8vJzGm94EoBZLA/z1j05MAY/sd+I58jBkwuVINsu4Oa6MoNNk9Bwzgtwhxj8DUDo+/hrcgjRsGkOWYG5bNAAn41ABRB8BFgnH/3INA8c2cZI4y15PQoXzKYLN5Cd9bGP5UJQSf5gsK7Od97BaKPXnugQxgEHZ6K220cJIzFgBKvhBN8jSnNXrMjkLK0xD6tjEfX/DDMuMzDgFH88B6RDBz6Jse117wPxSUT3Hjw8YCFmCX98RAfW6I3Ag6AgDVADCCq1veaJ53l/1UDwANwB4DpdGLiGRGhsQhoEd8OJkLJhAmb2tBWEhQQSCejXfcw4wAHHPC/Zkgb2OzzP8sRxbEABEAleHO+7YoOv/SiWCHgylRAZyIQeMFRo1sPCJVNuiCyUgjd2bZTxF7B8XsjbAA8aui1I6WxBYcCAH0q0ccR6C1EtkPhC1A4V7oWLuu+UaSz6FkJKxICkySypJ302QnUOhJ3YDhbE9UgekyZDZRdqGUqDjl7lwQkLoJspM42MgIdDmkQdbAkQvgxwGip5TGDcABYTSOd9ABjMRITyAMAJ1xgImP1s0DRq0s5A54eRxOxkCEJFSGA06njJ70pAEI+Qh90CIAfcRHbyxEJQHAWcLzicAAc4mRK1PUIAcIoiR/CUA7JUGQQGDDMuRhJmJMdI/CkSQeH0Ki12oQoDNipgDp3JwDiPKSjxz/iHLdCJBTEISfaFS0GVTUXIryF7h9jqBDF+KdRzQkiWPuEhQRcWfeIjOCsFyEdqGcATgBmZkBEJUw0muASiKzTppqBQFmqY9a3BeNoQZSpXfaZxOzR7l0JGYADGAGAb4aVkowyB0hhepUyCPGOfqSBsAU4T9glIDGMaAd7ZCGdwKT1jBehp//m2b97tfGld4Alq86ARHRt0QcJmgTzwOGQTrUlbTyVASNBSpukLQABezuH4h75T7h2FnRLUCNZY2PZRhAwnq4qB2CMaxDw1oYiV5SCOO8qUHDgNhdgXKzhMSl1bzpid5O57e0Me5xtSnatwr3uack7ihdqgXlkiFn/9jN7suoazNVWdcO2g3vllz13Zkl17wzKy96W6Pe9Zamve7tDHzjm5f50tcq9r1vTPKr34Xwt7/g+G+xLuKTWrJXJsiAz1FnpNTMZPS9CH6LS2wJoc768x7LXAADGAMf/yIYkAUhauFGByGzhA8d7ESKCsTL4ha7+MUwjpkJRKgABADyht2DkHE+isjqJMW2ANas+AonAJWyo1Y8RHEJxOfWINNixuSg2w1ziGQR7NUADsWmBp385CWTw8RdJHGYBNwfMheXy10GlJnRs+aZoFmzempzdORsCTo7t092nqig8nzbPb8ZyHzqwJ+bPOhU8bnQlzj0JbbBZUV/YXKUM/8BN7+JPUaOppEUZpijvYDVE0yacJXu4/jMu+kudFqYxBRIL5CRUFYqsBHr+EtFXoeT4cxW00KCNFHGaZduYMNvETlMNhTgkYkAYCwEOe2ll33ZipWaC50WAUadOhgAnDWi+fGJTjqIj9wtG4rRHtiztxBtxhFVstWmLLYxG76vUCR8BbFpfGYqmmbjOki6lmtgWgvIxr123W5sx2BcFJbDuM4dtv7nvU3FZCdPoF6VolieCudZNM/rAwULF8QQ/Sd+KYzjfyrYICQeJMCBHAYOC8TGlGRyEnz65AkLhMmE1PKTt8BjAeCAkfba7noA9IwJYEYYVZJhtdHDqCbyCTT/k30QjmUsX0Fiz+YYID0HNKCz76gIM6gM9PrUbQC+MIs0FgwAFr6kowyrgMCKdFLRQDobvZDKT8qOTR4nrhuiGWmk457Bgc28R1aluhnBWA+NSILrGBKO4cEtF6J01i42n01rFSDip6RoM0LnMA4bZOm5b86vmNGMqyOfp5qTfk2qGb1nYsz61ov39DnKFewT6x/4MpoLpqfGuJ9g+1C7QGupbMUsS5D7Yux+cHC4PQyAP/wTNr/z9ZV98gvwFxQX/aU4gbQgQudzfNBjOwhpps9BVzh7bH630Vfa86UAjODbQg5WXSfkyYcQ5lu76ioRaIq0txYM518agpcZTDEh/8VHDKCwAHvlEe5XBfMXS3GwDXljd2MTUF8kQYOQDQ00IL6GgZlzgW2XaR5GAqdjEGMFSVZQcaEAf75ATE0lNxeyRzN1IQGIQDvUDXMhg9JzRgXwRyAYDpvwD6O3UB9CcO8QRh5RUPp3fRoia6vjOWDkhExURtsBd7Bke4IAH1emNpaRDQanIg5FRTV4Dj7hhUMxeWQnE5twZOljT8hWEA1GdQQgb4nXgG14Wr4ADN0BPTlobSSRIr5wNsjwJlbxcn0mAqCVPhjUE+4xNzAyADlBVhJIeO3xP8PREwaEbUbGgWwiE4QYVCJwOtqGEBI0bPCGgEv1RM/TgmJRipX4P/80ZAJT9ofOEYivMAyCFiQ4VSLEFkTZQIRPGAgegVrnt26+2IrD5D+hNWL3AIhVOAzH1zNl5oxC8oxSkgvU+B/SZw24mI2ycI1EU3vSuI0x0InEVzfKRyrrt2Lp2E3WOI2RNAjkmEbm6Hs1MGm8tICRtI7AIwsSMC7fAgAVQHK1EknYFI/Qd0b0+Cr6mBALmVWx4DERcC8UoC4gQyO7gG2ZR1LM00JwQTZOuA70oGWqFQD2ow/Ytmri8Ythk5Fh43IhGR9OmEzSAEwbZjhd9FBMCJMkRVSd5T7MEgsZMwgrdyOKsX3TIwgD5VhgJD0J0AAVRzanyABgYRH9UDojZB//+sdEBSANW5dOa4FDjZNKPtUPYPcT3RGW87SD4aRihvhEdTgAUak50eaNI1ABhOCPREmQN1V2g1CEATBTXIQPWDYAbMVthoVS3LQNzNBRX8mYYlOY3iaJjnlSU7QiSYFVithtwGcAnTVWIkmXI+BxKJOXxVGQh5c/TZmBw+FCU8kXPJiY/nZ4p/gYODSbYqFlxviGVaWWC4YNzTYW/KBsLdRBSFGVWyYL9xIIUEeaSmOaKkmJKsEPUhlASDlwtcVIgwWbTnVXgEGb3JkYfgNRQNQT3ylYJBlMDTJbxVidHkJhoDkC7rJ2PfJdh1gFa+MXqveeIpAwC+MjxtV+WWmf/7aUADOVPrkwLwIZK9wYC39nBXMToExwjjZgkAYKjl3SftnAOIe1jviIkKOmAqZHoceZHvq5Bd3wO+bRkLyQkFfUg9R2SzdQgB56ZmDCDPOzS/RwOYxRbAsFF9JkEja2WkXRow1FPCH0T6rzOhD1DhAFGregofd0IonzAhIKCZ7kelh6CM8gaj3VNm/oWTpFRfjQYdKmgI8xkwjAU5Zjb1pRf6Mxlse2eC21AvUph1PqAlX6CFfaEFv6oZK4Qo0YWxUlTyJxSEP6VCplOadGgeMDmR0koqjCAnZhDsuoV9VZfkWKGIPnDKqzOUbFk+2DDe1gfZdaRqdlHYRhUEaYPf/VFxTGVKCx935Bww2UsDZjYWWzmVb4QFUdKFWHulKxOHVns1jzhllaBpxO6oJtBXTVtps+UW/4h2M6hD3f0zwJpDnsgXXCJKzWozurEae+s1SeZVXmZJixel18igIY6qfwEFA6CoyeV1EqYhyg96vyKjoB1HMkAUdulBOFcRiJkU0rMBJ3BSMmhRlud4GZyEQOxKha05k/tg0t8YEL608ZkZl0xzuDyTtEIRob9QlmsGYl+o8sgE6boU68KQAzyIcYNq3EWjbFOaMtEXh9iHigdau1yYfztIJhwQ57+EmymgcjGwyqISDRYIb6WjllxLAjuUYfOhIU1Dgt0VqFF2b/ZUVSLiJQq+pQHVZX64Ous8oJElCRgEYF+DmwaEcDyteZX4tcPSCj53oJdokBeFmhWECgK1Y/OKB8udW2w2UCCCgIsMqu12BMLtqnvdQJ/BKRhMZmIXsCIwgPD0alhksDkOoCu5ecAQMBFDOyvhW0NfGt7gGkCRcIYcWE5HE9TgiqD4CSiWQ/hQFMwNAOCuAdLKEMPYlEMecvu7uf/eK77wK8vPu7ANC7xUu8xpu8yBsI/Rlzzcu8wPu8ASC9/elxhEAsnrtcYOuSVAEf9eaWypBsEHiH/yOXcLeVfhROG3iVAzV2YUdQXNh3P8kJmrsunBupUAC3LXC5UrCnJVCf/wi0OZjJbVtUuT0Bse+wDZT5WE9lUXi3eAgMZ5CwuMs5vylwiaHFpXCVaYQaj/GYp9W4vSJorSV4Nt8rNsBZEGxpjAdRldtgVegGw7UqpzErwY4wt3U7ohcskuUYoxzsHB3qaZLkvyWQSLtowvp6uibyDlRHOSwMtTM6kvbDb1IMHn3UDVBsw38wtivWAmm7kReRZaJhVJPDUg6Vr1Z7IGBjFipJpk2qkhyFu6F6hzkaRixFeyJ8BGcLBHtctsFFeMvKl0bZlBXXSNY6AlG1HWl6IWvah93TwYfne2OxdXoolec7GDhLQ9EzeEVAxEiAt0EAyloMXTtcxH8palqDT/9GicjkoKjkcGSQnLGmrG2ScImc6VkRS5iGacuZBLpME44rkLZoUR0zSW+jwUIu5A81m6/BGlMXsnWS3G5K6T3UZxBg4aV3HLd/K7TArEo8AZfNABcGpzXlZ66AVQBorIyAdQDbwcZDRwIAKwnJ5BPb46FZ+66B3MmPG7ba2ASvWGf7zM3tuAQlcsgA7cvg1c2OawtZ2tCi0s8kOnt4HNESrb1HoL/8XNFz0gKBC693uqIaDAP8u80avdGSimIlKAMQeLi0eholDQS3AITpQ7pJTISpyzw7KcetKxqUOFixm52AUbvwyrrN9dKJC8iGqYbT470qC76GocLGRL4HYL7/2cNDaomVOsi+7oTOxnOt8nsF2SuOKgDAAwJua0XAL9So/xPBCixFDHyYU/TAcxfBRW3U+3jSoYgfJ9yl4RxM6cTCNfzCKRvDgz3DnlfDdW3XDrkCRmymfaSeOdnE11NOHZTFjAZMVCy7ho3FEBobis2OT9DHPiDanv3ZjhMFovwDqc0FYe2fC2rae2KhsH1Yrz3bMPocwzfSKWjbdoMCiSTM0Jd7C/jBLBrQvC2wKhC5yMDJIa1+QvwHrT2fLCDTVqaArfM6pUsS0ARCb2zHZafTIKmqUOi2xx1JymqYbPxSagFvo7bXJRBPfjPJp7mUlpw9mIzN9J3H5c1B0/2t/w3g2HiIaVild2L6p4vZl2yty4jDy+S9313MAhhlzX1oHDAIRZcVVWhR4OAaiP+sFdV8376TzdHl4Lft22pksJbRgW+UxIzxV6kUz89Jz1kZa+K9yiRN4uYtfFcR3TgCG0FsfDheJbUd5H58Z0SeZhR95Poj20qO5Avd5LTg0FI+5YoA5Qlt5a6N5dKt5T3O5V3u5RYJ5mEu5iLC42QO02c+kGk+5GtOGxWZCWTb5rQhARbAuQEgARBgAQkq561hvcHL574hcgYD6L+Rcg9D6L+hKIGwAYjuG9OyLnHe6K6RMUMp6bRhlzls6a7Rn5re6Z7+6a9A5aLOCKC+2NxV6v85/seojtzMter8zQpmbmixEOvHMuuurk8ycBPe2qE//kss3dIoIL+03jIzdoUZzJFe59zYhxOLAKK/rq6SMIX3cBSXkT/DDi0lcDtgpDsz1jgoSAt+c1IfnXsYvZfhqhWdTbK3ftvt896UXZj14N0y6T0slTZ8I4SrowzbrZ4v+cbqzU41Zu3rzurmTFQ9gUaaDBdcl0of1Yhf557snTYd8ZtUCa7dYBNKVnZFPvBOnlnfLYloZMuOSe8t+tFlHeBNcUgDzBOPSgnhtvEcD2R2tO1xqLRprUx6o5vhXu8PTxWSIUMYnhYUv4pkUeIx/+BjRDkH0H6JcfN3hIzlGe7/fanB957in9fiSmu64ulGAStHSH/0bvNKKmrSYB/2rD32R132Tk7Kag/zB932a19JcB/3NDr3bl8J175no773iGD3I+73Bgj4QC74Ck34tm74uJD3Ma/4HM/4A+/46w75ty75qhI97tNgfWBfptvVpCdCBOYHmu+06U16eVN5PneqJkIVfL/6U54Q/FBk8ryjIGcOvhCAVodud1+I04NlAiWb94f26zUcb5cZJuKeZZ4QnEkPsuyIIDccKxu6GUz5sT3TbpSzbPpn5DwUAMpS0s/qoyttse/Rs939c+rl5G/0UH7+Qg7m6v/q5n/87A//76/mVt6PzBKQ0mH//4j//0oOAlcQUQEVBRewsq37wrE807V94/kskiaq6oLCIbFoPCKTyiQm4HRiltIpddp8BqLVLbfr/YKPFWygEj6jl2OsOe1+w+NyFsoZmePz9Odd7/8DBr6UOFEIHn4RmiAyNjp2WQRYPFIqRU5WZmpu0kAEQHCG4niCipqeNkoESKC2uqiyusrOxk3Qytre6u7y9vr+AgcLDxPfkh0jJysvMzc7NzM+S09TV1sXEwcUayNyY7N4f/+GB5MDmm+Ll6d3q6+gu9PC987n1a/H07Mf3gP355v6dyYAAS8C4RzEQ8BJwSUJAWqCN+CJgBoDKroQMADGQhkEZ1x81zDIwzQlW/84CGAgTAKMUk5CfCQRAYCFDGiEvNExxkcZOYvADBN0gYIBG8EoGOkwpq6ZKxQYEOAkAYMFEwNAfbKShUYAAxI4oVnASQEERwusDABWJQAEWg1o/Xh1wAIAap1sfREUTFADCg4EOABAo1S4Cw2MDVDg5l22BBJrO7CWJgu3iiU7cTD4YmAhe5nyizGAJlwGAW6aXVh3RUjATg50NVoz8E6zK9DarShAQQsECbxiJCigwIIFLXMPLsAzGpEBmkMOL7jQ5W3NAXQrV6C5YwOaBxTcBFewQQMADJJGJ/IZdCCJb5XXVJ5SQcWfXDe2ps3NNgDcHxfCpgBZwImEAGUC0PT/EWLLtSOEawN2NdsKC1gWQIIFIQaYYB1BxpZ4/W01QFRHDbEee384tYJpNzVAomkHOPdCbBVpqFpyNUFlV0EOFADYAwDw6JVmOg5XXAEVKQifXswJIcBvABD1QIQ7wVVXAhcCsCB9g2nTHU/jlWcaARGWeKIsKa4glVoMLBRWlni1MCMAGhp32VgJ5PhEAQVdVYBycKkklxN06Zilki6YyAVMR1bWwJTcYKYYlgsCOtaca3X2YaSakemZma4kmkmoVYxqxHBvlPopQvsIkmoQaiaFqqqouNpIrUrcWkmus/LFanvx7MqrQb6eQ0OnLBwwFnWhBCusoq4c6xGTMkQL/+RGO7nQUYTV4sDtEc06Syq0JNIArnrGksuCozZ4q4e54b5kwwCJzYvVAQ8mUFdjK1W40mNPXOrmcFOt9eO/bO37IGUzvOspDGoGcG1iBgAaaHJ3LgDgEwhoBNhNqqm5WAsV0zTjvMep6wC+CzAaJQwNw5vEP7IZ1p9LPiJ3amW/aSehl98xMNy917W1UY4P8Eb0qe22ALMO6Ii5GQBH8xaStj0SZYC2R8VGU3fn3eRAeS9UGVsCgontFU3gIRvAA5Qe2nTMEclb0U4XMXAVwhgqtxtZGkrY4Ygibfbga0lKbYPTOaCzYOFkwGi3NhGitXWa1/4VWMWKjYwpbPhhhP90VAkgbZ7eBhBFQAJ5ITq3qHVLCJxvUO5tKM5BbikVAF7eR3hXOX64oJM3LI4D1KftbjTrVk9+ltaTP0l5ARuBDUMBmj0QmJxP/bVbebMvwJaTvDHoukyw3y0AAQKOlRbfXpH1J1mReR7hR10drBzi51lYQ/HEx8AyCZDYgJiXuMppg38cO0rNuOQmrszvcwRaQYto5y/2sSV8y5Kb+c7nBp254X+K+8X6VvOyDnowDLBSChpE6L9fJGBI5UNhg4bhwnIBi4a2IhaKcqjDGgrjhgzz4Q9bxUM/CHEJTFtSEY2YjWmN62lNdKINoWgReo3lLyuzy1r4pZX4ACxSJUv3TAIKBkaEdVFhxptie6zhxjfCcRlWxMlGasaoFeBMaYeaXc+44x3wCA0wFbEN1XLWt3S9kI2KnEVCDAicvH0RcX67TGc4hIXBFapjkJMkInG4yE/SKgeOvAj4apchtwEpO7rp0sISdz/lNe19w2McKGspikZKjjXqw6D7DAU/xchPMfR7ggQzSUDO7U9ArfSkLZupKzmAcFXOnKYjFrfCOSSRmto8oTuyuc1vvoOI4BynHLwpK3KiU5rqMGc6m8lOk7QzngMRpzzrSao44jOf+rQnP/vpz38CNKACHShBC2rQgyI0oQpdKEMb6tCHQjSiEp0oRU8UAgA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * In children under 8 years of age an uncuffed or cuffed endotracheal tube may be placed. In neonates, uncuffed endotracheal tubes should be placed.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: The Difficult Airway Course&reg;: Emergency and Walls RM, Murphy MF. Manual of Emergency Airway Management, 4th ed, Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_50_10021=[""].join("\n");
var outline_f9_50_10021=null;
var title_f9_50_10022="Oxazepam: Drug information";
var content_f9_50_10022=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Oxazepam: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?30/29/31188?source=see_link\">",
"    see \"Oxazepam: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F204465\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Oxazepam&reg;;",
"     </li>",
"     <li>",
"      Bio-Oxazepam;",
"     </li>",
"     <li>",
"      Novoxapram&reg;;",
"     </li>",
"     <li>",
"      Oxpam&reg;;",
"     </li>",
"     <li>",
"      Oxpram&reg;;",
"     </li>",
"     <li>",
"      PMS-Oxazepam;",
"     </li>",
"     <li>",
"      Riva-Oxazepam",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F204501\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Benzodiazepine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F204468\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Anxiety:",
"     </b>",
"     Oral: 10-30 mg 3-4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Ethanol withdrawal:",
"     </b>",
"     Oral: 15-30 mg 3-4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypnotic:",
"     </b>",
"     Oral: 15-30 mg",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F204469\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Anxiety: 10 mg 2-3 times/day; increase gradually as needed to a total of 30-45 mg/day. Dose titration should be slow to evaluate sensitivity.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F204470\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not dialyzable (0% to 5%)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F204441\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral: 10 mg, 15 mg, 30 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F204426\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F204503\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-IV",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F204446\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer orally in divided doses.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F204445\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of anxiety; management of ethanol withdrawal",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F204498\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Anticonvulsant in management of simple partial seizures; hypnotic",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F204510\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Oxazepam may be confused with oxaprozin, quazepam",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Serax may be confused with Eurax&reg;, Urex, ZyrTEC&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - high;  Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Murelax [Australia] may be confused with MiraLax brand name for polyethylene glycol 3350 [U.S.]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F204499\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Syncope (rare), edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Drowsiness, ataxia, dizziness, vertigo, memory impairment, headache, paradoxical reactions (excitement, stimulation of effect), lethargy, amnesia, euphoria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Decreased libido, menstrual irregularities",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Incontinence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Leukopenia, blood dyscrasias",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Jaundice",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Dysarthria, tremor, reflex slowing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision, diplopia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Drug dependence",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F204449\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to oxazepam or any component of the formulation (cross-sensitivity with other benzodiazepines may exist); narrow-angle glaucoma (not in product labeling, however, benzodiazepines are contraindicated); not indicated for use in the treatment of psychosis; pregnancy",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F204430\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anterograde amnesia: Benzodiazepines have been associated with anterograde amnesia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypotension: May cause hypotension (rare); use with caution in patients with cardiovascular or cerebrovascular disease, or in patients who would not tolerate transient decreases in blood pressure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Paradoxical reactions: Paradoxical reactions, including hyperactive or aggressive behavior, have been reported with benzodiazepines, particularly in adolescent/pediatric or psychiatric patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Depression: Use caution in patients with depression, particularly if suicidal risk may be present.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug abuse: Use with caution in patients with a history of drug abuse or acute alcoholism; potential for drug dependency exists. Tolerance, psychological and physical dependence may occur with prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Impaired gag reflex: Use with caution in patients with an impaired gag reflex.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory disease: Use with caution in patients with respiratory disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depressants/psychoactive medications: Use with caution in patients receiving other CNS depressants or psychoactive medication; effects with other sedative drugs or ethanol may be potentiated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Debilitated patients: Use with caution in debilitated patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: In older adults, benzodiazepines increase the  risk of impaired cognition, delirium, falls, fractures, and motor vehicle accidents. Due to increased sensitivity in this age group, avoid use for treatment of insomnia, agitation, or delirium. (Beers Criteria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Fall risk: Use with extreme caution in patients who are at risk of falls; benzodiazepines have been associated with falls and traumatic injury.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy in established in pediatric patients &lt;6 years of age; dose has not been established between 6-12 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Does not have analgesic, antidepressant, or antipsychotic properties.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Withdrawal: Rebound or withdrawal symptoms may occur following abrupt discontinuation or large decreases in dose. Use caution when reducing dose or withdrawing therapy; decrease slowly and monitor for withdrawal symptoms. Flumazenil may cause withdrawal in patients receiving long-term benzodiazepine therapy.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299801\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F204435\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Benzodiazepines may enhance the adverse/toxic effect of CloZAPine.  Management: Consider decreasing the dose of (or possibly discontinuing) benzodiazepines prior to initiating clozapine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Benzodiazepines may increase the serum concentration of Fosphenytoin. Short-term exposure to benzodiazepines may not present as much risk as chronic therapy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OLANZapine: May enhance the adverse/toxic effect of Benzodiazepines. Management: Avoid concomitant use of parenteral benzodiazepines and IM olanzapine due to risks of additive adverse events (e.g., cardiorespiratory depression). Olanzapine prescribing information provides no specific recommendations regarding oral administration.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: Benzodiazepines may increase the serum concentration of Phenytoin. Short-term exposure to benzodiazepines may not present as much risk as chronic therapy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: Benzodiazepines may enhance the CNS depressant effect of Sodium Oxybate.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: May diminish the therapeutic effect of Benzodiazepines.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Yohimbine: May diminish the therapeutic effect of Antianxiety Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F204460\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: Avoid valerian, St John's wort, kava kava, gotu kola (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F11229424\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oxazepam crosses the placenta. Teratogenic effects have been observed with some benzodiazepines; however, additional studies are needed. The incidence of premature birth and low birth weights may be increased following maternal use of benzodiazepines; hypoglycemia and respiratory problems in the neonate may occur following exposure late in pregnancy. Neonatal withdrawal symptoms may occur within days to weeks after birth and &ldquo;floppy infant syndrome&rdquo; (which also includes withdrawal symptoms) have been reported with some benzodiazepines.",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F11229425\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Drowsiness, lethargy, or weight loss in nursing infants have been observed in case reports following maternal use of some benzodiazepines.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F204452\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Oxazepam Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (100): $87.08",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     15 mg (100): $109.95",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     30 mg (100): $190.83",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F204438\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Respiratory and cardiovascular status",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F204442\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Therapeutic: 0.2-1.4 mcg/mL (SI: 0.7-4.9 micromole/L)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F204453\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Adumbran (AT, DE, GR);",
"     </li>",
"     <li>",
"      Alepam (AU, TW);",
"     </li>",
"     <li>",
"      Alopam (DK, NO);",
"     </li>",
"     <li>",
"      Anastil (VE);",
"     </li>",
"     <li>",
"      Anxiolit (AT, CH);",
"     </li>",
"     <li>",
"      Anxiolit Retard (CH);",
"     </li>",
"     <li>",
"      Enidrel (AR);",
"     </li>",
"     <li>",
"      Limbial (IT);",
"     </li>",
"     <li>",
"      Medopam (ZA);",
"     </li>",
"     <li>",
"      Murelax (AU);",
"     </li>",
"     <li>",
"      Nesontil (AR);",
"     </li>",
"     <li>",
"      Noripam (ZA);",
"     </li>",
"     <li>",
"      Nozepam (RU);",
"     </li>",
"     <li>",
"      Oksazepam (HR, PL);",
"     </li>",
"     <li>",
"      Opamox (FI);",
"     </li>",
"     <li>",
"      Ox-Pam (NZ);",
"     </li>",
"     <li>",
"      Oxazepam (PL);",
"     </li>",
"     <li>",
"      Oxazepam Efeka (LU);",
"     </li>",
"     <li>",
"      Oxazepam-Eurogenerics (LU);",
"     </li>",
"     <li>",
"      Oxazepam-ratiopharm (LU);",
"     </li>",
"     <li>",
"      Praxiten (AT, HR);",
"     </li>",
"     <li>",
"      Purata (ZA);",
"     </li>",
"     <li>",
"      Selars (TW);",
"     </li>",
"     <li>",
"      Serefar (UY);",
"     </li>",
"     <li>",
"      Serenal (PT);",
"     </li>",
"     <li>",
"      Serepax (AU, CN, IN, NZ, ZA);",
"     </li>",
"     <li>",
"      Seresta (BE, CH, FR, LU, NL);",
"     </li>",
"     <li>",
"      Simazepan (PY);",
"     </li>",
"     <li>",
"      Sobril (NO, SE);",
"     </li>",
"     <li>",
"      Suxidina (ES);",
"     </li>",
"     <li>",
"      Tranquo (LU);",
"     </li>",
"     <li>",
"      Vaben (IL);",
"     </li>",
"     <li>",
"      Youfei (CL)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F204429\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Binds to stereospecific benzodiazepine receptors on the postsynaptic GABA neuron at several sites within the central nervous system, including the limbic system, reticular formation. Enhancement of the inhibitory effect of GABA on neuronal excitability results by increased neuronal membrane permeability to chloride ions. This shift in chloride ions results in hyperpolarization (a less excitable state) and stabilization.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F204448\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Almost complete",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 86% to 99%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic to inactive compounds (primarily as glucuronides)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 2.8-5.7 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: 2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (as unchanged drug [50%] and metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"Transfer of Drugs and Other Chemicals Into Human Milk,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/50/10022/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/50/10022/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bergman U, Rosa FW, Baum C, et al, \"Effects of Exposure to Benzodiazepine During Fetal Life,\"",
"      <i>",
"       Lancet",
"      </i>",
"      , 1992, 340(8821):694-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/50/10022/abstract-text/1355799/pubmed\" id=\"1355799\" target=\"_blank\">",
"        1355799",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hicks R, Dysken MW, Davis JM, et al, &ldquo;The Pharmacokinetics of Psychotropic Medication in the Elderly: A Review,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 1981, 42(10):374-85.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/50/10022/abstract-text/7026541/pubmed\" id=\"7026541\" target=\"_blank\">",
"        7026541",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Iqbal MM, Sobhan T, Ryals T, et al, \"Effects of Commonly Used Benzodiazepines on the Fetus, the Neonate, and the Nursing Infant,\"",
"      <i>",
"       Psychiatr Serv",
"      </i>",
"      , 2002, 53(1):39-49.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/50/10022/abstract-text/11773648/pubmed\" id=\"11773648\" target=\"_blank\">",
"        11773648",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kangas L, Erkkola R, Kanto J, et al, \"Transfer of Free and Conjugated Oxazepam Across the Human Placenta,\"",
"      <i>",
"       Eur J Clin Pharmacol",
"      </i>",
"      , 1980, 17(4):301-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/50/10022/abstract-text/7398730/pubmed\" id=\"7398730\" target=\"_blank\">",
"        7398730",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mokhlesi B, Leikin JB, Murray P, et al, &ldquo;Adult Toxicology in Critical Care: Part II: Specific Poisonings,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2003, 123(3):897-922.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/50/10022/abstract-text/12628894/pubmed\" id=\"12628894\" target=\"_blank\">",
"        12628894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Moshkowitz M, Pines A, Finkelstein A, et al, &ldquo;Skin Blisters as a Manifestation of Oxazepam Toxicity,&rdquo;",
"      <i>",
"       J Toxicol Clin Toxicol",
"      </i>",
"      , 1990, 28(3):383-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/50/10022/abstract-text/2231838/pubmed\" id=\"2231838\" target=\"_blank\">",
"        2231838",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wikner BN, Stiller CO, Bergman U, et al, \"Use of Benzodiazepines and Benzodiazepine Receptor Agonists During Pregnancy: Neonatal Outcome and Congenital Malformations,\"",
"      <i>",
"       Pharmacoepidemiol Drug Saf",
"      </i>",
"      , 2007, 16(11):1203-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/50/10022/abstract-text/17894421/pubmed\" id=\"17894421\" target=\"_blank\">",
"        17894421",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zileli MS, Teletar F, Deniz S, et al, &ldquo;Oxazepam Intoxication Simulating Nonketo-Acidotic Diabetic Coma,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1971, 215(12):1986.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9726 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.131.240.2-13CD9D8202-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_50_10022=[""].join("\n");
var outline_f9_50_10022=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204465\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204501\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204468\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204469\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204470\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204441\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204426\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204503\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204446\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204445\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204498\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204510\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204499\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204449\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204430\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299801\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204435\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204460\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11229424\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11229425\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204452\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204438\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204442\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204453\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204429\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204448\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9726\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9726|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?30/29/31188?source=related_link\">",
"      Oxazepam: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_50_10023="Plasmacytoid dendritic cells anti-BDCA-2 in DM";
var content_f9_50_10023=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F53554&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F53554&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    Plasmacytoid dendritic cells anti-BDCA-2 in DM",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 341px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Plasmacytoid dendritic cells identified by immunoreactivity to anti-BDCA-2 antibody in a perimysial and perivascular location in dermatomyositis muscle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Steven A Greenberg, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_50_10023=[""].join("\n");
var outline_f9_50_10023=null;
var title_f9_50_10024="Sex chromosome abnormalities";
var content_f9_50_10024=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Sex chromosome abnormalities",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/50/10024/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/50/10024/contributors\">",
"     Carlos A Bacino, MD, FACMG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/50/10024/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/50/10024/contributors\">",
"     Helen V Firth, DM, FRCP, DCH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/50/10024/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/50/10024/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/50/10024/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H11420512\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sex chromosome abnormalities are due to numeric abnormalities (eg, aneuploidies such as monosomy X) or structural defects (eg, genomic disorders such as",
"    <em>",
"     MECP2",
"    </em>",
"    duplication syndrome). Congenital chromosomal abnormalities occur in at least 1 in 400 births [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/44/43717?source=see_link\">",
"     \"Glossary of genetic terms\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28087?source=see_link\">",
"     \"Genomic disorders: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other congenital cytogenetic abnormalities are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/0/23562?source=see_link\">",
"     \"Congenital cytogenetic abnormalities\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/14/34025?source=see_link\">",
"     \"Microdeletion syndromes (chromosomes 1 to 11)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/44/11978?source=see_link\">",
"     \"Microdeletion syndromes (chromosomes 12 to 22)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/17/37143?source=see_link\">",
"     \"Microduplication syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11420519\">",
"    <span class=\"h1\">",
"     NUMERIC ABNORMALITIES (ANEUPLOIDIES)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common sex chromosome aneuploidies are 45,X (Turner syndrome); 47,XXY (Klinefelter syndrome); 47,XYY; and 47,XXX, which have birth frequencies of approximately",
"    <span class=\"nowrap\">",
"     1/2500,",
"    </span>",
"    <span class=\"nowrap\">",
"     1/500",
"    </span>",
"    to",
"    <span class=\"nowrap\">",
"     1/1000,",
"    </span>",
"    <span class=\"nowrap\">",
"     1/900",
"    </span>",
"    to 1500, and",
"    <span class=\"nowrap\">",
"     1/1000,",
"    </span>",
"    respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/2-7\">",
"     2-7",
"    </a>",
"    ]. Sex chromosome mosaicism involving a normal cell line is not unusual. The two most common sex chromosome mosaicisms are",
"    <span class=\"nowrap\">",
"     45,X/46,XX",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     45,X/46,XY",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. The severity of the phenotype in patients with mosaicism is related to the percentage of abnormal cells [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11420526\">",
"    <span class=\"h2\">",
"     Monosomy X (45,X or Turner syndrome)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with Turner syndrome have monosomy for the X chromosome with a 45,X karyotype. Other forms of Turner include mosaicism for the X-chromosome (eg,",
"    <span class=\"nowrap\">",
"     45,X/46,XX)",
"    </span>",
"    or are a",
"    <span class=\"nowrap\">",
"     45,X/46,XY",
"    </span>",
"    mosaic with a partial deletion of the Y chromosome. The remaining patients have a structural abnormality of the second X chromosome (eg, an isochromosome of the long arm of X or a deletion involving the short arm of one X). Deletions involving the distal portion of the short arm of the Y chromosome are associated with the Turner phenotype because these individuals are missing the so-called &lsquo;anti-Turner&rsquo; genes (",
"    <em>",
"     SHOX",
"    </em>",
"    ,",
"    <em>",
"     RPSY4",
"    </em>",
"    , and",
"    <em>",
"     ZFY",
"    </em>",
"    ). Deletions of the short arm of the X chromosome are also associated with a Turner phenotype [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/12\">",
"     12",
"    </a>",
"    ]. Most cases represent sporadic events. (See",
"    <a class=\"local\" href=\"#H3195118\">",
"     '45,X/46,XX mosaicism'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H3195154\">",
"     '45,X/46,XY mosaicism'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H3287567\">",
"     'Isochromosome Xq'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H3287938\">",
"     'Xp22 SHOX deletions'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Turner syndrome is characterized by short stature together with some of the following features: dysmorphic features including low and posteriorly rotated ears, webbing of the neck, shield like chest (broad with wide-spaced nipples), lymphedema, cubitus valgus, short fourth metacarpal, hypoplastic nails, pigmented nevi, and congenital heart defects. The heart defects typically involve the left outflow tract and coarctation of the aorta is a common finding. In addition, Turner patients develop streak gonads with ovarian failure and pubertal delay. Renal anomalies can also occur (horseshoe kidneys). Lymphedema in the dorsum of hands and feet may be the only clinical features seen in newborns. Individuals with Turner syndrome that carry Y chromosome material (some mosaic Turner) are at increased risk of developing gonadoblastoma. Turner syndrome is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33449?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/63/14329?source=see_link\">",
"     \"Management of Turner syndrome (gonadal dysgenesis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11420533\">",
"    <span class=\"h2\">",
"     47,XXY Klinefelter syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Klinefelter syndrome is the most common sex chromosome abnormality causing primary hypogonadism. The 47,XXY karyotype results from nondisjunction of the sex chromosomes and can be maternal or paternal in origin. Most cases are detected postnatally and are diagnosed during evaluation for infertility, incomplete virilization, gynecomastia, cryptorchidism, or neurodevelopmental disorders.",
"   </p>",
"   <p>",
"    Male newborns with the 47,XXY karyotype are phenotypically normal, with normal male external genitalia and no apparent dysmorphic features. The major clinical manifestations of Klinefelter syndrome include tall stature, small testes, and infertility (azoospermia) that become noticeable after puberty. Patients with Klinefelter syndrome are at increased risk for psychiatric disorders, autism spectrum disorders, and social problems. Patients diagnosed with Klinefelter syndrome should have a neurodevelopmental evaluation and be referred to an endocrinologist. Klinefelter syndrome is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30536?source=see_link&amp;anchor=H3#H3\">",
"     \"Causes of primary hypogonadism in males\", section on 'Klinefelter's syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10073?source=see_link&amp;anchor=H20#H20\">",
"     \"The child with tall stature or abnormally rapid growth\", section on 'Klinefelter syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/54/11114?source=see_link&amp;anchor=H16#H16\">",
"     \"Causes of male infertility\", section on 'Klinefelter's syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11420540\">",
"    <span class=\"h2\">",
"     47,XYY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals with 47,XYY have tall stature and may have mild delay in motor and language development. A significant proportion of XYY males require special educational intervention but are generally educated in mainstream school [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/13\">",
"     13",
"    </a>",
"    ]. They have normal pubertal development and most are fertile [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10073?source=see_link\">",
"     \"The child with tall stature or abnormally rapid growth\"",
"    </a>",
"    .) Due to the subtlety of the phenotype and lack of associated health problems, many individuals with 47,XYY remain undiagnosed throughout their lifespan.",
"   </p>",
"   <p>",
"    In an early report, 47,XYY males were thought to have increased aggressive behavior [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/15\">",
"     15",
"    </a>",
"    ]. However, a subsequent large collaborative study by European and United States geneticists concluded that the increased rate of criminal activity in XYY males was related to a lack of judgment and lower socioeconomic status due to a lower mean IQ score (by 10 points), which led them into difficulty with the law and usually minor crimes [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. Higher rates of attention deficit hyperactivity disorder and autism spectrum disorders are reported in 47,XYY [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/19\">",
"     19",
"    </a>",
"    ]. A neurodevelopmental evaluation is recommended in patients diagnosed with 47,XYY, given the high prevalence of learning disabilities and behavioral problems.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11420547\">",
"    <span class=\"h2\">",
"     47,XXX",
"    </span>",
"    &nbsp;&mdash;&nbsp;47,XXX (also called triple X) is the most common female chromosomal abnormality [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/5\">",
"     5",
"    </a>",
"    ]. Most individuals with 47,XXX are diagnosed incidentally prenatally on genetic screening [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/20\">",
"     20",
"    </a>",
"    ]. These women do not appear to be at increased risk of having chromosomally abnormal offspring [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A review of 155 females with 47,XXX karyotype found that 62 percent of these individuals were physically normal [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/22\">",
"     22",
"    </a>",
"    ]. Thus, it is estimated that most individuals with 47,XXX are never diagnosed [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/5\">",
"     5",
"    </a>",
"    ]. 47,XXX females have a tendency to be tall, with many reaching the 80th centile by adolescence, but with average head circumference between the 25th to 35th centile [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/16\">",
"     16",
"    </a>",
"    ]. Puberty and fertility are generally the normal range, but premature ovarian failure can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/5,16\">",
"     5,16",
"    </a>",
"    ]. Another prospective study of eleven 47,XXX females identified in a newborn survey at birth reported that their verbal and performance intelligence quotient (IQ) scores were 15 to 20 points lower than those of their siblings [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/23\">",
"     23",
"    </a>",
"    ]. Thus, monitoring for developmental delays and psychologic problems is recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11420554\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over 100 cases of 49,XXXXY [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/24\">",
"     24",
"    </a>",
"    ], at least 20 cases of 49,XXXXX [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/25\">",
"     25",
"    </a>",
"    ], and a few cases of 49,XYYYY [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/26\">",
"     26",
"    </a>",
"    ] have been reported. There appears to be a direct relationship between the number of additional sex chromosomes and the severity of the phenotype. In addition, a review of tetrasomy and pentasomy of sex chromosomes concluded that polysomy of the X chromosome results in a more deleterious effect than polysomy of the Y chromosome [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/1\">",
"     1",
"    </a>",
"    ]. Studies have shown that the IQ is reduced by 10 points for every extra X chromosome beyond the normal number [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3287436\">",
"    <span class=\"h3\">",
"     49,XXXXY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The characteristic clinical features of the XXXXY karyotype are low nasal bridge with a wide or up-turned tip, wide-set eyes, epicanthal folds, skeletal anomalies (especially radioulnar synostosis), congenital heart disease, endocrine disorders, and severe hypogonadism and hypogenitalism [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/24,28,29\">",
"     24,28,29",
"    </a>",
"    ]. Severe intellectual disability and moderately short stature are usual. Although individuals with this karyotype are often labeled as Klinefelter variant, the characteristic features of XXXXY all point to a distinct phenotype [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/24,30\">",
"     24,30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3287443\">",
"    <span class=\"h3\">",
"     49,XXXXX",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intellectual disability is always present in females with 49,XXXXX (also called pentasomy X) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/25\">",
"     25",
"    </a>",
"    ]. Other findings, such as craniofacial, cardiovascular, and skeletal abnormalities are quite variable. Patients with pentasomy X may have clinical features resembling those seen in Down syndrome. Radioulnar synostosis is also commonly seen in patients with multiple X chromosomes. Some patients have mosaicism of 48,XXXX and 49,XXXXX [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=see_link\">",
"     \"Clinical features and diagnosis of Down syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3195118\">",
"    <span class=\"h2\">",
"     45,X/46,XX mosaicism",
"    </span>",
"    &nbsp;&mdash;&nbsp;This is the most common sex chromosome mosaicism diagnosed by amniocentesis and prenatal karyotyping [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Individuals with this type of mosaicism have milder clinical features of Turner syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/9,33-35\">",
"     9,33-35",
"    </a>",
"    ]. Many women undergo spontaneous puberty and have reproduced. (See",
"    <a class=\"local\" href=\"#H11420526\">",
"     'Monosomy X (45,X or Turner syndrome)'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33449?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/63/14329?source=see_link\">",
"     \"Management of Turner syndrome (gonadal dysgenesis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A review of 156 prenatally diagnosed cases of",
"    <span class=\"nowrap\">",
"     45,X/46,XX",
"    </span>",
"    with available outcome information found that 14 percent had an abnormal outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/36\">",
"     36",
"    </a>",
"    ]. There were two stillbirths and 20 cases with an abnormal phenotype (12 had some features of Turner syndrome and 8 showed anomalies possibly not related to Turner syndrome). Over 85 percent of cases appeared to result in phenotypically normal females either at birth or at termination. However, the major features of Turner syndrome (eg, short stature and lack of secondary sex characteristics) are only manifested later in childhood or adolescence and would not be detected among infants.",
"    <span class=\"nowrap\">",
"     45,X/46,XX",
"    </span>",
"    mosaicism is reported in some women with premature ovarian failure who are otherwise phenotypically normal [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3195154\">",
"    <span class=\"h2\">",
"     45,X/46,XY mosaicism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mosaicism involving",
"    <span class=\"nowrap\">",
"     45,X/46,XY",
"    </span>",
"    has a wide phenotypic spectrum [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. In a retrospective series of 151 postnatally diagnosed cases of",
"    <span class=\"nowrap\">",
"     45,X/46,XY",
"    </span>",
"    mosaicism, for example, 42 percent of patients were phenotypic females with typical or atypical Turner syndrome, 42 percent had ambiguous external genitalia and asymmetrical gonads (ie, mixed gonadal dysgenesis), and 15 percent had a male phenotype with incomplete masculinization [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/40\">",
"     40",
"    </a>",
"    ]. Thus, all postnatally diagnosed cases were phenotypically abnormal. However, this can be explained by the fact that children or adults with mosaicism and a normal phenotype are not likely to seek medical attention (ascertainment bias). In contrast, among 80 prenatally diagnosed cases of",
"    <span class=\"nowrap\">",
"     45,X/46,XY",
"    </span>",
"    mosaicism, 74 (92.5 percent) were grossly normal males [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11420526\">",
"     'Monosomy X (45,X or Turner syndrome)'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33449?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A high resolution ultrasound exam of the fetus with special emphasis on the external genitalia is recommended when a diagnosis of",
"    <span class=\"nowrap\">",
"     45,X/46,XY",
"    </span>",
"    is made prenatally. Visualization of male genitalia can be more reassuring to parents than a quantitative estimate of risk of phenotypic abnormality. However, it is not known whether linear growth and fertility may be influenced by the 45,X cell line in phenotypically normal male infants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11420561\">",
"    <span class=\"h1\">",
"     STRUCTURAL ABNORMALITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Structural abnormalities primarily consist of isochromosomes, deletions, duplications, ring chromosomes, and translocations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28087?source=see_link\">",
"     \"Genomic disorders: An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18167?source=see_link\">",
"     \"Chromosomal translocations, deletions, and inversions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3287567\">",
"    <span class=\"h2\">",
"     Isochromosome Xq",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isochromosome for the long arm of the X chromosome, isoXq or i(Xq), in which the short arm (p) is deleted and replaced with an exact copy of the long arm (q), is the most common structural sex chromosome abnormality [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/16,41\">",
"     16,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is not associated with increased parental age [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/42\">",
"     42",
"    </a>",
"    ]. 46,X,i(Xq) can occur as a nonmosaic or as a mosaic with a normal 46,XX cell line, 45,X cell line, or both. Isochromosomes Xq and Yq are associated with Turner syndrome, probably because the major anti-Turner syndrome gene,",
"    <em>",
"     SHOX",
"    </em>",
"    (short stature homeobox-containing gene on the X-chromosome), is located at the distal portion of the short arms of the X and Y chromosomes (at the pseudoautosomal pairing regions) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/40,43\">",
"     40,43",
"    </a>",
"    ]. The Xq isochromosome is also seen in patients with a variant of Klinefelter syndrome, 47,X,i(Xq),Y [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/44-48\">",
"     44-48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33449?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30536?source=see_link&amp;anchor=H3#H3\">",
"     \"Causes of primary hypogonadism in males\", section on 'Klinefelter's syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3287758\">",
"    <span class=\"h2\">",
"     Xp22.11 deletion",
"    </span>",
"    &nbsp;&mdash;&nbsp;A deletion in Xp22.11 involving",
"    <em>",
"     PTCHD1",
"    </em>",
"    (patched-related) gene was reported in several families with autism spectrum disorder and in three families with intellectual disability [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/49\">",
"     49",
"    </a>",
"    ].",
"    <em>",
"     PTCHD1",
"    </em>",
"    is a candidate gene for X-linked intellectual disability with or without autism [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/50\">",
"     50",
"    </a>",
"    ]. The function and role of this gene is unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3287831\">",
"    <span class=\"h2\">",
"     Xp22.3 deletion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deletion of this region is often associated with microphthalmia and linear skin defects (MLS) syndrome, an X-linked dominant disorder that is lethal in males and therefore only seen in females [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/51\">",
"     51",
"    </a>",
"    ]. A gene in this region encoding mitochondrial holocytochrome c-type synthetase (",
"    <em>",
"     HCCS",
"    </em>",
"    ) was found mutated in patients with MLS who did not have the deletion [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/52-55\">",
"     52-55",
"    </a>",
"    ]. The clinical presentation of MLS consists of microphthalmia and anophthalmia (unilateral or bilateral) and linear skin defects, mostly in the face and neck, that heal with time. Structural brain abnormalities, developmental delay, and seizures are part of the clinical spectrum. Heart defects (such as hypertrophic cardiomyopathy and arrhythmias), short stature, diaphragmatic hernia, nail dystrophy, preauricular pits and hearing loss, and genitourinary malformations are also common clinical findings.",
"   </p>",
"   <p>",
"    Screening evaluations include ophthalmologic evaluation (consider prosthesis), developmental and dermatology evaluations, echocardiogram, brain magnetic resonance imaging (MRI), and electroencephalogram (EEG). Patient may benefit from physical, occupation, and speech therapy (PT, OT and ST).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3287938\">",
"    <span class=\"h2\">",
"     Xp22 SHOX deletions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deletions of Xp22 encompassing the short stature homeobox-containing (",
"    <em>",
"     SHOX",
"    </em>",
"    ) gene is causative for idiopathic short stature [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/43,56,57\">",
"     43,56,57",
"    </a>",
"    ]. The",
"    <em>",
"     SHOX",
"    </em>",
"    gene is found in the pseudoautosomal region 1 (PAR1) of the X and Y chromosomes. This gene is considered a major player in the short stature of Turner syndrome and haploinsufficiency of this gene causes Leri-Weill dyschondrosteosis (LWD) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/43,58\">",
"     43,58",
"    </a>",
"    ]. LWD is characterized by short stature, more severe in females, and Madelung deformities (focal dysplasia of the distal radial physis). Homozygous deletions of SHOX cause Langer dysplasia, a more severe form of metaphyseal dysplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/59\">",
"     59",
"    </a>",
"    ]. SHOX deletions can also be seen in patients with short stature and no other specific skeletal signs. More than 60 percent of the SHOX rearrangements are gene deletions, therefore array comparative genomic hybridization (array CGH) should be considered in the workup of idiopathic short stature, followed by sequencing to ascertain point mutations if no deletions are found. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33449?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)\", section on 'Pathogenesis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/60/38855?source=see_link&amp;anchor=H22#H22\">",
"     \"Causes of chronic wrist pain in children and adolescents\", section on 'Madelung deformity'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=see_link&amp;anchor=H15538652#H15538652\">",
"     \"Cytogenetic and molecular genetic diagnostic tools\", section on 'Array comparative genomic hybridization'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28087?source=see_link&amp;anchor=H3390507#H3390507\">",
"     \"Genomic disorders: An overview\", section on 'Array comparative genomic hybridization'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/18/10537?source=see_link&amp;anchor=H15021208#H15021208\">",
"     \"Causes of short stature\", section on 'Idiopathic short stature'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8048794\">",
"    <span class=\"h2\">",
"     Xp11.22 deletions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deletions of the Xp11.22 region including the",
"    <em>",
"     PHF8",
"    </em>",
"    (PHD finger protein 8) gene have been reported in association with intellectual disability, cleft",
"    <span class=\"nowrap\">",
"     lip/palate,",
"    </span>",
"    and autistic spectrum disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/60\">",
"     60",
"    </a>",
"    ]. Truncating mutations of the",
"    <em>",
"     PHF8",
"    </em>",
"    gene are associated with the X-linked mental retardation Siderius-Hamel syndrome (MIM #300263).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8048822\">",
"    <span class=\"h2\">",
"     Xp22.31 duplication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Duplications in Xp22.31 have been extensively reported in the literature. There has been much debate about whether this duplication is pathogenic or a benign finding, underscoring the difficulties in determining the consequences of copy number variations (CNVs) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. This duplication involves the steroid sulfatase (",
"    <em>",
"     STS",
"    </em>",
"    ) gene. Deletions of this gene are associated with X-linked ichthyosis in males. This duplication has been reported in patients with intellectual disabilities. However, it has also been seen in the patients&rsquo; normal relatives as well as in the general population. While duplications of this gene may have no phenotypic consequences, triplications are consistently associated with intellectual disabilities [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/63\">",
"     63",
"    </a>",
"    ]. FISH studies can ultimately aid in distinguishing duplications from triplications or multiple copy number gains. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/63/5112?source=see_link&amp;anchor=H14#H14\">",
"     \"Overview of genetic variation\", section on 'Copy number variations (CNVs)'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28087?source=see_link&amp;anchor=H16722199#H16722199\">",
"     \"Genomic disorders: An overview\", section on 'Copy number variations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8048829\">",
"    <span class=\"h2\">",
"     MECP2 duplication syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in the gene encoding methyl-CpG binding protein 2 (",
"    <em>",
"     MECP2",
"    </em>",
"    ) located in Xq28 are responsible for Rett syndrome.",
"    <em>",
"    </em>",
"    Duplications of this region have little or no phenotypic significance in females, who are most likely normal due to X-inactivation of the abnormal X chromosome. Males with this duplication are severely impaired (MIM #300260). The clinical presentation includes early hypotonia, severe to profound intellectual disability, speech delay, feeding difficulties, frequent respiratory infections, and seizures ranging from tonic-clonic type to absence seizures, sometimes refractory to treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/64-67\">",
"     64-67",
"    </a>",
"    ]. Many patients with this duplication have been diagnosed with autism or autism spectrum disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/68\">",
"     68",
"    </a>",
"    ]. Similarly to what is seen in Rett syndrome, patients with",
"    <em>",
"     MECP2",
"    </em>",
"    duplication experience developmental regression. In addition they develop ataxia, progressive lower limbs spasticity, and often lose their ability to ambulate. Gastrointestinal problems and severe constipation have been reported. The prognosis is guarded and most males with this duplication die in their mid 20s secondary to respiratory infections. The gene for interleukin 1 receptor-associated kinase 1 (",
"    <em>",
"     IRAK1",
"    </em>",
"    ) is often involved in the duplication and may play a role in the immune abnormalities seen in this group of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10024/abstract/68\">",
"     68",
"    </a>",
"    ]. Triplication of this region produces an even more severe phenotype in males.",
"   </p>",
"   <p>",
"    Screening studies for these patients include an EEG, swallowing studies, and assessment of humoral and cellular immunity. Treatment may include management of hypotonia (PT and OT) and spasticity, speech therapy, gastrostomy tube (g-tube or g-button) for feeding difficulties, and management of respiratory infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8049117\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sex chromosome abnormalities can be due to numeric abnormalities (aneuploidies) or structural defects. (See",
"      <a class=\"local\" href=\"#H11420512\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common sex chromosome aneuploidies are: 45,X (Turner syndrome); 47,XXY (Klinefelter syndrome); 47,XYY; and 47,XXX. Sex chromosome mosaicism involving a normal cell line is not unusual. The two most common sex chromosome mosaicisms are",
"      <span class=\"nowrap\">",
"       45,X/46,XX",
"      </span>",
"      and",
"      <span class=\"nowrap\">",
"       45,X/46,XY.",
"      </span>",
"      The severity of the phenotype in patients with mosaicism is related to the percentage of abnormal cells. (See",
"      <a class=\"local\" href=\"#H11420519\">",
"       'Numeric abnormalities (aneuploidies)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Structural abnormalities of the X and Y chromosomes primarily consist of isochromosomes, deletions, duplications, ring chromosomes, and translocations. One example of a genomic disorder is duplication of",
"      <em>",
"       MECP2",
"      </em>",
"      in males, which is associated with hypotonia, severe to profound intellectual disability, speech delay, feeding difficulties, frequent respiratory infections, and seizures ranging from tonic-clonic type to absence seizures. (See",
"      <a class=\"local\" href=\"#H11420561\">",
"       'Structural abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/1\">",
"      Linden MG, Bender BG, Robinson A. Sex chromosome tetrasomy and pentasomy. Pediatrics 1995; 96:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/2\">",
"      Stochholm K, Juul S, Juel K, et al. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 2006; 91:3897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/3\">",
"      Herlihy AS, Halliday JL, Cock ML, McLachlan RI. The prevalence and diagnosis rates of Klinefelter syndrome: an Australian comparison. Med J Aust 2011; 194:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/4\">",
"      Stochholm K, Juul S, Gravholt CH. Diagnosis and mortality in 47,XYY persons: a registry study. Orphanet J Rare Dis 2010; 5:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/5\">",
"      Tartaglia NR, Howell S, Sutherland A, et al. A review of trisomy X (47,XXX). Orphanet J Rare Dis 2010; 5:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/6\">",
"      Nielsen J, Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 1991; 87:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/7\">",
"      Maeda T, Ohno M, Matsunobu A, et al. A cytogenetic survey of 14,835 consecutive liveborns. Jinrui Idengaku Zasshi 1991; 36:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/8\">",
"      Wilson MG, Lin MS, Fujimoto A, et al. Chromosome mosaicism in 6,000 amniocenteses. Am J Med Genet 1989; 32:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/9\">",
"      Koeberl DD, McGillivray B, Sybert VP. Prenatal diagnosis of 45,X/46,XX mosaicism and 45,X: implications for postnatal outcome. Am J Hum Genet 1995; 57:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/10\">",
"      Sarkar R, Marimuthu KM. Association between the degree of mosaicism and the severity of syndrome in Turner mosaics and Klinefelter mosaics. Clin Genet 1983; 24:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/11\">",
"      Homer L, Le Martelot MT, Morel F, et al. 45,X/46,XX mosaicism below 30% of aneuploidy: clinical implications in adult women from a reproductive medicine unit. Eur J Endocrinol 2010; 162:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/12\">",
"      Ogata T, Muroya K, Matsuo N, et al. Turner syndrome and Xp deletions: clinical and molecular studies in 47 patients. J Clin Endocrinol Metab 2001; 86:5498.",
"     </a>",
"    </li>",
"    <li>",
"     Jones KL. Smith's recognizable patterns of human malformation, 6th ed, Elsevier Saunders, Philadelphia 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/14\">",
"      Abdel-Razic MM, Abdel-Hamid IA, ElSobky ES. Nonmosaic 47,XYY syndrome presenting with male infertility: case series. Andrologia 2012; 44:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/15\">",
"      Jacobs PA, Brunton M, Melville MM, et al. Aggressive behavior, mental sub-normality and the XYY male. Nature 1965; 208:1351.",
"     </a>",
"    </li>",
"    <li>",
"     Robinson A, Linden MG, Bender BG, et al. Prenatal diagnosis of sex chromosome abnormalities. In: Genetic disorders and the fetus, 4th ed, Milunsky A (Ed), The Johns Hopkins University Press, Baltimore 1998. p.249.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/17\">",
"      Witkin HA, Mednick SA, Schulsinger F, et al. Criminality in XYY and XXY men. Science 1976; 193:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/18\">",
"      Stochholm K, Bojesen A, Jensen AS, et al. Criminality in men with Klinefelter's syndrome and XYY syndrome: a cohort study. BMJ Open 2012; 2:e000650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/19\">",
"      Ross JL, Roeltgen DP, Kushner H, et al. Behavioral and social phenotypes in boys with 47,XYY syndrome or 47,XXY Klinefelter syndrome. Pediatrics 2012; 129:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/20\">",
"      Lalatta F, Quagliarini D, Folliero E, et al. Triple X syndrome: characteristics of 42 Italian girls and parental emotional response to prenatal diagnosis. Eur J Pediatr 2010; 169:1255.",
"     </a>",
"    </li>",
"    <li>",
"     Gardner RJM, Sutherland GR. Chromosome abnormalities and genetic counseling, 3rd ed, Oxford University Press, 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/22\">",
"      Barr ML, Sergovich FR, Carr DH, Saver EL. The triplo-X female: an appraisal based on a study of 12 cases and a review of the literature. Can Med Assoc J 1969; 101:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/23\">",
"      Robinson A, Bender BG, Linden MG, Salbenblatt JA. Sex chromosome aneuploidy: the Denver Prospective Study. Birth Defects Orig Artic Ser 1990; 26:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/24\">",
"      Peet J, Weaver DD, Vance GH. 49,XXXXY: a distinct phenotype. Three new cases and review. J Med Genet 1998; 35:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/25\">",
"      Kassai R, Hamada I, Furuta H, et al. Penta X syndrome: a case report with review of the literature. Am J Med Genet 1991; 40:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/26\">",
"      Shanske A, Sachmechi I, Patel DK, et al. An adult with 49,XYYYY karyotype: case report and endocrine studies. Am J Med Genet 1998; 80:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/27\">",
"      Rovet J, Netley C, Bailey J, et al. Intelligence and achievement in children with extra X aneuploidy: a longitudinal perspective. Am J Med Genet 1995; 60:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/28\">",
"      Patacchiola F, Sciarra A, Di Fonso A, et al. 49, XXXXY syndrome: an Italian child. J Pediatr Endocrinol Metab 2012; 25:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/29\">",
"      Gropman AL, Rogol A, Fennoy I, et al. Clinical variability and novel neurodevelopmental findings in 49, XXXXY syndrome. Am J Med Genet A 2010; 152A:1523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/30\">",
"      Tartaglia N, Ayari N, Howell S, et al. 48,XXYY, 48,XXXY and 49,XXXXY syndromes: not just variants of Klinefelter syndrome. Acta Paediatr 2011; 100:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/31\">",
"      Ricci N, Dallapiccola B, Ventimiglia B, et al. 48,XXXX-49,XXXXX mosaic: asynchronies among the late-replicating X chromosomes. Cytogenetics 1968; 7:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/32\">",
"      Wood A, Kleis L, Toriello H, Cemeroglu AP. Mosaic pentasomy X/tetrasomy X syndrome and premature ovarian failure. Indian Pediatr 2011; 48:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/33\">",
"      Suri M, Kabra M, Jain U, et al. A clinical and cytogenetic study of Turner syndrome. Indian Pediatr 1995; 32:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/34\">",
"      Hsu LY. Prenatal diagnosis of 45,X/46,XX. Am J Hum Genet 1996; 58:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/35\">",
"      Gunther DF, Eugster E, Zagar AJ, et al. Ascertainment bias in Turner syndrome: new insights from girls who were diagnosed incidentally in prenatal life. Pediatrics 2004; 114:640.",
"     </a>",
"    </li>",
"    <li>",
"     Hsu LYF. Prenatal diagnosis of chromosomal abnormalities through amniocentesis. In: Genetic disorders and the fetus, 4th ed, Milansky A (Ed), The Johns Hopkins University Press, Baltimore 1998. p.179.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/37\">",
"      Devi AS, Metzger DA, Luciano AA, Benn PA. 45,X/46,XX mosaicism in patients with idiopathic premature ovarian failure. Fertil Steril 1998; 70:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/38\">",
"      Devi A, Benn PA. X-chromosome abnormalities in women with premature ovarian failure. J Reprod Med 1999; 44:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/39\">",
"      El Moussaif N, Haddad NE, Iraqi N, Gaouzi A. 45,X/46,XY mosaicisme: report of five cases and clinical review. Ann Endocrinol (Paris) 2011; 72:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/40\">",
"      Hsu LY. Phenotype/karyotype correlations of Y chromosome aneuploidy with emphasis on structural aberrations in postnatally diagnosed cases. Am J Med Genet 1994; 53:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/41\">",
"      Scott SA, Cohen N, Brandt T, et al. Large inverted repeats within Xp11.2 are present at the breakpoints of isodicentric X chromosomes in Turner syndrome. Hum Mol Genet 2010; 19:3383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/42\">",
"      James RS, Dalton P, Gustashaw K, et al. Molecular characterization of isochromosomes of Xq. Ann Hum Genet 1997; 61:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/43\">",
"      Rao E, Weiss B, Fukami M, et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 1997; 16:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/44\">",
"      Kalousek D, Biddle CJ, Rudner M, et al. 47,X,i(Xq),Y karyotype in Klinefelter's syndrome. Hum Genet 1978; 43:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/45\">",
"      Donlan MA, Dolan CR, Metcalf MJ, et al. Trisomy Xq in a male: the isochromosome X Klinefelter syndrome. Am J Med Genet 1987; 27:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/46\">",
"      Fryns JP, Kleczkowska A, Steeno O. Isochromosome Xq in Klinefelter syndrome. Am J Med Genet 1990; 36:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/47\">",
"      Arps S, Koske-Westphal T, Meinecke P, et al. Isochromosome Xq in Klinefelter syndrome: report of 7 new cases. Am J Med Genet 1996; 64:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/48\">",
"      Demirhan O, Pazarba��i A, Tanriverdi N, et al. The clinical effects of isochromosome Xq in Klinefelter syndrome: report of a case and review of literature. Genet Couns 2009; 20:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/49\">",
"      Filges I, R&ouml;thlisberger B, Blattner A, et al. Deletion in Xp22.11: PTCHD1 is a candidate gene for X-linked intellectual disability with or without autism. Clin Genet 2011; 79:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/50\">",
"      Noor A, Whibley A, Marshall CR, et al. Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. Sci Transl Med 2010; 2:49ra68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/51\">",
"      al-Gazali LI, Mueller RF, Caine A, et al. Two 46,XX,t(X;Y) females with linear skin defects and congenital microphthalmia: a new syndrome at Xp22.3. J Med Genet 1990; 27:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/52\">",
"      Schaefer L, Ballabio A, Zoghbi HY. Cloning and characterization of a putative human holocytochrome c-type synthetase gene (HCCS) isolated from the critical region for microphthalmia with linear skin defects (MLS). Genomics 1996; 34:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/53\">",
"      Wimplinger I, Morleo M, Rosenberger G, et al. Mutations of the mitochondrial holocytochrome c-type synthase in X-linked dominant microphthalmia with linear skin defects syndrome. Am J Hum Genet 2006; 79:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/54\">",
"      Sharma VM, Ruiz de Luzuriaga AM, Waggoner D, et al. Microphthalmia with linear skin defects: a case report and review. Pediatr Dermatol 2008; 25:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/55\">",
"      Wimplinger I, Rauch A, Orth U, et al. Mother and daughter with a terminal Xp deletion: implication of chromosomal mosaicism and X-inactivation in the high clinical variability of the microphthalmia with linear skin defects (MLS) syndrome. Eur J Med Genet 2007; 50:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/56\">",
"      Huber C, Rosilio M, Munnich A, et al. High incidence of SHOX anomalies in individuals with short stature. J Med Genet 2006; 43:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/57\">",
"      Morizio E, Stuppia L, Gatta V, et al. Deletion of the SHOX gene in patients with short stature of unknown cause. Am J Med Genet A 2003; 119A:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/58\">",
"      Cormier-Daire V, Belin V, Cusin V, et al. SHOX gene mutations and deletions in dyschondrosteosis or Leri-Weill syndrome. Acta Paediatr Suppl 1999; 88:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/59\">",
"      Robertson SP, Shears DJ, Oei P, et al. Homozygous deletion of SHOX in a mentally retarded male with Langer mesomelic dysplasia. J Med Genet 2000; 37:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/60\">",
"      Qiao Y, Liu X, Harvard C, et al. Autism-associated familial microdeletion of Xp11.22. Clin Genet 2008; 74:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/61\">",
"      Furrow A, Theisen A, Velsher L, et al. Duplication of the STS region in males is a benign copy-number variant. Am J Med Genet A 2011; 155A:1972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/62\">",
"      Li F, Shen Y, K&ouml;hler U, et al. Interstitial microduplication of Xp22.31: Causative of intellectual disability or benign copy number variant? Eur J Med Genet 2010; 53:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/63\">",
"      Liu P, Erez A, Nagamani SC, et al. Copy number gain at Xp22.31 includes complex duplication rearrangements and recurrent triplications. Hum Mol Genet 2011; 20:1975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/64\">",
"      del Gaudio D, Fang P, Scaglia F, et al. Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet Med 2006; 8:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/65\">",
"      Meins M, Lehmann J, Gerresheim F, et al. Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. J Med Genet 2005; 42:e12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/66\">",
"      Ramocki MB, Tavyev YJ, Peters SU. The MECP2 duplication syndrome. Am J Med Genet A 2010; 152A:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/67\">",
"      Van Esch H, Bauters M, Ignatius J, et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet 2005; 77:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10024/abstract/68\">",
"      Ramocki MB, Peters SU, Tavyev YJ, et al. Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome. Ann Neurol 2009; 66:771.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16974 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-61.234.146.186-D9A34E86B4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_50_10024=[""].join("\n");
var outline_f9_50_10024=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8049117\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11420512\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11420519\">",
"      NUMERIC ABNORMALITIES (ANEUPLOIDIES)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11420526\">",
"      Monosomy X (45,X or Turner syndrome)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11420533\">",
"      47,XXY Klinefelter syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11420540\">",
"      47,XYY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11420547\">",
"      47,XXX",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11420554\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3287436\">",
"      - 49,XXXXY",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3287443\">",
"      - 49,XXXXX",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3195118\">",
"      45,X/46,XX mosaicism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3195154\">",
"      45,X/46,XY mosaicism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11420561\">",
"      STRUCTURAL ABNORMALITIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3287567\">",
"      Isochromosome Xq",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3287758\">",
"      Xp22.11 deletion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3287831\">",
"      Xp22.3 deletion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3287938\">",
"      Xp22 SHOX deletions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8048794\">",
"      Xp11.22 deletions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8048822\">",
"      Xp22.31 duplication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8048829\">",
"      MECP2 duplication syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8049117\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/60/38855?source=related_link\">",
"      Causes of chronic wrist pain in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/54/11114?source=related_link\">",
"      Causes of male infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30536?source=related_link\">",
"      Causes of primary hypogonadism in males",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/18/10537?source=related_link\">",
"      Causes of short stature",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18167?source=related_link\">",
"      Chromosomal translocations, deletions, and inversions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=related_link\">",
"      Clinical features and diagnosis of Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33449?source=related_link\">",
"      Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/0/23562?source=related_link\">",
"      Congenital cytogenetic abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=related_link\">",
"      Cytogenetic and molecular genetic diagnostic tools",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28087?source=related_link\">",
"      Genomic disorders: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/44/43717?source=related_link\">",
"      Glossary of genetic terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/63/14329?source=related_link\">",
"      Management of Turner syndrome (gonadal dysgenesis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/14/34025?source=related_link\">",
"      Microdeletion syndromes (chromosomes 1 to 11)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/44/11978?source=related_link\">",
"      Microdeletion syndromes (chromosomes 12 to 22)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/17/37143?source=related_link\">",
"      Microduplication syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/63/5112?source=related_link\">",
"      Overview of genetic variation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10073?source=related_link\">",
"      The child with tall stature or abnormally rapid growth",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_50_10025="Role of cytokines in rheumatic diseases";
var content_f9_50_10025=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Role of cytokines in rheumatic diseases",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/50/10025/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/50/10025/contributors\">",
"     Iain B McInnes, FRCP, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/50/10025/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/50/10025/contributors\">",
"     Daniel E Furst, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/50/10025/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/50/10025/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/50/10025/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cytokines are proteins that regulate the immune system and that participate in intercellular communications. A complex cytokine network is involved in normal immune function, and this network is comprised of positive and negative feedback loops that enhance or suppress the response. Many immune-mediated diseases (especially rheumatic diseases) involve the abnormal regulation of cytokines (",
"    <a class=\"graphic graphic_table graphicRef55029 \" href=\"UTD.htm?12/13/12507\">",
"     table 1",
"    </a>",
"    ). This can be manifested either by defective production of suppressive factors or by overproduction of proinflammatory cytokines (",
"    <a class=\"graphic graphic_figure graphicRef52469 \" href=\"UTD.htm?10/50/11048\">",
"     figure 1",
"    </a>",
"    ). As a result, understanding cytokine regulation abnormalities in these diseases could ultimately lead to novel and specific treatments. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/22/16746?source=see_link\">",
"     \"Cytokine networks in rheumatic diseases: Implications for therapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/19/3384?source=see_link\">",
"     \"Overview of biologic agents in the rheumatic diseases\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Issues relating to the role of cytokines in rheumatic diseases are reviewed here. Overviews of the effects of cytokines on the immune response the therapeutic implications of cytokine networks in rheumatic disease are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/8/4231?source=see_link\">",
"     \"Role of cytokines in the immune system\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/22/16746?source=see_link\">",
"     \"Cytokine networks in rheumatic diseases: Implications for therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RHEUMATOID ARTHRITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is more information on the role of cytokines in rheumatoid arthritis (RA) than in any other rheumatic disease. In addition, these studies have led to clinical trials with several novel agents designed to interrupt the cytokine network of RA. Anticytokine therapy has shown clear evidence of clinical efficacy, especially with tumor necrosis factor (TNF)-alpha directed approaches. In general, T cell derived factors are not as prominent as macrophage and fibroblast cytokines in the rheumatoid joint.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     T cell cytokines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Interferon (IFN)-gamma was the initial target of cytokine research in RA. This was due, in part, to the availability of sensitive IFN bioassays. The synovial fluid of patients with RA demonstrated IFN-like activity using viral cytopathic inhibition assays, which take advantage of the fact that interferons protect cells from viral infection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/1\">",
"     1",
"    </a>",
"    ]. The presence of HLA-DR expression in RA synovium also suggested the presence of IFN-gamma, since this cytokine was the most potent DR inducer known. These observations, along with later studies demonstrating putative IL-2 activity in synovial effusions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/2\">",
"     2",
"    </a>",
"    ] and the presence of T-cell surface markers associated with activation (MHC DR+, VLA4+, CD69+), tended to support the hypothesis that the T cells in RA were highly activated and that the local milieu contained significant concentrations of T cell derived cytokines.",
"   </p>",
"   <p>",
"    Subsequently, however, this view had to be reconsidered when specific immunoassays demonstrated only limited amounts of IFN-gamma in RA joints, far below that typically required to induce HLA-DR expression [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/3\">",
"     3",
"    </a>",
"    ]. The IFN-like activity that was detected in joints was actually due to non-IFN factors (demonstrating the vagaries of bioassays).",
"   </p>",
"   <p>",
"    The relatively low expression of IFN-gamma in RA is especially striking when it is compared with diseases known to be caused by T cells, such as tuberculous pleuritis. Substantial quantities of IFN-gamma and other T cell factors can be detected in these pleural effusions and may provide a yardstick for comparing cytokine production in RA [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The situation is similar with many other T cell factors in RA (",
"    <a class=\"graphic graphic_table graphicRef82355 \" href=\"UTD.htm?31/19/32060\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/5\">",
"     5",
"    </a>",
"    ]. Cytokines produced by the Th2 subset of T cells, including IL-4, are conspicuously absent. Th1 cytokines other than IFN-gamma are present to some degree, although in very small quantities. As an example, immunoassays have failed to detect significant amounts of IL-2 in synovial fluid, although RNA transcripts of T cell cytokines can be detected using reverse transcriptase-polymerase chain reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/6\">",
"     6",
"    </a>",
"    ]. Only small amounts of most T cell cytokines have been detected in synovial fluid or synovial tissues.",
"   </p>",
"   <p>",
"    One exception is interleukin (IL)-17, a Th17 cell derived cytokine that exhibits many of the same activities as IL-1 and TNF-alpha. Thus, IL-17 can independently increase production of metalloproteinases and inducible nitric oxide synthase in synoviocytes. More importantly, it can interact synergistically with IL-1 to greatly amplify its activity within the rheumatoid joint. In one study of 43 patients with RA and 20 controls, for example, the synovial fluid level of IL-17 was significantly higher in those with RA [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/7\">",
"     7",
"    </a>",
"    ]. IL-17 may be of particular importance in up-regulating the expression of the protein known variously as RANK-ligand, TRANCE, and osteoclast differentiation factor (ODF), which, in turn, is partially responsible for activating osteoclasts and thereby promoting bone erosion. It is not clear whether the majority of the synovial IL-17 production is derived from T cells, although IL-17 is a product of the Th17 cell subset; more IL-17 appears to come from mast cells than T cells under some circumstances [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is still unclear in general, therefore, why T cell products are so difficult to find in the rheumatoid joint. There are several possible explanations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The local production of suppressive factors and cytokine inhibitors may overwhelm the activating effects of antigens or",
"      <span class=\"nowrap\">",
"       macrophage/fibroblast",
"      </span>",
"      cytokines in chronic arthritis (see below).",
"     </li>",
"     <li>",
"      The cells may have entered a state of arrested activation or reached a dormant state that resembles anergy. This notion is supported by the observation that some synovial T cells contain IL-2 mRNA even though they do not secrete IL-2, a phenotype that has been described in anergy.",
"     </li>",
"     <li>",
"      Small amounts of cytokines produced in the microenvironment might be sufficient to sustain synovial inflammation.",
"     </li>",
"     <li>",
"      Cytokines may be inactivated by proteases derived from the neutrophilic inflammatory infiltrate in the synovial fluid.",
"     </li>",
"     <li>",
"      Synovial T cells may have not been activated by their specific antigen. This is almost certainly true for the vast majority of T cells in the joint, since recruitment into the joint is mediated by antigen-independent processes like chemokines and adhesion molecules. Antigen specific cells at an inflamed site comprise only a small percentage of the total number of T cells, perhaps less than one percent of lymphocytes. These cells might release cytokines into the microenvironment in amounts below the sensitivity of available assays, yet still be able to orchestrate a local response. Alternatively, cytokines might not be released by these activated cells but remain bound to cell membranes. However, this possibility is less likely since T cell-derived IL-2, IFN-gamma, and granulocyte macrophage colony-stimulating factor (GM-CSF) are abundant in other inflammatory diseases such as tuberculosis and asthma.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Direct cell-cell contacts between T cells and macrophages that are independent of T cell cytokine expression may also be important in the pathogenesis of rheumatoid arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Macrophage and fibroblast cytokines",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to T cell cytokines, products secreted by activated macrophages and fibroblasts, such as IL-1, tumor necrosis factor-alpha (TNF-alpha), IL-6, GM-CSF, M-CSF, transforming growth factor-beta (TGF-beta), and a host of chemotactic cytokines known as chemokines (eg, IL-8, monocyte chemoattractant protein-1, macrophage inhibitory protein-1 and ENA-78) are abundant in synovial fluids and synovial tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Interleukin-1",
"    </span>",
"    &nbsp;&mdash;&nbsp;Interleukin (IL)-1 is one of the primary pro-inflammatory cytokines in RA. It is present in RA synovial fluid and in culture supernatants of RA synovial cells. High affinity receptors for IL-1 are also expressed by human rheumatoid synovial cells.",
"   </p>",
"   <p>",
"    Synovial macrophages are the major source of IL-1 in RA synovium, and more than one-half of these cells contain IL-1 mRNA [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/12\">",
"     12",
"    </a>",
"    ]. Immunohistologic studies confirm this observation, with abundant IL-1 protein detected in synovial lining macrophages. IL-1 production in RA is enhanced by a variety of soluble factors, including TNF-alpha, GM-CSF, immunoglobulin Fc fragments, collagen fragments, and, to a lesser extent, immune complexes.",
"   </p>",
"   <p>",
"    IL-1 has many activities that are relevant to RA, including inducing prostaglandin and collagenase production. It also regulates fibroblast proliferation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/13\">",
"     13",
"    </a>",
"    ], stimulates synovial cell synthesis of IL-6, chemokines, and GM-CSF [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/14\">",
"     14",
"    </a>",
"    ], and enhances collagen production. In addition, IL-1 stimulates glycosaminoglycan biosynthesis in human synovial fibroblast cultures [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/15\">",
"     15",
"    </a>",
"    ], serves as a chemotactic factor for B and T cells, and induces adhesion molecule expression (eg, vascular cell adhesion molecule-1 and intercellular adhesion molecule-1) on fibroblast-like synoviocytes and endothelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Tumor necrosis factor-alpha",
"    </span>",
"    &nbsp;&mdash;&nbsp;TNF-alpha was originally characterized by its ability to cause necrosis in certain tumors in mice. It is now known to also be a potent proinflammatory and immunoregulatory mediator with considerable importance in rheumatic diseases. TNF-alpha stimulates collagenase and PGE2 production by human synovial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/17\">",
"     17",
"    </a>",
"    ], induces bone resorption [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/18\">",
"     18",
"    </a>",
"    ], inhibits bone formation and proteoglycan synthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/19\">",
"     19",
"    </a>",
"    ], and stimulates resorption of proteoglycan. IL-1 and TNF-alpha share many activities, including the ability to enhance cytokine production, adhesion molecule expression, proliferation, and metalloproteinase production by cultured synoviocytes.",
"   </p>",
"   <p>",
"    TNF-alpha is present in rheumatoid synovial fluid and serum, and levels of TNF-alpha correlate with the erythrocyte sedimentation rate and synovial fluid leukocyte counts. In situ hybridization and immunohistochemistry indicate that TNF-alpha, like IL-1, is primarily a product of synovial macrophages in RA.",
"   </p>",
"   <p>",
"    TNF-alpha blockade demonstrated some efficacy in animal models of arthritis, like collagen induced arthritis in mice [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/20\">",
"     20",
"    </a>",
"    ]. In addition, studies using monoclonal antibodies that inactivate TNF-alpha suggested that this approach would be useful in RA [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Subsequent clinical trials have proven the efficacy of anti-TNF therapies in RA. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/19/3384?source=see_link&amp;anchor=H13#H13\">",
"     \"Overview of biologic agents in the rheumatic diseases\", section on 'TNF inhibition'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20354882\">",
"    <span class=\"h3\">",
"     Interleukin-6",
"    </span>",
"    &nbsp;&mdash;&nbsp;IL-6 is a pleiotropic cytokine with effects upon a wide range of leukocytes. It is highly upregulated in the RA joint, a product of macrophages and fibroblasts predominantly but also of B cells and T cells. It also plays a crucial role in regulating the acute phase response and many of the systemic features of RA, including fatigue, reduced cognitive function, and altered hypothalamic pituitary adrenal axis function. Recent proof of concept comes in the licensing and wide use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/19/44342?source=see_link\">",
"     tocilizumab",
"    </a>",
"    , a monoclonal antibody that blocks IL-6R and thereby interferes with the function of IL-6. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/8/4231?source=see_link\">",
"     \"Role of cytokines in the immune system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Other cytokines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several other cytokines, predominantly expressed by macrophages are present in rheumatoid synovium. These include IL-12, IL-15, and IL-18 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/23-25\">",
"     23-25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      IL-12 promotes the development of T cells into a Th1 phenotype",
"     </li>",
"     <li>",
"      IL-15 has pleiotropic activities including activation of T cells, neutrophils, and other macrophages",
"     </li>",
"     <li>",
"      IL-18 also activates T cells, neutrophils, and fibroblasts",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These three cytokines are synergistic in their activities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Local cytokine inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cytokine inhibitors are also present in RA synovium [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/26\">",
"     26",
"    </a>",
"    ], although they apparently are not produced in sufficient quantities to interrupt the cytokine network. One example is IL-1ra, which is a natural inhibitor of IL-1. Even though IL-1ra is expressed by synovial macrophages, it is a relatively weak inhibitor and the amount produced is only a fraction of that required to inhibit synovial IL-1 activity [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/27\">",
"     27",
"    </a>",
"    ]. Human recombinant IL-1ra has proven to have efficacy in RA treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/19/3384?source=see_link&amp;anchor=H19#H19\">",
"     \"Overview of biologic agents in the rheumatic diseases\", section on 'IL-1 inhibition'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The suppressive cytokines IL-10, IL-13, and TGF-beta are also produced by the synovium and can dampen the local cytokine response. Their concentrations or activities, however, are not able to control rheumatoid synovitis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, otherwise suppressive cytokines may contribute to joint destruction. TGF-beta treatment in vitro, for example, augmented expression of collagenase-3 (MMP 13) by chondrocytes in cartilage from patients with RA [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/30\">",
"     30",
"    </a>",
"    ]; TGF-beta was also shown to inhibit CD95-mediated apoptosis of rheumatoid synovial cells in vitro, thus potentially augmenting pannus formation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The lack of IFN-gamma and IL-4 also contribute to the inflammatory process, since they suppress synoviocyte activation by IL-1 and TNF-alpha. Thus, the relative absence (as opposed to the presence) of some T cell factors might actually contribute to the perpetuation of chronic RA. This hypothesis is supported by the observation that Th2 cytokines, such as IL-4 or IL-10, can decrease joint inflammation in animal models of arthritis. As a result, therapeutic modalities designed to increase production of Th2 cytokines might be useful in RA. In one example of this approach, IL-10 gene expression was enhanced in RA synovial tissue explants by using an adenoviral construct encoding the IL-10 gene in the severe combined immune deficiency (SCID) mouse model [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/32\">",
"     32",
"    </a>",
"    ]. This led to decreased cartilage invasion by the synovium and reduced expression of metalloproteinases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Implications of the cytokine network in RA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dissection of the cytokine network in RA has led to the notion that positive feedback loops contribute to the perpetuation of synovial inflammation (",
"    <a class=\"graphic graphic_figure graphicRef82586 \" href=\"UTD.htm?31/53/32605\">",
"     figure 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      IL-1 and TNF-alpha, both of which are produced by synovial macrophages, stimulate fibroblast proliferation and increase production of IL-6, IL-8 (and other chemoattractant molecules known as chemokines), GM-CSF, and destructive enzymes such as stromelysin and collagenase.",
"     </li>",
"     <li>",
"      GM-CSF, which is produced by synovial macrophages and activated fibroblasts, is a potent inducer of IL-1, TNF-alpha and IL-8 secretion. GM-CSF, especially in combination with TNF-alpha, also activates macrophages and induces HLA-DR expression.",
"     </li>",
"     <li>",
"      Fibroblast-like cells produce autocrine stimulation and contribute to their own dysregulation through the elaboration of growth factors like fibroblast growth factor. Similar cells derived from the synovium of patients with RA also produce macrophage migration inhibitory factor (MIF), a cytokine which stimulates production of TNF-alpha from macrophages in vitro [",
"      <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/33\">",
"       33",
"      </a>",
"      ]. Other cell types (eg, T cells, macrophages, and endothelial cells) also produce MIF, and fibroblast-likes synovial cells respond to this cytokine with increased expression of proinflammatory and proteolytic factors (eg, phospholipase A2, cyclooxygenase 2, and metalloproteinases) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/34\">",
"       34",
"      </a>",
"      ]. Compared to those with osteoarthritis, increased amounts of MIF have been found in the synovial fluid of patients with RA [",
"      <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/33,35\">",
"       33,35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The local production of cytokines by macrophages and fibroblasts induces angiogenesis, increases adhesion molecule expression, and recruits other inflammatory cells with chemotactic signals. Thus, providing the potential for positive feedback and perpetuation of inflammation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The cytokine network in RA suggests that this disease might not be strictly an autoimmune process. The relative paucity of T cell factors in the joint and the presence of potent endogenous T cell suppressive agents (eg, IL-10 and TGF-beta) indicate that chronic RA is more complex. This conclusion has important therapeutic implications, since T cell specific therapies have met with only modest success in RA. T cell suppression might be very useful during the initial phases of RA when there could be more evidence of an antigen driven process, but appears to be less applicable in late disease. Greater success at this stage may result from therapy directed at the macrophages and fibroblasts, which are known to be activated and produce abundant cytokines, proteases, and prostaglandins. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/19/3384?source=see_link\">",
"     \"Overview of biologic agents in the rheumatic diseases\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SYSTEMIC LUPUS ERYTHEMATOSUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic lupus erythematosus (SLE) is a multisystem disease marked by B cell hyperreactivity and production of autoantibodies. Circulating immune complexes comprised of autoantibodies and antigen can lead to end organ disease, as with renal deposition of immune complexes containing anti-DNA antibodies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/43/37562?source=see_link\">",
"     \"Epidemiology and pathogenesis of systemic lupus erythematosus\"",
"    </a>",
"    .) While the precise role of cytokines in this disease is not as well understood as in RA, several cytokine abnormalities have been identified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Interferon-alpha",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perhaps the most striking cytokine abnormality in SLE is the presence of interferon-alpha (IFN-alpha) in serum. Most patients have significant levels, whereas normal individuals have little or no circulating IFN-alpha [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/36\">",
"     36",
"    </a>",
"    ]. Furthermore, the IFN-alpha observed among patients with SLE is unusual in that it is acid labile (all other types of IFN-alpha are acid-stable), a phenomenon that has also been observed in human immunodeficiency virus infection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/37\">",
"     37",
"    </a>",
"    ]. Acid lability is conferred by a circulating factor in SLE serum (possibly a protease or an IFN binding protein) that interacts with acid-stable IFN-alpha [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The relative proportion of IFN-alpha that is acid labile seems to correlate with disease activity, with higher levels during flares and a reversion to an acid-stable form during clinical remission [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/39\">",
"     39",
"    </a>",
"    ]. Elevated serum levels of IFN-alpha especially correlate with skin disease in SLE. Other laboratory parameters known to correlate with disease activity also correlate with high titers of IFN-alpha, including hypocomplementemia, lymphopenia, and anti-DNA antibodies. IFN-alpha is also probably responsible for lupus inclusions (tubuloreticular structures) present within some leukocytes that are comprised of a novel 36 kD protein [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is unclear what leads to the elevated circulating levels of IFN-alpha. One hypothesis suggests that viral infection, ultraviolet light, and other insults cause some cells to undergo apoptosis; apoptotic cells produce substances that induce the production of IFN-alfa [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/41\">",
"     41",
"    </a>",
"    ]. Immune complexes of nuclear antigens from dying cells and antinuclear antibodies may also stimulate dendritic cells to secrete IFN-alfa, the presence of which stimulates antibody production. The potential for positive feedback is present if autoantibody production is thus enhanced.",
"   </p>",
"   <p>",
"    In contrast to IFN-alpha, only one third of patients have detectable IFN-gamma in serum. The levels tend to be very low and do not correlate with disease activity.",
"   </p>",
"   <p>",
"    Surprisingly, circulating anti-IFN-alpha antibodies are also found in the sera of about five to 10 percent of patients with SLE [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/42\">",
"     42",
"    </a>",
"    ]. These antibodies neutralize IFN-alpha but not IFN-beta or -gamma. Most patients with anti-IFN-alpha antibodies have inactive disease, leading to speculation that blocking IFN activity in SLE might contribute to clinical remissions.",
"   </p>",
"   <p>",
"    The role of IFN-alpha in SLE remains unknown. Parenteral administration of IFN-alpha to humans can lead to fever, malaise, alopecia, and myalgias, which also occur in lupus. These signs and symptoms, however, are very nonspecific. Lymphopenia is another side effect of IFN-alpha administration, and the degree of lymphopenia correlates with the amount of IFN-alpha in serum in SLE. However, the lack of full blown lupus in patients treated with IFN-alpha suggests that this cytokine alone does not account for the entire clinical spectrum of SLE.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Tumor necrosis factor-alpha",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tumor necrosis factor (TNF)-alpha has been detected in the serum of about 25 percent of SLE patients but not in control sera [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/43\">",
"     43",
"    </a>",
"    ]. There is no correlation between the concentration of TNF and disease activity. In addition, two reports of TNF-alpha production by peripheral blood cells suggest that SLE patients actually have",
"    <strong>",
"     low",
"    </strong>",
"    TNF production.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the first study, TNF produced by stimulated blood mononuclear cells was lower in patients with SLE than in matched controls, especially in patients with active nephritis [",
"      <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The second study also compared TNF production by blood mononuclear cells from normals and patients with SLE [",
"      <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/45\">",
"       45",
"      </a>",
"      ]. This study divided normal individuals into three groups based upon TNF production (high, intermediate, and low). Serial measurements indicated that the TNF phenotype for a particular individual was stable over time. Analysis of MHC associations with TNF phenotype showed that most low TNF-alpha producers possessed the",
"      <span class=\"nowrap\">",
"       HLA-DR2/DQwl",
"      </span>",
"      phenotype. In contrast, HLA-DR3 and DR4 were strongly associated with high TNF-alpha production. The SLE patients with the low TNF-alpha phenotype had an unusually high incidence of nephritis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Both studies suggest that a subpopulation of SLE patients have diminished capacity to synthesize TNF-alpha and that this population has a distinctive HLA genotype that correlates with renal disease. In addition, the serum of patients with SLE contains high levels of soluble TNF receptors that can neutralize the biologic activity of circulating TNF-alpha [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Interleukin-2 and interleukin-2 receptors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Interleukin (IL)-2 is a T cell derived cytokine that plays a central role in immune responses by:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Inducing the proliferation of activated T cells",
"     </li>",
"     <li>",
"      Participating in the activation and differentiation of B cells into immunoglobulin secreting cells",
"     </li>",
"     <li>",
"      Modulating macrophage function and phenotype",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    IL-2 receptors are normally expressed at low levels on a variety of cells, including B cells, activated T cells, and monocytes. The receptor has several components, one of which can be shed from cells in a soluble form. The soluble IL-2 receptor has very low affinity to IL-2 and is therefore an inefficient IL-2 inhibitor with limited capacity for absorbing excess IL-2.",
"   </p>",
"   <p>",
"    IL-2 levels in serum are increased in about one-half of patients with active SLE, but not when patients are in remission. Treatment of patients with glucocorticoids",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    corrects the IL-2 defect. In vitro production of IL-2 by peripheral blood mononuclear cells, however, is essentially normal in lupus patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The presence of soluble IL-2R in serum also appears to be a marker for disease activity [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. About one-third of patients with SLE have elevated serum levels of soluble IL-2R, and a significant correlation exists between disease flares and the soluble IL-2R concentration. An elevated erythrocyte sedimentation rate, hypocomplementemia, and proteinuria correlate with soluble IL-2R levels in the blood, although complement levels and DNA antibodies do not. As a result, the measurement of soluble IL-2R has potential as a method to monitor disease activity, but further studies are needed to assess its utility.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Interleukin-6",
"    </span>",
"    &nbsp;&mdash;&nbsp;Interleukin (IL)-6 has multiple activities that are probably important in SLE and other rheumatic diseases, including B cell stimulation and induction of acute phase reactants. Serum IL-6 levels in SLE are similar to controls. However, high concentrations of IL-6 are present in the cerebrospinal fluid of lupus patients with active central nervous system (CNS) disease, even when the serum levels are normal [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/51\">",
"     51",
"    </a>",
"    ]. Thus, IL-6 production might be important in CNS lupus, where local cytokine and concomitant immunoglobulin production (including antineuronal antibodies) have pathogenic significance. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/11/33978?source=see_link\">",
"     \"Neurologic manifestations of systemic lupus erythematosus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Transforming growth factor-beta",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transforming growth factor (TGF)-beta exhibits many activities of potential relevance to the pathogenesis of arthritis, including suppression of T cell proliferation and collagenase production while increasing collagen synthesis. It is produced as an inactive latent protein that must be activated by limited proteolysis. The increase in collagen synthesis by fibroblasts exposed to TGF-beta appears to depend, at least in part, upon the induction of another cytokine, connective tissue growth factor [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are several observations suggesting that systemic TGF-beta has antiinflammatory activity:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Systemic therapy, either by administration of exogenous protein or using gene therapy, suppresses streptococcal cell arthritis [",
"      <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/53\">",
"       53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      TGF-beta also has demonstrated utility in other autoimmunity models, including experimental allergic encephalomyelitis, collagen-induced arthritis, and diabetes mellitus.",
"     </li>",
"     <li>",
"      Animals null for the TGF-beta gene develop systemic autoimmunity and diffuse inflammation in a variety of tissues [",
"      <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    By comparison, the local injection of this cytokine into joints of rats induces synovial intimal lining hyperplasia; together, these observations suggest that the consequences of local injection may differ from those of systemic administration.",
"   </p>",
"   <p>",
"    TGF-beta production by lymphocytes may be reduced in patients with SLE, possibly contributing to flares of the disease. This was illustrated in a study in which 17 patients with SLE were compared with 17 patients with RA and 23 healthy controls [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/55\">",
"     55",
"    </a>",
"    ]. Lymphocytes from the patients with SLE, particularly those with very active disease, produced significantly less of the activated form of TGF-beta.",
"   </p>",
"   <p>",
"    The functional significance of interleukins (IL)-12, -15, and -18 in SLE is uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Cytokine networks in animal models of SLE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Animal models of SLE are also dependent upon cytokine networks. As an example, NZB and",
"    <span class=\"nowrap\">",
"     NZB/NZW",
"    </span>",
"    mice serve as useful models for human SLE. NZB mice develop autoimmune hemolytic anemia with hepatosplenomegaly and occasional immune complex glomerulonephritis, while",
"    <span class=\"nowrap\">",
"     NZB/NZW",
"    </span>",
"    mice develop a progressive SLE-like illness marked by fatal immune complex glomerulonephritis accompanied by the production of antinuclear antibodies (including anti-dsDNA antibodies). The data suggest the possibility that overproduction of IFN and underproduction of TNF may play a role in the pathogenesis of this disorder.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      IFN-gamma has been used to treat both strains of mice. The IFN treated NZB mice develop hemolytic anemia earlier than control mice; in addition, the",
"      <span class=\"nowrap\">",
"       NZB/NZW",
"      </span>",
"      strain treated with IFN have a significant increase in renal immune complex deposition, proteinuria, and renal failure [",
"      <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/56,57\">",
"       56,57",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In a separate study,",
"      <span class=\"nowrap\">",
"       NZB/NZW",
"      </span>",
"      mice treated with recombinant IFN-gamma developed early renal disease and died earlier than the placebo group [",
"      <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/58\">",
"       58",
"      </a>",
"      ]. In the placebo group, for example, the mean life span was about 9.5 months (with death usually due to renal failure), whereas almost 80 percent of mice in the IFN-gamma treated cohort were dead in less than eight months. Another group of mice treated with monoclonal antibody to IFN-gamma had a dramatic decrease in mortality compared to animals given with an irrelevant antibody or saline.",
"     </li>",
"     <li>",
"      Animal studies also support a correlation between SLE and a TNF-alpha production phenotype. As with humans, mice can be divided into high and low TNF-alpha producers [",
"      <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/59\">",
"       59",
"      </a>",
"      ]. High TNF-producing strains are resistant to lupus-like disease, whereas low TNF-producers, like the",
"      <span class=\"nowrap\">",
"       NZB/NZW",
"      </span>",
"      strain, are susceptible. This is similar to the observation, mentioned previously, that HLA-DR2 positive SLE patients have a \"low TNF\" phenotype and tend to develop nephritis. In another study, parenteral administration of TNF-alpha to",
"      <span class=\"nowrap\">",
"       NZB/NZW",
"      </span>",
"      mice prior to the onset of nephritis significantly delayed (but did not prevent) proteinuria and death [",
"      <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/60\">",
"       60",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These data suggest that TNF-alpha, in contrast to IFN-gamma, might exert a protective effect in SLE. As a result, SLE appears to be an illness in which IFN overproduction and TNF-alpha underproduction might have pathogenetic importance. This contrasts sharply with RA, where defective IFN-gamma production and overproduction of TNF-alpha might play a role. It is of interest in this regard that patients with RA who have been treated with an anti-TNF-alpha antibody have an increased incidence of antinuclear antibodies. It is therefore possible that individuals with an autoimmune diathesis are directed towards SLE in the absence of adequate TNF-alpha production.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SCLERODERMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Our understanding of cytokine regulation in scleroderma is fairly rudimentary. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/63/19450?source=see_link\">",
"     \"Pathogenesis of systemic sclerosis (scleroderma)\"",
"    </a>",
"    .) There is an overabundance of factors that encourage deposition of collagen, such as transforming growth factor-beta (TGF) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/61\">",
"     61",
"    </a>",
"    ]. TGF-beta inhibits production of collagenase and increases collagen production by skin fibroblasts. This growth factor has also been identified in scleroderma skin and lung tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/62\">",
"     62",
"    </a>",
"    ]. TGF-beta might also serve to sensitize dermal fibroblasts to the effects of platelet derived growth factor and fibroblast growth factor.",
"   </p>",
"   <p>",
"    A variety of other cytokines have been detected in the skin of patients with scleroderma. TNF-alpha, IL-1, platelet derived growth factor, fibroblast growth factor, and IL-6 are abundant and could be involved in regulating skin fibroblast activation and proliferation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/63-65\">",
"     63-65",
"    </a>",
"    ]. Some of these factors can also be detected in the serum, including TGF-beta and IL-6. Serum IL-6 levels are especially high in scleroderma and the concentrations correlate with clinical disease activity, but not with the erythrocyte sedimentation rate or C reactive protein. Cultured dermal fibroblasts in scleroderma also constitutively produce much more IL-6 than normal fibroblasts, especially if they are obtained from involved skin [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/66\">",
"     66",
"    </a>",
"    ]. In addition, IL-1 appears to be produced in greater amounts by scleroderma fibroblasts.",
"   </p>",
"   <p>",
"    It is not known whether the scleroderma fibroblast is fundamentally different from normal skin fibroblasts or whether it is simply responding to a cytokine milieu that encourages collagen deposition. Some evidence of autonomous growth in the absence of serum can be explained by autocrine production of platelet derived growth factor by scleroderma fibroblasts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/50/10025/abstract/67\">",
"     67",
"    </a>",
"    ]. These cells also have an exaggerated proliferative response to other cytokines, including IL-6, endothelin-1 and TGF-beta.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4424501\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cytokines are proteins that regulate the immune system and that participate in intercellular communications. A complex cytokine network is involved in normal immune function, and this network is comprised of positive and negative feedback loops that enhance or suppress the response. Many immune-mediated diseases, including rheumatic diseases, involve the abnormal regulation of cytokines. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Anticytokine therapy has shown clear evidence of clinical efficacy in rheumatoid arthritis (RA), especially with tumor necrosis factor (TNF)-alpha-directed approaches. In general, T cell-derived factors are not as prominent as macrophage and fibroblast cytokines in the rheumatoid joint. One exception is interleukin (IL)-17, a Th17 cell derived cytokine that exhibits many of the same activities as IL-1 and TNF-alpha. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Rheumatoid arthritis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'T cell cytokines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In contrast to T cell cytokines, products secreted by activated macrophages and fibroblasts, such as IL-1, TNF-alpha, IL-6, GM-CSF, M-CSF, transforming growth factor-beta (TGF)-beta, and a host of chemotactic cytokines known as chemokines (eg, IL-8, monocyte chemoattractant protein-1, macrophage inhibitory protein-1, and ENA-78), are abundant in synovial fluids and synovial tissues. Dissection of the cytokine network in RA has led to the notion that positive feedback loops contribute to the perpetuation of synovial inflammation (",
"      <a class=\"graphic graphic_figure graphicRef82586 \" href=\"UTD.htm?31/53/32605\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Macrophage and fibroblast cytokines'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Implications of the cytokine network in RA'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The precise role of cytokines in systemic lupus erythematosus is not as well understood as in RA, but several cytokine abnormalities have been identified. These include elevated serum levels of interferon (IFN)-alpha and increased serum IL-2 levels in many patients with active disease. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Systemic lupus erythematosus'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Interferon-alpha'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Interleukin-2 and interleukin-2 receptors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is limited understanding of cytokine regulation in scleroderma. There is an overabundance of factors that encourage deposition of collagen, such as TGF-beta. It is not known whether the scleroderma fibroblast is fundamentally different from normal skin fibroblasts or whether it is simply responding to a cytokine milieu that encourages collagen deposition. Some evidence of autonomous growth of scleroderma fibroblasts can be explained by autocrine production of platelet derived growth factor by these cells, which also have an exaggerated proliferative response to other cytokines, including IL-6, endothelin-1, and TGF-beta. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Scleroderma'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/1\">",
"      Hooks JJ, Moutsopoulos HM, Geis SA, et al. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 1979; 301:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/2\">",
"      Ruschen S, Lemm G, Warnatz H. Interleukin-2 secretion by synovial fluid lymphocytes in rheumatoid arthritis. Br J Rheumatol 1988; 27:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/3\">",
"      Firestein GS, Zvaifler NJ. Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that gamma-interferon is not the primary macrophage activating factor. Arthritis Rheum 1987; 30:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/4\">",
"      Barnes PF, Fong SJ, Brennan PJ, et al. Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol 1990; 145:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/5\">",
"      Miossec P, Naviliat M, Dupuy d'Angeac A, et al. Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis. Arthritis Rheum 1990; 33:1180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/6\">",
"      Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci U S A 1994; 91:8562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/7\">",
"      Kotake S, Udagawa N, Takahashi N, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999; 103:1345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/8\">",
"      Hueber AJ, Asquith DL, Miller AM, et al. Mast cells express IL-17A in rheumatoid arthritis synovium. J Immunol 2010; 184:3336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/9\">",
"      McInnes IB, Leung BP, Liew FY. Cell-cell interactions in synovitis. Interactions between T lymphocytes and synovial cells. Arthritis Res 2000; 2:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/10\">",
"      Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990; 33:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/11\">",
"      Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 1990; 33:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/12\">",
"      Firestein GS, Alvaro-Gracia JM, Maki R, Alvaro-Garcia JM. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990; 144:3347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/13\">",
"      Postlethwaite AE, Lachman LB, Kang AH. Induction of fibroblast proliferation by interleukin-1 derived from human monocytic leukemia cells. Arthritis Rheum 1984; 27:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/14\">",
"      Koch AE, Kunkel SL, Harlow LA, et al. Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J Clin Invest 1994; 94:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/15\">",
"      Yaron I, Meyer FA, Dayer JM, Yaron M. Human recombinant interleukin-1 beta stimulates glycosaminoglycan production in human synovial fibroblast cultures. Arthritis Rheum 1987; 30:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/16\">",
"      Morales-Ducret J, Wayner E, Elices MJ, et al. Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J Immunol 1992; 149:1424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/17\">",
"      Dayer JM, Beutler B, Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985; 162:2163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/18\">",
"      Bertolini DR, Nedwin GE, Bringman TS, et al. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986; 319:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/19\">",
"      Saklatvala J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986; 322:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/20\">",
"      Williams RO, Mason LJ, Feldmann M, Maini RN. Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. Proc Natl Acad Sci U S A 1994; 91:2762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/21\">",
"      Elliott MJ, Maini RN, Feldmann M, et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 1994; 344:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/22\">",
"      Ulfgren AK, Andersson U, Engstr&ouml;m M, et al. Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis. Arthritis Rheum 2000; 43:2391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/23\">",
"      Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/24\">",
"      McInnes IB, Leung BP, Sturrock RD, et al. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med 1997; 3:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/25\">",
"      Gracie JA, Forsey RJ, Chan WL, et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999; 104:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/26\">",
"      Weckmann AL, Alcocer-Varela J. Cytokine inhibitors in autoimmune disease. Semin Arthritis Rheum 1996; 26:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/27\">",
"      Firestein GS, Boyle DL, Yu C, et al. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 1994; 37:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/28\">",
"      Katsikis PD, Chu CQ, Brennan FM, et al. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994; 179:1517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/29\">",
"      Isom&auml;ki P, Luukkainen R, Toivanen P, Punnonen J. The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum 1996; 39:1693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/30\">",
"      Moldovan F, Pelletier JP, Hambor J, et al. Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor beta. Arthritis Rheum 1997; 40:1653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/31\">",
"      Kawakami A, Eguchi K, Matsuoka N, et al. Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor beta 1. Arthritis Rheum 1996; 39:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/32\">",
"      Jorgensen C, Apparailly F, Canovas F, et al. Systemic viral interleukin-10 gene delivery prevents cartilage invasion by human rheumatoid synovial tissue engrafted in SCID mice. Arthritis Rheum 1999; 42:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/33\">",
"      Leech M, Metz C, Hall P, et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999; 42:1601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/34\">",
"      Morand EF, Bucala R, Leech M. Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis. Arthritis Rheum 2003; 48:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/35\">",
"      Onodera S, Tanji H, Suzuki K, et al. High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints. Cytokine 1999; 11:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/36\">",
"      von Wussow P, Jakschies D, Hartung K, Deicher H. Presence of interferon and anti-interferon in patients with systemic lupus erythematosus. Rheumatol Int 1988; 8:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/37\">",
"      Capobianchi MR, De Marco F, Di Marco P, Dianzani F. Acid-labile human interferon alpha production by peripheral blood mononuclear cells stimulated by HIV-infected cells. Arch Virol 1988; 99:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/38\">",
"      Yee AM, Buyon JP, Yip YK. Interferon alpha associated with systemic lupus erythematosus is not intrinsically acid labile. J Exp Med 1989; 169:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/39\">",
"      Yee AM, Yip YK, Fischer HD, Buyon JP. Serum activity that confers acid lability to alpha-interferon in systemic lupus erythematosus: its association with disease activity and its independence from circulating alpha-interferon. Arthritis Rheum 1990; 33:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/40\">",
"      Rich SA. De novo synthesis and secretion of a 36-kD protein by cells that form lupus inclusions in response to alpha-interferon. J Clin Invest 1995; 95:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/41\">",
"      R&ouml;nnblom L, Alm GV. A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J Exp Med 2001; 194:F59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/42\">",
"      Suit BE, Axelrod D, Moutsopoulos HM, et al. Detection of anti-interferon antibodies in systemic lupus erythematosus. Clin Exp Rheumatol 1983; 1:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/43\">",
"      Maury CP, Teppo AM. Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis Rheum 1989; 32:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/44\">",
"      Yu CL, Chang KL, Chiu CC, et al. Defective phagocytosis, decreased tumour necrosis factor-alpha production, and lymphocyte hyporesponsiveness predispose patients with systemic lupus erythematosus to infections. Scand J Rheumatol 1989; 18:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/45\">",
"      Jacob CO, Fronek Z, Lewis GD, et al. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A 1990; 87:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/46\">",
"      Aderka D, Wysenbeek A, Engelmann H, et al. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum 1993; 36:1111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/47\">",
"      Draeger AM, Swaak AJ, van den Brink HG, Aarden LA. T cell function in systemic lupus erythematosus: normal production of and responsiveness to interleukin 2. Clin Exp Immunol 1986; 64:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/48\">",
"      Sibbitt WL Jr, Kenny C, Spellman CW, et al. Lymphokines in autoimmunity: relationship between interleukin-2 and interferon-gamma production in systemic lupus erythematosus. Clin Immunol Immunopathol 1984; 32:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/49\">",
"      Tokano Y, Murashima A, Takasaki Y, et al. Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus. Ann Rheum Dis 1989; 48:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/50\">",
"      Campen DH, Horwitz DA, Quismorio FP Jr, et al. Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum 1988; 31:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/51\">",
"      Hirohata S, Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 1990; 33:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/52\">",
"      Stratton R, Shiwen X, Martini G, et al. Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. J Clin Invest 2001; 108:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/53\">",
"      Song XY, Gu M, Jin WW, et al. Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J Clin Invest 1998; 101:2615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/54\">",
"      Kulkarni AB, Ward JM, Yaswen L, et al. Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders. Am J Pathol 1995; 146:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/55\">",
"      Ohtsuka K, Gray JD, Stimmler MM, Horwitz DA. The relationship between defects in lymphocyte production of transforming growth factor-beta1 in systemic lupus erythematosus and disease activity or severity. Lupus 1999; 8:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/56\">",
"      Heremans H, Billiau A, Colombatti A, et al. Interferon treatment of NZB mice: accelerated progression of autoimmune disease. Infect Immun 1978; 21:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/57\">",
"      Adam C, Thoua Y, Ronco P, et al. The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice. Clin Exp Immunol 1980; 40:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/58\">",
"      Jacob CO, van der Meide PH, McDevitt HO. In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J Exp Med 1987; 166:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/59\">",
"      Jacob CO, McDevitt HO. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature 1988; 331:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/60\">",
"      Jacob CO, Hwang F, Lewis GD, Stall AM. Tumor necrosis factor alpha in murine systemic lupus erythematosus disease models: implications for genetic predisposition and immune regulation. Cytokine 1991; 3:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/61\">",
"      Higley H, Persichitte K, Chu S, et al. Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Arthritis Rheum 1994; 37:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/62\">",
"      Corrin B, Butcher D, McAnulty BJ, et al. Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. Histopathology 1994; 24:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/63\">",
"      Kawaguchi Y, Harigai M, Hara M, et al. Increased interleukin 1 receptor, type I, at messenger RNA and protein level in skin fibroblasts from patients with systemic sclerosis. Biochem Biophys Res Commun 1992; 184:1504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/64\">",
"      Berman B, Wietzerbin J. Tumor necrosis factor-alpha (TNF-alpha), interferon-alpha (IFN-alpha) and interferon-gamma (IFN-gamma) receptors on human normal and scleroderma dermal fibroblasts in vitro. J Dermatol Sci 1992; 3:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/65\">",
"      Romero LI, Pincus SH. In situ localization of interleukin-6 in normal skin and atrophic cutaneous disease. Int Arch Allergy Immunol 1992; 99:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/66\">",
"      Feghali CA, Bost KL, Boulware DW, Levy LS. Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J Rheumatol 1992; 19:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/50/10025/abstract/67\">",
"      LeRoy EC, Mercurio S, Sherer GK. Replication and phenotypic expression of control and scleroderma human fibroblasts: responses to growth factors. Proc Natl Acad Sci U S A 1982; 79:1286.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7997 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-199.231.185.123-EFBF5593C3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_50_10025=[""].join("\n");
var outline_f9_50_10025=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4424501\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RHEUMATOID ARTHRITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      T cell cytokines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Macrophage and fibroblast cytokines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Interleukin-1",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Tumor necrosis factor-alpha",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20354882\">",
"      - Interleukin-6",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Other cytokines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Local cytokine inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Implications of the cytokine network in RA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SYSTEMIC LUPUS ERYTHEMATOSUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Interferon-alpha",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Tumor necrosis factor-alpha",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Interleukin-2 and interleukin-2 receptors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Interleukin-6",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Transforming growth factor-beta",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Cytokine networks in animal models of SLE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SCLERODERMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4424501\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/7997\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7997|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/50/11048\" title=\"figure 1\">",
"      Cytokine synovial interactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/53/32605\" title=\"figure 2\">",
"      Cytokines which perpetuate RA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7997|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/13/12507\" title=\"table 1\">",
"      Cytokines in rheumatic diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/19/32060\" title=\"table 2\">",
"      Cytokine profile in RA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/22/16746?source=related_link\">",
"      Cytokine networks in rheumatic diseases: Implications for therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/43/37562?source=related_link\">",
"      Epidemiology and pathogenesis of systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/11/33978?source=related_link\">",
"      Neurologic manifestations of systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/19/3384?source=related_link\">",
"      Overview of biologic agents in the rheumatic diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/63/19450?source=related_link\">",
"      Pathogenesis of systemic sclerosis (scleroderma)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/8/4231?source=related_link\">",
"      Role of cytokines in the immune system",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_50_10026="Endodermal sinus tumor histo";
var content_f9_50_10026=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F83636&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F83636&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ovarian endodermal sinus tumor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 374px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Yolk sac (endodermal sinus tumor). The tumor is composed of dilated tubular spaces lined by flattened cells with an edematous stroma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rubin E, Farber JL. Pathology, 3rd Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 1999. Copyright &copy; 1999 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_50_10026=[""].join("\n");
var outline_f9_50_10026=null;
var title_f9_50_10027="WHO classification CRC";
var content_f9_50_10027=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F68703&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F68703&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    World Health Organization classification of carcinomas of the colon and rectum",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Adenocarcinoma in situ/severe dysplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adenocarcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mucinous (colloid) adenocarcinoma (&gt;50 percent mucinous)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Signet-ring cell carcinoma (&gt;50 percent signet-ring cells)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Squamous cell (epidermoid) carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adenosquamous carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Small-cell (oat cell) carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Medullary carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Undifferentiated carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other (eg, papillary carcinoma)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * The term \"carcinoma, NOS\" (not otherwise specified) is not part of the WHO classification.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_50_10027=[""].join("\n");
var outline_f9_50_10027=null;
var title_f9_50_10028="Histologic idiopathic HTN";
var content_f9_50_10028=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F80624&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F80624&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Histologic findings in patients with idiopathic portal hypertension",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Histological feature*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Frequency, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Irregular intimal thickening of portal veins",
"       </td>",
"       <td>",
"        75-100&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Organizing thrombus and/or recanalization of portal veins",
"       </td>",
"       <td>",
"        20-100&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intralobular fibrous septa",
"       </td>",
"       <td>",
"        95",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abnormal blood vessels in the lobules",
"       </td>",
"       <td>",
"        75",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Subcapsular atrophy",
"       </td>",
"       <td>",
"        70",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dense portal fibrosis and portal venous obliteration",
"       </td>",
"       <td>",
"        32-52",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Periductal fibrosis of interlobular bile ducts",
"       </td>",
"       <td>",
"        50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Portal inflammation",
"       </td>",
"       <td>",
"        47",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nodular hyperplasia of parenchyma",
"       </td>",
"       <td>",
"        25-40",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Needle biopsies from patients with IPH are often normal or commonly show only nonspecific morphologic changes. Specific abnormalities are more commonly seen in larger wedge biopsies or autopsy specimens.",
"     <br>",
"      &bull; Studies showing findings in 100 percent of patients were based upon autopsy specimens.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      1. Sarin SK, Kapoor D. Non-cirrhotic portal fibrosis: current concepts and management. J Gastroenterol Hepatol 2002; 17:526.",
"      <br>",
"       2. Hillaire S, Bonte E, Denninger MH, et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 2002; 51:275.",
"       <br>",
"        3. Ludwig J, Hashimoto E, Obata H, Baldus WP. Idiopathic portal hypertension; a histopathological study of 26 Japanese cases. Histopathology 1993; 22:227.",
"        <br>",
"         4. Nakanuma Y, Hoso M, Sasaki M, et al. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology 1996; 28:195.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_50_10028=[""].join("\n");
var outline_f9_50_10028=null;
var title_f9_50_10029="PCA dosing guideline";
var content_f9_50_10029=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F51791&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F51791&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    PCA dosing",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\" rowspan=\"1\">",
"        Drug",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Morphine",
"       </td>",
"       <td class=\"subtitle2\">",
"        Dilaudid",
"       </td>",
"       <td class=\"subtitle2\">",
"        Fentanyl",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"        General PCA dosing*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Standard Concentration",
"       </td>",
"       <td>",
"        1 mg/ml",
"       </td>",
"       <td>",
"        1 mg/ml",
"       </td>",
"       <td>",
"        10 mcg/ml",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        PCA Dose",
"       </td>",
"       <td>",
"        1.5 mg",
"       </td>",
"       <td>",
"        0.2 mg",
"       </td>",
"       <td>",
"        20 mcg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lockout Interval",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4 Hour Dose Limit",
"       </td>",
"       <td>",
"        30 mg",
"       </td>",
"       <td>",
"        3 mg",
"       </td>",
"       <td>",
"        300 mcg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\" rowspan=\"1\">",
"        Continuous infusion dosing should be avoided (0 mg/hr)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Typical PCA Dose Change",
"       </td>",
"       <td>",
"        0.5 mg",
"       </td>",
"       <td>",
"        0.1 mg",
"       </td>",
"       <td>",
"        5 mcg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rescue Doses",
"       </td>",
"       <td>",
"        3 mg IV q 5 min x3",
"       </td>",
"       <td>",
"        0.3 mg IV q 5 min x3",
"       </td>",
"       <td>",
"        25 mcg IV q 5 min x3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Notes",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Preferred in renal dysfunction over morphine",
"       </td>",
"       <td>",
"        Shorter clinical effect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"        High Risk PCA dosing&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Standard Concentration",
"       </td>",
"       <td>",
"        1 mg/ml",
"       </td>",
"       <td>",
"        1 mg/ml",
"       </td>",
"       <td>",
"        10 mcg/ml",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        PCA Dose",
"       </td>",
"       <td>",
"        1 mg",
"       </td>",
"       <td>",
"        0.1 mg",
"       </td>",
"       <td>",
"        15 mcg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lockout Interval",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4 Hour Dose Limit",
"       </td>",
"       <td>",
"        30 mg",
"       </td>",
"       <td>",
"        3 mg",
"       </td>",
"       <td>",
"        300 mcg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\" rowspan=\"1\">",
"        Continuous infusion dosing should be avoided (0 mg/hr)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Typical PCA Dose Change",
"       </td>",
"       <td>",
"        0.5 mg",
"       </td>",
"       <td>",
"        0.1 mg",
"       </td>",
"       <td>",
"        5 mcg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rescue Doses",
"       </td>",
"       <td>",
"        2 mg q15 min, may repeat x1 prn",
"       </td>",
"       <td>",
"        0.2 mg q 15 min, may repeat x1 prn",
"       </td>",
"       <td>",
"        25 mcg I q 15 min, may repeat x1 prn",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Notes",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Preferred in renal dysfunction over morphine",
"       </td>",
"       <td>",
"        Shorter clinical effect",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     IV: intravenous; q: every; prn: as needed; PCA: patient controlled analgesia; mg: milligrams; mcg: micrograms; ml: milliliters.",
"     <br>",
"      * May be recorded as: PCA dose/lockout interval/4 hour limit/infusion rate).",
"      <br>",
"       &bull; May be recorded as: PCA dose/lockout interval/4 hour limit/infusion rate). Indications for High Risk are: Patients identified as elderly (age 70 or above), morbidly obese, history of sleep apnea, or patients who have received more than 25 mg morphine sulfate IV (or its equivalent).",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pain Management Tables and Guidelines. Dana Farber Cancer Institute/Brigham and Women's Hospital Pain and Pallitative Care Program. Copyright &copy; 2004.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_50_10029=[""].join("\n");
var outline_f9_50_10029=null;
var title_f9_50_10030="Diagnosis nodular masses I";
var content_f9_50_10030=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F69807%7ERHEUM%2F82043&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F69807%7ERHEUM%2F82043&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of nodular soft tissue masses-I",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Type of nodule",
"      </td>",
"      <td class=\"subtitle1\">",
"       Location",
"      </td>",
"      <td class=\"subtitle1\">",
"       Characteristic features",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Noninflammatory",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Ganglia",
"      </td>",
"      <td>",
"       Doral wrists; any synovial-lined joint",
"      </td>",
"      <td>",
"       Globular, transilluminates, &plusmn; tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Surfer's nodule",
"      </td>",
"      <td>",
"       Extensor surface of forelegs and feet",
"      </td>",
"      <td>",
"       Firm, ovoid, &plusmn; tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Painter's bosses",
"      </td>",
"      <td>",
"       Extensor surface of forelegs",
"      </td>",
"      <td>",
"       Firm, ovoid, &plusmn; tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Epidermoid cyst",
"      </td>",
"      <td>",
"       Volar surface of digits, web between digits",
"      </td>",
"      <td>",
"       Hard, round, &plusmn; tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Epidermal inclusion cyst",
"      </td>",
"      <td>",
"       Volar aspect of the distal phalanx of the index or middle finger, or within the interdigital webs",
"      </td>",
"      <td>",
"       Soft, round, &plusmn; tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Dorsal exostosis",
"      </td>",
"      <td>",
"       Palpable bony exostosis",
"      </td>",
"      <td>",
"       Hard, tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Herniation of anterior tibialis muscle",
"      </td>",
"      <td>",
"       Foreleg at anterior ankle",
"      </td>",
"      <td>",
"       Nodular swelling, accentuated by weightbearing",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Tumors",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Lipoma",
"      </td>",
"      <td>",
"       Trunk, arms, hips, thighs",
"      </td>",
"      <td>",
"       Soft, oval, painless, asymmetric",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Fibroma",
"      </td>",
"      <td>",
"       Digits, other soft tissue, bone",
"      </td>",
"      <td>",
"       Soft to hard, nontender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Neuroma",
"      </td>",
"      <td>",
"       Skin, forefoot",
"      </td>",
"      <td>",
"       Rarely palpable, pain and paresthesia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Giant cell tumors",
"      </td>",
"      <td>",
"       Tendons, bone",
"      </td>",
"      <td>",
"       Variable pain, can be malignant",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Sarcoma",
"      </td>",
"      <td>",
"       Head, neck, trunk, extremities",
"      </td>",
"      <td>",
"       Well localized, nontender, movable",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Sometimes inflammatory",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Rheumatoid nodules",
"      </td>",
"      <td>",
"       Bilateral, extensor joint surfaces of extremities",
"      </td>",
"      <td>",
"       Round/ovoid, firm, &plusmn; tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Rheumatic fever nodules",
"      </td>",
"      <td>",
"       Over a bony surface or prominence, or near tendons",
"      </td>",
"      <td>",
"       &lt;1 cm, nontender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Pseudorheumatoid nodules",
"      </td>",
"      <td>",
"       Forelegs of infants and children",
"      </td>",
"      <td>",
"       Firm, nontender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Tophi",
"      </td>",
"      <td>",
"       Bilateral, extensor joint surfaces of extremities",
"      </td>",
"      <td>",
"       Nontender, soft to firm",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Periarticular dystrophic calcification",
"      </td>",
"      <td>",
"       Feet, elbow, other soft tissue",
"      </td>",
"      <td>",
"       Hard, linear, tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Heterotopic ossification",
"      </td>",
"      <td>",
"       Thigh, elbow",
"      </td>",
"      <td>",
"       Irregular, bony hard, tender",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Synovial cyst",
"      </td>",
"      <td>",
"       Hip, knee, elbow",
"      </td>",
"      <td>",
"       1 to 2 cm, tender, firm",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Cubital bursitis and antecubital cyst",
"      </td>",
"      <td>",
"       Antecubital and anteromedial border of elbow",
"      </td>",
"      <td>",
"       Soft to firm cystic swelling",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Xanthoma",
"      </td>",
"      <td>",
"       Over pressure points, extensor surfaces, or Achilles tendons",
"      </td>",
"      <td>",
"       Pinkish yellow papules; bilateral",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of nodular soft tissue masses-II",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Type of nodule",
"      </td>",
"      <td class=\"subtitle1\">",
"       Location",
"      </td>",
"      <td class=\"subtitle1\">",
"       Characteristic features",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\" colspan=\"3\">",
"       Inflammatory",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Nodular panniculitis (erythema induratum)",
"      </td>",
"      <td>",
"       Subcutaneous, lower limbs (calf), often bilateral",
"      </td>",
"      <td>",
"       Erythematous, warm, tender, may recur, may ulcerate",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Systemic nodular panniculitis (Weber-Christian disease)",
"      </td>",
"      <td>",
"       Multifocal widespread",
"      </td>",
"      <td>",
"       2 to 10 cm, painful, with late induration and deeply indented scars; often with fever, arthralgia, eosinophilia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Enzymatic panniculitis",
"      </td>",
"      <td>",
"       Any fatty tissue",
"      </td>",
"      <td>",
"       Erythematous, irregular, painful",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Lupus profundus",
"      </td>",
"      <td>",
"       Widespread in fatty tissues",
"      </td>",
"      <td>",
"       Scaly erythematous skin, often painful, may scar; other lupus features",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Erythema nodosum",
"      </td>",
"      <td>",
"       Bilateral forelegs, ankles",
"      </td>",
"      <td>",
"       Erythematous, may recur",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Polyarteritis nodosa",
"      </td>",
"      <td>",
"       Lower limbs, symmetrical",
"      </td>",
"      <td>",
"       Purpuric papules, occasionally urticarial, recur; fever, hypertension, mononeuritis multiplex",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\" colspan=\"3\">",
"       Infections",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Atypical mycobacteria",
"      </td>",
"      <td>",
"       Extremities, hands",
"      </td>",
"      <td>",
"       Localized group of papules or erythema nodosa-like",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Sporotrichosis",
"      </td>",
"      <td>",
"       Face, extremities",
"      </td>",
"      <td>",
"       Ulcerating red papule",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Treponemal",
"      </td>",
"      <td>",
"       Digits, face, nipples, extremities",
"      </td>",
"      <td>",
"       Ulcerating papules with regional lymphadenopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Meningococcus",
"      </td>",
"      <td>",
"       Multifocal widespread",
"      </td>",
"      <td>",
"       Petechial, purpuric, necrotic centers",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Gonococcus",
"      </td>",
"      <td>",
"       Extremities, fingers, toes",
"      </td>",
"      <td>",
"       Painful papules, pustules, bullae on erythematous base",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Hepatitis associated vasculitis",
"      </td>",
"      <td>",
"       Lower limbs, symmetrical",
"      </td>",
"      <td>",
"       Purpuric papules, occasionally urticarial, recur",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_50_10030=[""].join("\n");
var outline_f9_50_10030=null;
var title_f9_50_10031="Bronchoscopy specimen trap";
var content_f9_50_10031=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F64093&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F64093&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bronchoscopy specimen trap",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 336px; height: 249px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A specimen trap connected to the suction port of a flexible bronchoscope to collect bronchoalveolar lavage or washing fluid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_50_10031=[""].join("\n");
var outline_f9_50_10031=null;
